<SEC-DOCUMENT>0001104659-17-071866.txt : 20171205
<SEC-HEADER>0001104659-17-071866.hdr.sgml : 20171205
<ACCEPTANCE-DATETIME>20171205125440
ACCESSION NUMBER:		0001104659-17-071866
CONFORMED SUBMISSION TYPE:	N-CSR
PUBLIC DOCUMENT COUNT:		19
CONFORMED PERIOD OF REPORT:	20170930
FILED AS OF DATE:		20171205
DATE AS OF CHANGE:		20171205
EFFECTIVENESS DATE:		20171205

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			TEKLA LIFE SCIENCES INVESTORS
		CENTRAL INDEX KEY:			0000884121
		IRS NUMBER:				043147016
		STATE OF INCORPORATION:			MA
		FISCAL YEAR END:			0930

	FILING VALUES:
		FORM TYPE:		N-CSR
		SEC ACT:		1940 Act
		SEC FILE NUMBER:	811-06565
		FILM NUMBER:		171239168

	BUSINESS ADDRESS:	
		STREET 1:		100 FEDERAL STREET
		STREET 2:		19TH FLOOR
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02110
		BUSINESS PHONE:		6177728515

	MAIL ADDRESS:	
		STREET 1:		100 FEDERAL STREET
		STREET 2:		19TH FLOOR
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02110

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	H&Q LIFE SCIENCES INVESTORS
		DATE OF NAME CHANGE:	19920929
</SEC-HEADER>
<DOCUMENT>
<TYPE>N-CSR
<SEQUENCE>1
<FILENAME>a17-24477_1ncsr.htm
<DESCRIPTION>CERTIFIED ANNUAL SHAREHOLDER REPORT
<TEXT>


<html>
<head>






  </head>
<body link=blue lang="EN-US">
<div style="font-family:Times New Roman;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="24%" valign="top" style="padding:0in 0in 0in 0in;width:24.96%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="border:none;border-right:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:50.04%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="25%" colspan="2" valign="top" style="border:solid windowtext 1.0pt;border-left:none;padding:0in 0in 0in 0in;width:25.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="1" face="Times New Roman" style="font-size:8.0pt;">OMB   APPROVAL</font></p>    </td>   </tr>
<tr>
<td width="24%" valign="top" style="padding:0in 0in 0in 0in;width:24.96%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="border:none;border-right:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:50.04%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="top" style="border:none;padding:0in 0in 0in 0in;width:12.5%;">
<p style="margin:0in 0in .0001pt;"><font size="1" face="Times New Roman" style="font-size:8.0pt;">OMB Number:</font></p>    </td>
<td width="12%" valign="top" style="border:none;border-right:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:12.5%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="1" face="Times New Roman" style="font-size:8.0pt;">3235-0570</font></p>    </td>   </tr>
<tr>
<td width="24%" valign="top" style="padding:0in 0in 0in 0in;width:24.96%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="border:none;border-right:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:50.04%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="top" style="border:none;padding:0in 0in 0in 0in;width:12.5%;">
<p style="margin:0in 0in .0001pt;"><font size="1" face="Times New Roman" style="font-size:8.0pt;">Expires:</font></p>    </td>
<td width="12%" valign="top" style="border:none;border-right:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:12.5%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="1" face="Times New Roman" style="font-size:8.0pt;">August   31, 2020</font></p>    </td>   </tr>
<tr height="1" style="height:1.0pt;">
<td width="24%" height="1" valign="top" style="height:1.0pt;padding:0in 0in 0in 0in;width:24.96%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" height="1" valign="bottom" style="border:none;border-right:solid windowtext 1.0pt;height:1.0pt;padding:0in 0in 0in 0in;width:50.04%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="3" face="Times New Roman" style="font-size:12.0pt;">UNITED   STATES</font></p>    </td>
<td width="25%" colspan="2" height="1" valign="top" style="border-bottom:solid windowtext 1.0pt;border-left:none;border-right:solid windowtext 1.0pt;border-top:none;height:1.0pt;padding:0in 0in 0in 0in;width:25.0%;">
<p style="margin:0in 0in .0001pt;"><font size="1" face="Times New Roman" style="font-size:8.0pt;">Estimated average burden hours   per response. . . . . . . . . . . . . . .20.6</font></p>    </td>   </tr>
<tr height="1" style="height:1.0pt;">
<td width="24%" height="1" valign="top" style="height:1.0pt;padding:0in 0in 0in 0in;width:24.96%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" height="1" valign="top" style="height:1.0pt;padding:0in 0in 0in 0in;width:50.04%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="3" face="Times New Roman" style="font-size:12.0pt;">SECURITIES   AND EXCHANGE COMMISSION</font></p>    </td>
<td width="25%" colspan="2" height="1" valign="top" style="height:1.0pt;padding:0in 0in 0in 0in;width:25.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="24%" valign="top" style="padding:0in 0in 0in 0in;width:24.96%;">
<p align="center" style="margin:2.0pt 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.04%;">
<p align="center" style="margin:2.0pt 0in .0001pt;text-align:center;"><font size="3" face="Times New Roman" style="font-size:12.0pt;">Washington, D.C. 20549</font></p>    </td>
<td width="25%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:25.0%;">
<p align="center" style="margin:2.0pt 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>  </table>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="4" face="Times New Roman" style="font-size:14.0pt;font-weight:bold;">FORM N-CSR</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="3" face="Times New Roman" style="font-size:12.0pt;font-weight:bold;">CERTIFIED SHAREHOLDER REPORT OF REGISTERED<br> MANAGEMENT INVESTMENT COMPANIES</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="29%" colspan="3" valign="top" style="padding:0in 0in 0in 0in;width:29.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Investment Company Act file number</font></p>    </td>
<td width="70%" colspan="7" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:70.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">811-06565</font></p>    </td>   </tr>
<tr>
<td width="100%" colspan="10" valign="top" style="padding:0in 0in 0in 0in;width:100.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="100%" colspan="10" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:100.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Tekla Life Sciences Investors</font></p>    </td>   </tr>
<tr>
<td width="100%" colspan="10" valign="top" style="padding:0in 0in 0in 0in;width:100.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(Exact name of registrant as   specified in charter)</font></p>    </td>   </tr>
<tr>
<td width="100%" colspan="10" valign="top" style="padding:0in 0in 0in 0in;width:100.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="66%" colspan="8" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:66.0%;">
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">100 Federal Street, 19</font><font size="1" style="font-size:6.5pt;position:relative;top:-3.0pt;">th</font><font style="position:relative;top:-3.0pt;">&nbsp;</font>Floor,   Boston, MA</p>    </td>
<td width="2%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="32%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:32.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">02110</font></p>    </td>   </tr>
<tr>
<td width="66%" colspan="8" valign="top" style="padding:0in 0in 0in 0in;width:66.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(Address of principal executive   offices)</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="32%" valign="top" style="padding:0in 0in 0in 0in;width:32.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(Zip code)</font></p>    </td>   </tr>
<tr>
<td width="100%" colspan="10" valign="top" style="padding:0in 0in 0in 0in;width:100.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="100%" colspan="10" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:100.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Laura Woodward, Chief Compliance Officer   and Vice President of Fund Administration</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">100 Federal Street, 19</font><font size="1" style="font-size:6.5pt;position:relative;top:-3.0pt;">th</font>&nbsp;Floor, Boston, MA 02110</p>    </td>   </tr>
<tr>
<td width="100%" colspan="10" valign="top" style="padding:0in 0in 0in 0in;width:100.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(Name and address of agent for   service)</font></p>    </td>   </tr>
<tr>
<td width="100%" colspan="10" valign="top" style="padding:0in 0in 0in 0in;width:100.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="39%" colspan="5" valign="top" style="padding:0in 0in 0in 0in;width:39.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Registrant&#146;s telephone number, including   area code:</font></p>    </td>
<td width="22%" colspan="2" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:22.82%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">617-772-8500</font></p>    </td>
<td width="37%" colspan="3" valign="top" style="padding:0in 0in 0in 0in;width:37.34%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="100%" colspan="10" valign="top" style="padding:0in 0in 0in 0in;width:100.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="18%" valign="top" style="padding:0in 0in 0in 0in;width:18.08%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Date of fiscal year end:</font></p>    </td>
<td width="19%" colspan="3" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:19.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">September 30</font></p>    </td>
<td width="62%" colspan="6" valign="top" style="padding:0in 0in 0in 0in;width:62.92%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="100%" colspan="10" valign="top" style="padding:0in 0in 0in 0in;width:100.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="19%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:19.42%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Date of reporting period:</font></p>    </td>
<td width="31%" colspan="4" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:31.42%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">October 1,   2016 to September 30, 2017</font></p>    </td>
<td width="49%" colspan="4" valign="top" style="padding:0in 0in 0in 0in;width:49.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr height="0">
<td width="128" style="border:none;"></td>
<td width="10" style="border:none;"></td>
<td width="69" style="border:none;"></td>
<td width="56" style="border:none;"></td>
<td width="20" style="border:none;"></td>
<td width="78" style="border:none;"></td>
<td width="84" style="border:none;"></td>
<td width="24" style="border:none;"></td>
<td width="14" style="border:none;"></td>
<td width="227" style="border:none;"></td>   </tr> </table>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\109206\17-24477-1\task8658027\24477-1-be.htm',USER='109206',CD='Dec  3 04:02 2017' -->


<br clear="all" style="page-break-before:always;">
<div>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">ITEM 1. REPORTS TO STOCKHOLDERS.</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>
</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\106406\14-22610-1\task7089019\22610-1-bg.htm',USER='106406',CD='Nov 25 14:29 2014' -->


<br clear="all" style="page-break-before:always;">
<!-- Document name: 17-24477-2.aa-->
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:19pt;"><b>TEKLA LIFE SCIENCES INVESTORS</b></font></p>
</div>
<p style="margin:12pt 0pt 12pt 0pt;"><img src="j17244772_aa015.jpg"></p>
<p style="margin:12pt 0pt 12pt 0pt;"><img src="j17244772_aa016.jpg"></p>
<p style="margin:12pt 0pt 12pt 0pt;"><img src="j17244772_aa017.jpg"></p>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:30pt;"><b><i>Annual Report</i></b></font></p>
<p style="margin:11pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:13pt;">&nbsp;&nbsp;2&nbsp;&nbsp;0&nbsp;&nbsp;1&nbsp;&nbsp;7</font></p>
</div>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=1,FOLIO='',FILE='17-24477-2.aa',USER='bjonesc',CD='Nov 23 01:53 2017' -->
<br clear="all" style="page-break-before:always;">
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 6pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:19pt;"><b>TEKLA LIFE SCIENCES INVESTORS</b></font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Distribution policy:</b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"> The Fund has implemented a managed distribution policy (the Policy) that provides for quarterly distributions at a rate set by the Board of Trustees. Under the current Policy, the Fund intends to make quarterly distributions at a rate of 2% of the Fund's net assets to shareholders of record. The Policy would result in a return of capital to shareholders, if the amount of the distribution exceeds the Fund's net investment income and realized capital gains. A return of capital may occur, for example, when some or all of the money that you invested in the Fund is paid back to you. A return of capital distribution does not necessarily reflect the Fund's investment performance and should not be confused with "yield" or "income."</font></p>
<p style="margin:6pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">The amounts and sources of distributions reported in the Fund's notices pursuant to Section 19(a) of the Investment Company Act of 1940 are only estimates and are not being provided for tax reporting purposes. The actual amounts and sources of the amounts for tax reporting purposes will depend upon the Fund's investment experience during its fiscal year and may be subject to changes based on tax regulations. The Fund will send you a Form 1099-DIV for the calendar year that tells you how to report distributions for federal income tax purposes.</font></p>
<p style="margin:6pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">You should not draw any conclusions about the Fund's investment performance from the amount of distributions pursuant to the Policy or from the terms of the Policy. The Policy has been established by the Trustees and may be changed or terminated by them without shareholder approval. The Trustees regularly review the Policy and the frequency and rate of distributions considering the purpose and effect of the Policy, the financial market environment, and the Fund's income, capital gains and capital available to pay distributions. The suspension or termination of the Policy could have the effect of creating a trading discount or widening an existing trading discount. At this time there are no reasonably foreseeable circumstances that might cause the Trustees to terminate the Policy.</font></p>
<p style="margin:6pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Consider these risks before investing:</b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"> As with any investment company that invests in equity securities, the Fund is subject to market risk&#151;the possibility that the prices of equity securities will decline over short or extended periods of time. As a result, the value of an investment in the Fund's shares will fluctuate with the market generally and market sectors in particular. You could lose money over short or long periods of time. Political and economic news can influence market wide trends and can cause disruptions in the U.S. or world financial markets. Other factors may be ignored by the market as a whole but may cause movements in the price of one company's stock or the stock of companies in one or more industries. All of these factors may have a greater impact on initial public offerings and emerging company shares. Different types of equity securities tend to shift into and out of favor with investors, depending on market and economic conditions. The performance of funds that invest in equity securities of Healthcare Companies may at times be better or worse than the performance of funds that focus on other types of securities or that have a broader investment style.</font></p>
</div>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=2,FOLIO='',FILE='17-24477-2.aa',USER='bjonesc',CD='Nov 23 01:53 2017' -->
<br clear="all" style="page-break-before:always;">


<br clear="all" style="page-break-before:always;">
<!-- Document name: 17-24477-2.ba-->
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 6pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:19pt;"><b>TEKLA LIFE SCIENCES INVESTORS</b></font></p>
<p style="margin:9pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Dear Shareholders,</font></p>
<p style="margin:9pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">In the last ten to fifteen year period, the performance of the healthcare sector, and that of the biotechnology sub-sector in particular, has been impressive. Note in the following graph that both the S&amp;P Composite 1500<sup>&reg;</sup> Health Care Index* ("S15HLTH") and the NASDAQ Biotechnology Index<sup>&reg;</sup>* ("NBI") materially outperformed the broad S&amp;P 500<sup>&reg;</sup> Index* ("SPX") in the fifteen year period ending September 30, 2017.</font></p>
<p style="margin:2pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:11pt;"><b>Biotechnology, Healthcare, and S&amp;P 500 Performance<BR>2002 &#150; 2017</b></font></p>
<p style="margin:9pt 0pt 0pt 0pt;" align="center"><img src="j17244772_ba018.jpg">
</p>
<p style="margin:9pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">We believe that a consistent record of discovery, development and commercialization of new drugs and products that improve quality of life, address medical need and ultimately save lives is the basis for this performance. Nearly everyone has heard of the remarkable genetic engineering and related technologies that are the basis of these new medical products. Moreover, just about everyone we know has a friend or relative who has benefitted from these products and technologies. We think that the combination of accomplishment and positive sentiment has driven healthcare/biotech sector performance.</font></p>
<p style="margin:9pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">We also feel that, despite the long history of fundamental progress, angst over drug industry profitability in general, and over drug pricing in particular, has had a negative effect on sector sentiment as of late. These issues were front and center during the recently concluded presidential election cycle and have remained a controversial topic since then as Congress debated the potential repeal and/or replacement of Obamacare. In particular, we think that outrage over drug pricing, justified or (maybe) not, has hurt sentiment for the healthcare/biotech sector.</font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times"><br>1</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=3,FOLIO='1',FILE='17-24477-2.ba',USER='bjonesc',CD='Nov 23 01:53 2017' -->
<br clear="all" style="page-break-before:always;">
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Despite these challenges, recent sector performance has been quite positive. In fact, the broad SPX was up approximately 20% in calendar 2017 while the healthcare and biotech indices we track were up closer to 30%. As the quarter ended, we were quite upbeat.</font></p>
<p style="margin:9pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">However, third quarter 2017 healthcare/biotech sector company reports (made in the month or so after the September 30, 2017 end of the Fund's fiscal year) were mediocre overall, particularly for the large bellwether biotech and pharma companies. This has caused a pullback of approximately 10% in the healthcare sector. As of this writing in early November 2017, both the broad SPX and the healthcare and biotech indices are up approximately 20% in calendar 2017. Such a move in the markets in a ten-month period would always be welcome. However, given both the apparent sentiment and a weak quarter, we have taken a step back to review our thoughts on the healthcare/biotech sector.</font></p>
<p style="margin:9pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">More detail is provided later in this note, but in summary, we remain optimistic about the sector. Overall, we expect a continuation of the impressive innovation we have seen. In just the last few years, there have been remarkable developments in immuno-oncology, gene therapy and other areas. In addition, the FDA (while remaining formidable) appears to have become incrementally more accommodative. The IPO market continues to produce new public companies. Our aggregate view is that, in combination with the broad creation and funding of a new generation of public companies, this continued innovation will lead to the discovery and development of many new and novel medical products that will propel the healthcare and biotech sectors forward. We expect these newly formed companies to either be acquired by or to replace the current industry leaders forming the next generation of healthcare/biotech growth. Although we may see some volatility as this renewal process sorts itself out, this makes us optimistic about the medium- and<BR>long-term.</font></p>
<p style="margin:9pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">As always, we thank you for your consideration of the Tekla Funds. Please call us if you have any questions.</font></p>
<p style="margin:6pt 0pt 1pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Respectfully yours,</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="19" align="right" valign="top" style="padding:0pt .7pt 0pt 0pt;">
<img src="j17244772_ba019.jpg">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"> </font></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="8" align="left" valign="top" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><img src="j17244772_ba020.jpg">
</p></td>
<td colspan="1">&nbsp;</td>
</tr>
</table>

<p style="margin:0pt 0pt 0pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Daniel R. Omstead. Ph.D.<BR>President and Portfolio Manager</font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times"><br>2</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=4,FOLIO='2',FILE='17-24477-2.ba',USER='bjonesc',CD='Nov 23 01:53 2017' -->
<br clear="all" style="page-break-before:always;">
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><b>Perspective on the Biotechnology and Healthcare Sectors</b></font></p>
<p style="margin:0pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">For some time, Tekla has been positive about the long-term prospects for the healthcare/biotech sector. Over any reasonable multi-year timeframe, we are bullish. As we and others have noted, this sector continues to be a large portion of the US GDP. Healthcare spending is expected to reach 20% of the US economy within the next decade. While the sector comprises a smaller portion of the GDP of other countries, spending is considerable and expected to grow meaningfully in many developed countries. Furthermore, it is reported that overall US Medicare health spending is expected to grow at 5.8% for at least the next decade. In particular, prescription drug spending is expected to grow at 6.7% per year in this same timeframe. We think these projections make the sector attractive.</font></p>
<p style="margin:2pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><b>Actual and Projected Net Medicare Spending <BR>2010 &#150; 2027</b></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><img src="j17244772_ba021.jpg">
</p>
<p style="margin:3pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Long-term sector fundamentals are also attractive when we consider healthcare spending on an individual basis. As seen in the figure below and the citation above, the population of the largest countries is expected to age in the coming years. Since more is spent on healthcare as individuals get older, overall healthcare spending should grow. This suggests that, over the long-term, demand for healthcare products and services should continue to grow, likely at an attractive rate.</font></p>
<p style="margin:2pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><b>Population 65 to 84 and 85 Years and Over in the World's Four Largest Countries: 2012, 2030, and 2050</b></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><img src="j17244772_ba022.jpg">
</p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times"><br>3</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=5,FOLIO='3',FILE='17-24477-2.ba',USER='bjonesc',CD='Nov 23 01:53 2017' -->
<br clear="all" style="page-break-before:always;">
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">In the intermediate term, we see the continued creation of new and differentiated medical products that are safer and/or more efficacious than existing products and that address currently unmet medical needs in the US and non-US population. These products will be the basis for continued growth in the sector.</font></p>
<p style="margin:9pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">The creation of new and novel products depends on the advancement of science in key areas, the identification and clinical testing of newly discovered drugs, and the regulatory approval of such drugs. We see evidence of these accomplishments. The following three charts present favorable trends in the publication of new NIH papers, in the number of registered clinical trials and in the approval of new drugs. For additional data and information, visit fda.gov, clintrials.gov and i2.wp.com.</font></p>
<p style="margin:6pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:11pt;"><b>National Institute of Health (NIH) <BR>Funded Papers Per Year</b></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><img src="j17244772_ba023.jpg">
</p>
<p style="margin:6pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:11pt;"><b>Number of Registered Clinical Trials</b></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><img src="j17244772_ba024.jpg">
</p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times"><br>4</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=6,FOLIO='4',FILE='17-24477-2.ba',USER='bjonesc',CD='Nov 23 01:53 2017' -->
<br clear="all" style="page-break-before:always;">
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:11pt;"><b>New Molecular Entity (NME) and New Biologic License <BR>Application (BLA) Approvals by Calendar Year</b></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><img src="j17244772_ba025.jpg">
</p>
<p style="margin:9pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">These data suggest that the pipeline of new drugs should continue to grow over time. As previously reported, an entirely new generation of public companies has been created and funded in the last several years. For example, note that Bloomberg reports that since 2014, there have been 839 IPOs and follow-on financings which raised an aggregate of $49.21 billion.</font></p>
<p style="margin:9pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">In combination with existing corporations, this new generation of well-funded companies will sponsor the new and novel products we anticipate. We continue to see encouraging technological and clinical results. As an example, we point to the coming of age of cell, gene and RNAi therapies. These technologies have been in development for many years; each of these somewhat related approaches have accomplished major milestones. For example, we have seen the approval of an antisense product (Biogen's SPINRAZA<sup>TM</sup>) which treats an otherwise lethal pediatric condition called Spinal Muscular Atrophy, the approval of two T cell based therapies (Novartis AG's KYMRIAH<sup>TM</sup> and Gilead Sciences, Inc./Kite's Yescarta) that are remarkably effective in certain hematologic cancers, and clear proof of principle by an RNAi based product (Alnylam Pharmaceuticals, Inc.'s patisiran) in the treatment of a form of amyloidosis, and finally, a positive FDA panel recommendation for Spark Therapeutic's Luxturna to treat a rare genetic form of blindness.</font></p>
<p style="margin:9pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">These are just a few examples of the encouraging developments we are seeing. There are certainly many challenges to overcome but, in aggregate, these and other developments are an important part of our underlying optimism toward the healthcare/biotech sector.</font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times"><br>5</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=7,FOLIO='5',FILE='17-24477-2.ba',USER='bjonesc',CD='Nov 23 01:53 2017' -->
<br clear="all" style="page-break-before:always;">
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 6pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:19pt;"><b>TEKLA LIFE SCIENCES INVESTORS</b></font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:11pt;"><b>Fund Essentials</b></font></p>
<p style="margin:18pt 0pt 0pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><b>Objective of the Fund</b></font></p>
<p style="margin:3pt 0pt 0pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">The Fund's investment objective is to seek long-term capital appreciation by investing primarily in securities of Life Sciences companies.</font></p>
</div>
<div style="width:48%;float:left;margin-top:10pt;margin-right:3%">
<p style="margin:0pt 0pt 0pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><b>Description of the Fund</b></font></p>
<p style="margin:3pt 0pt 0pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Tekla Life Sciences Investors ("HQL") is a non-diversified closed-end healthcare fund traded on the New York Stock Exchange under the ticker HQL. HQL primarily invests in the life sciences industries and will emphasize the smaller, emerging companies with a maximum of 40% of the Fund's assets in restricted securities of both public and private companies.</font></p>
<p style="margin:6pt 0pt 0pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><b>Investment Philosophy</b></font></p>
<p style="margin:3pt 0pt 0pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Tekla Capital Management LLC, the Investment Adviser to the Fund, believes that:</font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">&bull;&nbsp;&nbsp;Aging demographics and adoption of new medical products and services can provide long-term tailwinds for healthcare companies</font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">&bull;&nbsp;&nbsp;Late stage biotechnology product pipeline could lead to significant increases in biotechnology sales</font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">&bull;&nbsp;&nbsp;Robust M&amp;A activity in healthcare may create additional investment opportunities</font></p>
</div>
<div style="width:48%;float:left;margin-top:10pt;margin-right:0%">
<p style="margin:0pt 0pt 3pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><b>Fund Overview and Characteristics</b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"> as of 9/30/17</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="3" width="103" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Market Price<sup>1</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>$</b></font></p></td>
<td colspan="1" width="65" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>21.48</b></font></p></td>
<td colspan="1" width="22" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="103" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">NAV<sup>2</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="20" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>$</b></font></p></td>
<td colspan="1" width="65" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>21.62</b></font></p></td>
<td colspan="1" width="22" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="103" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Premium/(Discount)</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="65" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>-0.65</b></font></p></td>
<td colspan="1" width="22" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>%</b></font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="103" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Average 30 Day Volume</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="65" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>47,299</b></font></p></td>
<td colspan="1" width="22" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="103" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Net Assets</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>$</b></font></p></td>
<td colspan="1" width="65" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>466,350,804</b></font></p></td>
<td colspan="1" width="22" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="103" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Ticker</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="0" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="107" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>HQL</b></font></p></td>
<td colspan="1" width="0" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="103" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">NAV Ticker</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="0" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="107" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>XHQLX</b></font></p></td>
<td colspan="1" width="0" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="103" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Commencement of<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Operations Date</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="0" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="107" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>5/8/92</b></font></p></td>
<td colspan="1" width="0" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="103" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Fiscal Year to Date<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Distributions<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Per Share</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>$</b></font></p></td>
<td colspan="1" width="65" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>1.59</b></font></p></td>
<td colspan="1" width="22" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
</table>

<p style="margin:3pt 0pt 0pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:6pt;"><i><sup>1</sup></i><i> The closing price at which the Fund's shares were traded on the exchange.</i></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:6pt;"><i><sup>2</sup></i><i> Per-share dollar value of the Fund, calculated by dividing the total value of all the securities in its portfolio, plus any other assets and less liabilities, by the number of Fund shares outstanding.</i></font></p>
</div>
<div style="clear:both"></div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><b>Holdings of the Fund</b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"> </font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><i>(Data is based on net assets)</i></font></p>
</div>
<div style="width:48%;float:left;margin-top:10pt;margin-right:3%">
<p style="margin:0pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Asset Allocation as of 9/30/17</font></p>
<p style="margin:0pt 0pt 0pt 0pt;"><img src="j17244772_ba026.jpg">
</p>
</div>
<div style="width:48%;float:left;margin-top:10pt;margin-right:0%">
<p style="margin:0pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Sub-Sector Allocation as of 9/30/17</font></p>
<p style="margin:0pt 0pt 0pt 0pt;"><img src="j17244772_ba027.jpg">
</p>
</div>
<div style="clear:both"></div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:6pt;">*Amount is less than 0.05%</font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;"><i>This data is subject to change on a daily basis.</i></font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times"><br>6</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=8,FOLIO='6',FILE='17-24477-2.ba',USER='bjonesc',CD='Nov 23 01:53 2017' -->
<br clear="all" style="page-break-before:always;">
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 6pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:19pt;"><b>TEKLA LIFE SCIENCES INVESTORS</b></font></p>
<p style="margin:2pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:11pt;"><b>Largest Holdings by Issuer</b></font></p>
<p style="margin:2pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>(Excludes Short-Term Investments)</b></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><i>As of September 30, 2017</i></font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="3" width="269" align="left" valign="bottom" style="padding:11pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Issuer &#150; </b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><i>Sector</i></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="80" align="center" valign="bottom" style="padding:11pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>% of Net<BR></b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Assets</b></font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="269" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>Gilead Sciences, Inc.</b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"> &#150; </font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><i>Biotechnology</i></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="49" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">8.8</font></p></td>
<td colspan="1" width="23" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">%</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="269" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>Celgene Corporation</b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"> &#150; </font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><i>Biotechnology </i></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="49" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">8.4</font></p></td>
<td colspan="1" width="23" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">%</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="269" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>Biogen Inc.</b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"> &#150; </font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><i>Biotechnology </i></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="49" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">7.9</font></p></td>
<td colspan="1" width="23" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">%</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="269" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>Vertex Pharmaceuticals Incorporated</b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"> &#150; </font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><i>Biotechnology </i></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="49" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">5.4</font></p></td>
<td colspan="1" width="23" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">%</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="269" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>Incyte Corporation</b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"> &#150; </font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><i>Biotechnology </i></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="49" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">4.9</font></p></td>
<td colspan="1" width="23" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">%</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="269" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>Alexion Pharmaceuticals, Inc.</b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"> &#150; </font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><i>Biotechnology </i></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="49" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">4.8</font></p></td>
<td colspan="1" width="23" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">%</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="269" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>Regeneron Pharmaceuticals, Inc.</b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"> &#150; </font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><i>Biotechnology </i></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="49" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">4.7</font></p></td>
<td colspan="1" width="23" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">%</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="269" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>Amgen Inc.</b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"> &#150; </font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><i>Biotechnology </i></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="49" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">4.6</font></p></td>
<td colspan="1" width="23" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">%</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="269" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>Illumina, Inc.</b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"> &#150; </font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><i>Life Sciences Tools &amp; Services</i></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="49" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">3.6</font></p></td>
<td colspan="1" width="23" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">%</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="269" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>BioMarin Pharmaceutical Inc.</b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"> &#150; </font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><i>Biotechnology </i></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="49" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">3.0</font></p></td>
<td colspan="1" width="23" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">%</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="269" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>SPDR S&amp;P Biotech ETF </b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">&#150; </font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><i>Exchanged Traded Fund</i></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="49" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">2.3</font></p></td>
<td colspan="1" width="23" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">%</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="269" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>IDEXX Laboratories, Inc.</b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"> &#150; </font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><i>Health Care Equipment &amp; Supplies</i></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="49" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">1.8</font></p></td>
<td colspan="1" width="23" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">%</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="269" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>Neurocrine Biosciences, Inc.</b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"> &#150; </font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><i>Biotechnology </i></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="49" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">1.8</font></p></td>
<td colspan="1" width="23" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">%</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="269" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>Jazz Pharmaceuticals plc</b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"> &#150; </font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><i>Pharmaceuticals </i></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="49" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">1.8</font></p></td>
<td colspan="1" width="23" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">%</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="269" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>Mylan NV</b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"> &#150; </font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><i>Pharmaceuticals </i></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="49" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">1.6</font></p></td>
<td colspan="1" width="23" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">%</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="269" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>Galapagos NV</b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"> &#150; </font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><i>Biotechnology </i></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="49" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">1.4</font></p></td>
<td colspan="1" width="23" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">%</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="269" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>Shire plc</b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"> &#150; </font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><i>Pharmaceuticals</i></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="49" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">1.4</font></p></td>
<td colspan="1" width="23" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">%</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="269" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>Pieris Pharmaceuticals, Inc.</b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"> &#150; </font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><i>Biotechnology </i></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="49" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">1.0</font></p></td>
<td colspan="1" width="23" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">%</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="269" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>Thermo Fisher Scientific Inc.</b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"> &#150; </font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><i>Life Sciences Tools &amp; Services</i></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="49" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">1.0</font></p></td>
<td colspan="1" width="23" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">%</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="269" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>Alnylam Pharmaceuticals, Inc.</b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"> &#150; </font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><i>Biotechnology </i></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="49" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">0.9</font></p></td>
<td colspan="1" width="23" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">%</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
</table>

<p style="margin:12pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><b>Fund Performance</b></font></p>
<p style="margin:9pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">HQL is a closed-end fund which invests predominantly in life science companies. Subject to regular consideration, the Trustees of HQL have instituted a policy of making quarterly distributions to shareholders. The Fund seeks to make such distributions in the form of long-term capital gains.</font></p>
<p style="margin:9pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">The Fund considers investments in companies of all sizes and in all life science subsectors, including but not limited to, biotechnology, pharmaceuticals, healthcare equipment, healthcare supplies, life science tools and services, healthcare distributors, managed healthcare, healthcare technology, and healthcare facilities. The Fund emphasizes innovation, investing both in public and pre-public venture companies. The Fund considers its venture investments to be a differentiating characteristic. Among the various healthcare subsectors, HQL has considered the </font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times"><br>7</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=9,FOLIO='7',FILE='17-24477-2.ba',USER='bjonesc',CD='Nov 23 01:53 2017' -->
<br clear="all" style="page-break-before:always;">
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">biotechnology subsector, including both pre-public and public companies, to be a key contributor to the healthcare sector. The Fund holds biotech assets, including both public and pre-public, often representing 65-75% of net assets.</font></p>
<p style="margin:9pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">There is no commonly published index which matches the investment strategy of HQL. The S15HLTH consists of more than 160 companies representing most or all of the healthcare subsectors in which HQL typically invests; biotechnology often represents 15-20% of this index. By contrast, the NBI, which contains approximately 160 securities, is much more narrowly constructed. The vast majority of this index is comprised of biotechnology, pharmaceutical and life science tools companies. In recent years, biotechnology has often represented 72-82% of the NBI. Neither the S15HLTH nor NBI indices contain any material amount of pre-public company assets.</font></p>
<p style="margin:9pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">We present both NAV and stock returns for the Fund in comparison to several commonly published indices. One index, the SPX, is a commonly considered broad based index comprised of companies in many areas of the economy, including, but not limited to healthcare. As described above, the NBI is a healthcare index mostly focused in three healthcare sectors with a uniquely high level of biotechnology comparison. The S15HLTH contains a wider representation of healthcare subsectors, but typically contains a much lower biotechnology composition.</font></p>
<p style="margin:9pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">HQL generally invests in a combination of large cap growth-oriented and earlier stage innovative healthcare companies with a focus on the biotechnology sector. Generally, HQL targets biotechnology exposure below that of the NBI and targets a higher biotechnology exposure than does the S15HLTH. We note that in recent periods, biotechnology has been a significant contributor to returns (both positive and negative) associated with those indices. We believe this sector continues to have significant potential for growth in the future.</font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times"><br>8</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=10,FOLIO='8',FILE='17-24477-2.ba',USER='bjonesc',CD='Nov 23 01:53 2017' -->
<br clear="all" style="page-break-before:always;">
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><img src="j17244772_ba028.jpg">
</p>
<p style="margin:0pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:6pt;"><i>All performance over one-year has been annualized.</i></font></p>
<p style="margin:0pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:6pt;"><i>Performance data quoted represents past performance, which is no guarantee of future results, and current performance may be lower or higher than the figures shown. The NAV total return takes into account the Fund's total annual expenses and does not reflect transaction charges. If transaction charges were reflected, NAV total return would be reduced. All distributions are assumed to be reinvested either in accordance with the dividend reinvestment plan (DRIP) for market price returns or NAV for NAV returns. The market price returns reflect the reinvestment at the closing market price on the last business day of the month.</i></font></p>
<p style="margin:12pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><b>Portfolio Highlights as of September 30, 2017</b></font></p>
<p style="margin:9pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Among other investments, HQL's performance benefitted in the past year by the following:</font></p>
<p style="margin:9pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><i>Incyte Corporation (INCY)</i></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"> is a large cap biopharmaceutical company that has outperformed based on progression of their lead immuno-oncology asset into pivotal phase III clinical studies earlier than expected. We look forward to seeing further clinical data at the American Society of Hematology (ASH) conference in December.</font></p>
<p style="margin:9pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><i>Pieris Pharmaceuticals, Inc. (PIRS).</i></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"> A global deal with Astra-Zeneca on the company's second asset has drawn the market's attention to Pieris Pharmaceuticals and the stock has performed well. The growing immuno-oncology pipeline based on their novel modular anticalin platform has advanced to the clinic and the market has begun to give it credit.</font></p>
<p style="margin:9pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><i>Galapagos NV (GLPG)</i></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"> a Belgium based biotech has potential best in class treatments for cystic fibrosis (partnered with Abbvie Inc.) and a JAK inhibitor for the treatment of Rheumatoid arthritis. GLPG also has a deep pipeline that is starting to generate interest in the stock beyond the JAKs and the CF programs, namely the wholly-owned IPF (idiopathic pulmonary fibrosis) program, and partnered OA (osteoarthritis) and atopic dermatitis programs. We continue to believe that the depth of GLPG's pipeline make it an attractive take-out target for 2018.</font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times"><br>9</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=11,FOLIO='9',FILE='17-24477-2.ba',USER='bjonesc',CD='Nov 23 01:53 2017' -->
<br clear="all" style="page-break-before:always;">
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Among other examples, HQL's performance was negatively impacted by the following:</font></p>
<p style="margin:9pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">The Fund was underweight in </font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><i>Kite Pharma, Inc. (KITE)</i></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"> a mid cap biopharmaceutical company. We have largely avoided the CAR T-cell platform companies that utilize a patient's own cells as product material except for selectively investing in particular clinical trial events. This has been due to concerns with competitive technologies that use more "off-the-shelf" products that could enter the market in the mid-term. For that reason, we did not have exposure to Kite Pharma when Gilead purchased them for a high multiple after a large run up in stock price.</font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:6pt;">*The trademarks NASDAQ Biotechnology Index<sup>&reg;</sup>, S&amp;P Composite 1500<sup>&reg;</sup> Healthcare Index, and S&amp;P 500<sup>&reg;</sup> Index referenced in this report are the property of their respective owners. These trademarks are not owned by or associated with the Fund or its service providers, including Tekla Capital Management LLC.</font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times"><br>10</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=12,FOLIO='10',FILE='17-24477-2.ba',USER='bjonesc',CD='Nov 23 01:53 2017' -->
<br clear="all" style="page-break-before:always;">


<br clear="all" style="page-break-before:always;">
<!-- Document name: 17-24477-2.ca-->
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 6pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:19pt;"><b>TEKLA LIFE SCIENCES INVESTORS</b></font></p>
<p style="margin:2pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:12pt;"><b>SCHEDULE OF INVESTMENTS</b></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:11pt;"><i>SEPTEMBER 30, 2017</i></font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="3" width="95" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>SHARES</b></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="252" align="center" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>CONVERTIBLE PREFERRED AND WARRANTS </b><b><sup>(a) (b)</sup></b><b> - <BR></b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>2.8% of Net Assets</b></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="108" align="center" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>VALUE</b></font></p></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="95" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="7" width="368" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><i>Biotechnology - 1.1%</i></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">1,400,000</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="252" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Amphivena Therapeutics, Inc. Series B <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">(Restricted)<sup> </sup></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">$</font></p></td>
<td colspan="1" width="67" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">2,100,000</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">1,153,847</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="252" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">BioClin Therapeutics, Inc. Series A (Restricted)<sup> </sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">750,001</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">445,633</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="252" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">BioClin Therapeutics, Inc. Series B (Restricted)<sup> </sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">333,333</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">2,568,939</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="252" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">EBI Life Sciences, Inc. Series A (Restricted)<sup> (c)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">13,102</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">933,333</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="252" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">GenomeDx Biosciences, Inc. Series C <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">(Restricted)<sup> </sup></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">1,400,000</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">90,000</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="252" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Trillium Therapeutics, Inc. Series II<sup> (d)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">463,500</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="7" width="355" valign="bottom" style="padding:2.5pt .7pt 2.5pt 0pt;">
&nbsp;</td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:2.5pt .7pt 2.5pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom" style="padding:2.5pt .7pt 2.5pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">5,059,936</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:2.5pt .7pt 2.5pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="252" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><i>Health Care Equipment &amp; Supplies <BR></i></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><i>(Restricted) - 0.8%</i></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="108" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">2,338,198</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="252" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">AlterG, Inc. Series C</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">865,133</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">79,330</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="252" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">CardioKinetix, Inc. Series C</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">0</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">142,574</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="252" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">CardioKinetix, Inc. Series D</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">0</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">439,333</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="252" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">CardioKinetix, Inc. Series E</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">0</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">481,378</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="252" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">CardioKinetix, Inc. Series F</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">0</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">N/A <sup>(e)</sup></font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="252" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">CardioKinetix, Inc. Warrants <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">(expiration 12/11/19)</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">0</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">N/A <sup>(e)</sup></font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="252" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">CardioKinetix, Inc. Warrants <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">(expiration 6/03/20)</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">0</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">8,822</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="252" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">CardioKinetix, Inc. Warrants <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">(expiration 8/15/24)</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">0</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">951,000</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="252" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">IlluminOss Medical, Inc. Series AA</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">0</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">895,848</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="252" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">IlluminOss Medical, Inc. Junior Preferred</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">0</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">71,324</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="252" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">IlluminOss Medical, Inc. Warrants <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">(expiration 3/31/27)</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">0</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">3,280,000</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="252" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Tibion Corporation Series B</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">0</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">N/A <sup>(e)</sup></font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="252" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Tibion Corporation Warrants <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">(expiration 10/30/17)</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">0</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">N/A <sup>(e)</sup></font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="252" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Tibion Corporation Warrants <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">(expiration 11/28/17)</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">0</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">2,606,033</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="252" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Veniti, Inc. Series A<sup> (c)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">1,563,620</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">1,307,169</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="252" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Veniti, Inc. Series B<sup> (c)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">823,516</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">716,720</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="252" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Veniti, Inc. Series C<sup> (c)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">530,373</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="7" width="355" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 2.5pt 0pt;">
&nbsp;</td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 2.5pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 2.5pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">3,782,642</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 2.5pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="95" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1">&nbsp;</td>
<td colspan="7" width="368" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><i>Life Sciences Tools &amp; Services (Restricted) - 0.7%</i></font></p></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">2,446,016</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="252" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Labcyte, Inc. Series C</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">3,081,980</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">107,178</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="252" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Labcyte, Inc. Series D</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">147,906</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">81,480</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="252" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Labcyte, Inc. Series E</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">131,183</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="7" width="355" valign="bottom" style="padding:2.5pt .7pt 2.5pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:2.5pt .7pt 2.5pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom" style="padding:2.5pt .7pt 2.5pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">3,361,069</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:2.5pt .7pt 2.5pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
</table>

</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times">The accompanying notes are an integral part of these financial statements.<br>11</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=13,FOLIO='11',FILE='17-24477-2.ca',USER='pvangb',CD='Nov 24 09:30 2017' -->
<br clear="all" style="page-break-before:always;">
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 6pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:19pt;"><b>TEKLA LIFE SCIENCES INVESTORS</b></font></p>
<p style="margin:2pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:12pt;"><b>SCHEDULE OF INVESTMENTS</b></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:11pt;"><i>SEPTEMBER 30, 2017</i></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">(continued)</font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="3" width="95" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>SHARES</b></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="252" align="center" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><i>Pharmaceuticals (Restricted) - 0.2%</i></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="108" align="center" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>VALUE</b></font></p></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">2,862,324</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="252" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Euthymics Biosciences, Inc. Series A<sup> (c)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">$</font></p></td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">0</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">659,244</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="252" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Milestone Pharmaceuticals, Inc. Series C<sup> (d)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">900,000</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="7" width="355" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 2.5pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 2.5pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 2.5pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">900,000</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 2.5pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt;">
&nbsp;</td>
<td colspan="1" width="66" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="252" align="left" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><b>TOTAL CONVERTIBLE PREFERRED <BR></b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><b>AND WARRANTS<BR></b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">(Cost $24,259,253)</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">13,103,647</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="95" align="left" valign="bottom" style="padding:12pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>PRINCIPAL<BR></b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>AMOUNT</b></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="252" align="center" valign="bottom" style="padding:12pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>CONVERTIBLE AND NON-CONVERTIBLE <BR></b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>NOTES - 0.0% of Net Assets</b></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="108" align="center" valign="bottom" style="padding:12pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b> <BR></b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b> </b></font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="95" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="7" width="368" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>Convertible Notes (Restricted)</b><b><sup> (a)</sup></b><b> - 0.0%</b></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="95" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1">&nbsp;</td>
<td colspan="7" width="368" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><i>Health Care Equipment &amp; Supplies - 0.0%</i></font></p></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">$</font></p></td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">12,336</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="252" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">AlterG, Inc. Promissory Note, <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">6.00%, due 9/8/18<sup> </sup></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">12,336</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">51,741</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="252" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">CardioKinetix, Inc. Promissory Note, <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">5.00%, due 7/31/18<sup> (b)</sup></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">0</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">285,294</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="252" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">IlluminOss Medical, Inc. Promissory Note, <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">8.00%, due 3/31/18</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">142,647</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="7" width="355" valign="bottom" style="padding:2.5pt .7pt 2.5pt 0pt;">
&nbsp;</td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:2.5pt .7pt 2.5pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom" style="padding:2.5pt .7pt 2.5pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">154,983</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:2.5pt .7pt 2.5pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="95" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="7" width="368" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><i>Pharmaceuticals - 0.0%</i></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">8,975</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="252" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Euthymics Biosciences, Inc. Promissory Note, <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">1.00%, due 5/31/18 <sup>(b) (c)</sup></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">0</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">26,924</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="252" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Euthymics Biosciences, Inc. Promissory Note, <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">8.00%, due 5/31/18<sup> (b) (c)</sup></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">0</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="7" width="355" valign="bottom" style="padding:2.5pt .7pt 2.5pt 0pt;">
&nbsp;</td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:2.5pt .7pt 2.5pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom" style="padding:2.5pt .7pt 2.5pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">0</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:2.5pt .7pt 2.5pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt;">
&nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="252" bgcolor="#cceeff" align="left" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><b>TOTAL CONVERTIBLE NOTES</b></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">154,983</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="95" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="252" align="center" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>Non-Convertible Notes (Restricted)</b><b><sup> (a) (b)</sup></b><b> - 0.0%</b></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="108" align="center" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="95" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1">&nbsp;</td>
<td colspan="7" width="368" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><i>Health Care Equipment &amp; Supplies - 0.0%</i></font></p></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">238,286</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="252" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Tibion Corporation Non-Cvt. Promissory Note, <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">0.00%, due 12/31/18<sup> </sup></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">0</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
&nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">28,211</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="252" align="left" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Tibion Corporation Non-Cvt. Promissory Note, <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">6.00%, due 4/17/18<sup> </sup></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 2pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom" style="padding:0pt .7pt 2pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">0</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 2pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt;">
&nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="252" bgcolor="#cceeff" align="left" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><b>TOTAL NON-CONVERTIBLE NOTES</b></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">0</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt;">
&nbsp;</td>
<td colspan="1" width="66" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="252" align="left" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><b>TOTAL CONVERTIBLE AND <BR></b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><b>NON-CONVERTIBLE NOTES<BR></b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">(Cost $652,085)</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">154,983</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
</table>

</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times">The accompanying notes are an integral part of these financial statements.<br>12</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=14,FOLIO='12',FILE='17-24477-2.ca',USER='pvangb',CD='Nov 24 09:30 2017' -->
<br clear="all" style="page-break-before:always;">
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 6pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:19pt;"><b>TEKLA LIFE SCIENCES INVESTORS</b></font></p>
<p style="margin:2pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:12pt;"><b>SCHEDULE OF INVESTMENTS</b></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:11pt;"><i>SEPTEMBER 30, 2017</i></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">(continued)</font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="3" width="95" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>SHARES</b></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="252" align="center" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>COMMON STOCKS AND WARRANTS - 92.0% <BR></b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>of Net Assets</b></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="108" align="center" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b><BR></b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>VALUE</b></font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="95" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="7" width="368" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><i>Biotechnology - 73.7%</i></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">12,686</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="252" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">AC Immune SA<sup> (b) (d)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">$</font></p></td>
<td colspan="1" width="67" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">143,352</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">616,000</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="252" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Achillion Pharmaceuticals, Inc.<sup> (b)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">2,765,840</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">396,500</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="252" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Adaptimmune Therapeutics plc<sup> (b) (f)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">3,247,335</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">93,025</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="252" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Adverum Biotechnologies, Inc.<sup> (b)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">339,541</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">159,699</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="252" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Alexion Pharmaceuticals, Inc.<sup> (b)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">22,404,173</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">34,026</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="252" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Alnylam Pharmaceuticals, Inc.<sup> (b)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">3,997,715</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">291,997</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="252" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Amarin Corporation plc<sup> (b) (f)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">1,021,989</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">115,532</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="252" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Amgen Inc.</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">21,540,941</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">160,730</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="252" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Amicus Therapeutics, Inc.<sup> (b)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">2,423,808</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">811,227</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="252" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">ARCA biopharma, Inc.<sup> (b) (c)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">892,350</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">324,491</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="252" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">ARCA biopharma, Inc. Warrants <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">(expiration 6/11/22)<sup> (a) (b) (c)</sup></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">32,449</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">320,135</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="252" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Ardelyx, Inc.<sup> (b)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">1,792,756</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">75,000</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="252" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Argenx SE<sup> (b) (f)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">1,683,000</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">10,000</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="252" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">AveXis, Inc.<sup> (b)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">967,300</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">60,000</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="252" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Bellicum Pharmaceuticals, Inc.<sup> (b)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">693,000</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">323,255</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="252" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">BioCryst Pharmaceuticals, Inc.<sup> (b)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">1,693,856</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">117,555</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="252" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Biogen Inc.<sup> (b)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">36,808,822</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">148,570</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="252" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">BioMarin Pharmaceutical Inc.<sup> (b)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">13,827,410</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">13,273</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="252" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">bluebird bio, Inc.<sup> (b)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">1,823,046</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">140,709</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="252" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Cascadian Therapeutics, Inc.<sup> (b)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">575,500</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">268,531</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="252" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Celgene Corporation<sup> (b)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">39,157,190</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">40,000</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="252" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Cellectis S.A.<sup> (b) (f)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">1,138,000</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">286,472</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="252" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Cidara Therapeutics, Inc.<sup> (b)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">2,320,423</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">22,800</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="252" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Clovis Oncology, Inc.<sup> (b)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">1,878,720</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">159,027</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="252" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">CytomX Therapeutics, Inc.<sup> (b)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">2,889,521</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">117,799</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="252" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Dermira, Inc.<sup> (b)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">3,180,573</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">9,619</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="252" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Eiger BioPharmaceuticals, Inc.<sup> (b)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">105,809</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">329</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="252" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Eiger BioPharmaceuticals, Inc. Warrants <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">(expiration 10/10/18)<sup> (a) (b)</sup></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">0</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">135,250</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="252" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Epizyme, Inc.<sup> (b)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">2,576,512</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">115,874</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="252" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Exelixis, Inc.<sup> (b)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">2,807,627</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">46,000</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="252" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Galapagos NV<sup> (b) (d)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">4,685,928</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">19,000</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="252" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Galapagos NV<sup> (b) (f)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">1,933,250</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">506,120</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="252" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Gilead Sciences, Inc.</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">41,005,842</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">62,500</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="252" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Global Blood Therapeutics, Inc.<sup> (b)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">1,940,625</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">195,822</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="252" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Incyte Corporation<sup> (b)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">22,860,260</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">74,612</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="252" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Innoviva, Inc.<sup> (b)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">1,053,521</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">37,600</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="252" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Intercept Pharmaceuticals, Inc.<sup> (b)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">2,182,304</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">256,355</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="252" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Karyopharm Therapeutics Inc.<sup> (b)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">2,814,778</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">142,583</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="252" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Merus B.V.<sup> (b) (d)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">2,833,124</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
</table>

</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times">The accompanying notes are an integral part of these financial statements.<br>13</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=15,FOLIO='13',FILE='17-24477-2.ca',USER='pvangb',CD='Nov 24 09:30 2017' -->
<br clear="all" style="page-break-before:always;">
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 6pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:19pt;"><b>TEKLA LIFE SCIENCES INVESTORS</b></font></p>
<p style="margin:2pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:12pt;"><b>SCHEDULE OF INVESTMENTS</b></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:11pt;"><i>SEPTEMBER 30, 2017</i></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">(continued)</font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="3" width="95" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>SHARES</b></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="252" align="center" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><i>Biotechnology - continued</i></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="108" align="center" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>VALUE</b></font></p></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">152,900</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="252" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Momenta Pharmaceuticals, Inc.<sup> (b)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">$</font></p></td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">2,828,650</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">120,000</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="252" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Myovant Sciences Ltd.<sup> (b)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">1,856,400</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">91,321</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="252" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Natera, Inc.<sup> (b)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">1,177,128</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">139,631</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="252" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Neurocrine Biosciences, Inc.<sup> (b)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">8,556,588</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">358,000</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="252" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Novavax, Inc.<sup> (b)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">408,120</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">48,761</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="252" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Ovid Therapeutics Inc.<sup> (b)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">417,882</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">111,986</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="252" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Ovid Therapeutics Inc. (Restricted)<sup> (a) (b)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">863,748</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">829,191</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="252" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Pieris Pharmaceuticals, Inc.<sup> (b)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">4,776,140</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">23,821</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="252" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Pieris Pharmaceuticals, Inc., <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Series A Warrants (expiration 6/8/21)<sup> (a) (b)</sup></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">68,128</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">11,911</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="252" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Pieris Pharmaceuticals, Inc., <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Series B Warrants (expiration 6/8/21)<sup> (a) (b)</sup></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">39,902</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">2,425</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="252" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Protagonist Therapeutics, Inc.<sup> (b)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">42,850</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">119,945</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="252" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Ra Pharmaceuticals, Inc.<sup> (b)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">1,751,197</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">49,382</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="252" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Regeneron Pharmaceuticals, Inc.<sup> (b)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">22,079,680</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">68,850</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="252" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Sarepta Therapeutics, Inc.<sup> (b)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">3,123,036</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">67,110</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="252" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Seattle Genetics, Inc.<sup> (b)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">3,651,455</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">24,300</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="252" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Spark Therapeutics, Inc.<sup> (b)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">2,166,588</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">200,000</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="252" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Syndax Pharmaceuticals, Inc.<sup> (b)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">2,340,000</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">17,577</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="252" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">TESARO, Inc.<sup> (b)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">2,269,191</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">150,000</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="252" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Trillium Therapeutics Inc.<sup> (b) (d)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">772,500</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">45,639</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="252" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Ultragenyx Pharmaceutical Inc.<sup> (b)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">2,430,733</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">164,327</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="252" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Vertex Pharmaceuticals Incorporated<sup> (b)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">24,984,277</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">20,000</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="252" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Xencor, Inc.<sup> (b)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">458,400</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">233,331</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="252" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Xenon Pharmaceuticals Inc.<sup> (b)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">688,326</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">13,307</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="252" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Zafgen, Inc.<sup> (b)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">46,841</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="7" width="355" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 2.5pt 0pt;">
&nbsp;</td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 2.5pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 2.5pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">343,835,950</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 2.5pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="95" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1">&nbsp;</td>
<td colspan="7" width="368" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><i>Health Care Equipment &amp; Supplies - 4.4%</i></font></p></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">495,000</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="252" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Alliqua BioMedical, Inc.<sup> (b)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">180,724</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">130,000</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="252" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Cercacor Laboratories, Inc. (Restricted)<sup> (a) (b)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">284,302</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">209,962</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="252" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">CymaBay Therapeutics, Inc.<sup> (b)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">1,692,294</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">294,749</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="252" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">GenMark Diagnostics, Inc.<sup> (b)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">2,838,433</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">63,707</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="252" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Glaukos Corporation<sup> (b)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">2,102,331</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">55,158</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="252" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">IDEXX Laboratories, Inc.<sup> (b)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">8,576,517</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">23,012</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="252" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Nevro Corp.<sup> (b)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">2,091,331</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">48,299</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="252" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">NuVasive, Inc.<sup> (b)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">2,678,663</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">36,847</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="252" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Quotient Limited<sup> (b)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">181,656</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">7,157</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="252" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">TherOx, Inc. (Restricted)<sup> (a) (b)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">143</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="7" width="355" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 2.5pt 0pt;">
&nbsp;</td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 2.5pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 2.5pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">20,626,394</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 2.5pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="95" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1">&nbsp;</td>
<td colspan="7" width="368" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><i>Health Care Providers &amp; Services - 0.1%</i></font></p></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
&nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">148,148</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="252" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">InnovaCare Health, Inc. (Restricted)<sup> (a) (b) (g)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 2pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 2pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">322,963</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 2pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
</table>

</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times">The accompanying notes are an integral part of these financial statements.<br>14</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=16,FOLIO='14',FILE='17-24477-2.ca',USER='pvangb',CD='Nov 24 09:30 2017' -->
<br clear="all" style="page-break-before:always;">
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 6pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:19pt;"><b>TEKLA LIFE SCIENCES INVESTORS</b></font></p>
<p style="margin:2pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:12pt;"><b>SCHEDULE OF INVESTMENTS</b></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:11pt;"><i>SEPTEMBER 30, 2017</i></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">(continued)</font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="3" width="95" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>SHARES</b></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="252" align="center" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><i>Life Sciences Tools &amp; Services - 5.7%</i></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="108" align="center" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>VALUE</b></font></p></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">150,000</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="252" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Accelerate Diagnostics, Inc.<sup> (b)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">$</font></p></td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">3,367,500</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">84,774</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="252" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Illumina, Inc.<sup> (b)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">16,886,981</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">113,500</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="252" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">NanoString Technologies, Inc.<sup> (b)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">1,834,160</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">24,400</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="252" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Thermo Fisher Scientific Inc.</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">4,616,480</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="7" width="355" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 2.5pt 0pt;">
&nbsp;</td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 2.5pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 2.5pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">26,705,121</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 2.5pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="95" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1">&nbsp;</td>
<td colspan="7" width="368" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><i>Pharmaceuticals - 8.1%</i></font></p></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">56,011</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="252" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Acceleron Pharma Inc.<sup> (b)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">2,090,330</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">17,547</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="252" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Allergan plc</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">3,596,258</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">232,351</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="252" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Auris Medical Holding AG<sup> (b) (d)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">190,528</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">233,000</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="252" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Avadel Pharmaceuticals plc<sup> (b) (f)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">2,446,500</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">29,100</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="252" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Endo International plc<sup> (b)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">249,241</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">124,140</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="252" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Foamix Pharmaceuticals Ltd.<sup> (b) (d)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">688,977</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">35,949</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="252" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Impax Laboratories, Inc.<sup> (b)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">729,765</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">57,022</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="252" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Jazz Pharmaceuticals plc<sup> (b)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">8,339,467</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">231,280</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="252" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Mylan NV<sup> (b)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">7,255,254</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">42,015</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="252" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Shire plc<sup> (f)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">6,434,177</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">284,378</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="252" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Tetraphase Pharmaceuticals, Inc.<sup> (b)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">1,945,146</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">115,500</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="252" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Verona Pharma plc<sup> (b) (f)</sup></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">1,772,925</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">929,053</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="252" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Verona Pharma plc (Restricted)<sup> (b) (d)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">1,568,612</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">371,622</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="252" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Verona Pharma plc, warrants <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">(expiration 4/27/22)<sup> (a) (b) (d)</sup></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">138,636</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="7" width="355" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 2.5pt 0pt;">
&nbsp;</td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 2.5pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 2.5pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">37,445,816</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 2.5pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt;">
&nbsp;</td>
<td colspan="1" width="66" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="252" align="left" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><b>TOTAL COMMON STOCKS AND WARRANTS<BR></b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">(Cost $278,038,448)</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">428,936,244</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="95" bgcolor="#cceeff" valign="bottom" style="padding:12pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="7" width="368" bgcolor="#cceeff" align="left" valign="bottom" style="padding:12pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>EXCHANGE TRADED FUND - 2.2% of Net Assets</b></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
&nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">121,460</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="252" align="left" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">SPDR S&amp;P Biotech ETF</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 2pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom" style="padding:0pt .7pt 2pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">10,514,792</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 2pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt;">
&nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="252" bgcolor="#cceeff" align="left" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><b>TOTAL EXCHANGE TRADED FUND<BR></b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">(Cost $8,564,136)</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">10,514,792</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
</table>

</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times">The accompanying notes are an integral part of these financial statements.<br>15</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=17,FOLIO='15',FILE='17-24477-2.ca',USER='pvangb',CD='Nov 24 09:30 2017' -->
<br clear="all" style="page-break-before:always;">
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 6pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:19pt;"><b>TEKLA LIFE SCIENCES INVESTORS</b></font></p>
<p style="margin:2pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:12pt;"><b>SCHEDULE OF INVESTMENTS</b></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:11pt;"><i>SEPTEMBER 30, 2017</i></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">(continued)</font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="3" width="95" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>PRINCIPAL<BR></b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>AMOUNT</b></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="252" align="center" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>SHORT-TERM INVESTMENT - 2.1% of<BR></b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>Net Assets</b></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="108" align="center" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>VALUE</b></font></p></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">$</font></p></td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">9,609,000</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="252" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Repurchase Agreement, Fixed Income Clearing <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Corp., repurchase value $9,609,000, 0.12%, <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">dated 09/29/17, due 10/02/17 (collateralized <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">by U.S. Treasury Note 1.50%, due 8/15/26, <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">market value $9,804,037)</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 2pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">$</font></p></td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 2pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">9,609,000</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 2pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt;">
&nbsp;</td>
<td colspan="1" width="66" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="252" align="left" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><b>TOTAL SHORT-TERM INVESTMENT<BR></b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">(Cost $9,609,000)</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">9,609,000</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt;">
&nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="252" bgcolor="#cceeff" align="left" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><b>TOTAL INVESTMENTS BEFORE <BR></b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><b>MILESTONE INTERESTS - 99.1%<BR></b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">(Cost $321,122,922)</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">462,318,666</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="95" align="left" valign="bottom" style="padding:12pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>INTEREST</b></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="252" align="center" valign="bottom" style="padding:12pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>MILESTONE INTERESTS (Restricted)</b><b><sup> (a) (b)</sup></b><b> - 1.0% <BR></b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b>of Net Assets</b></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="108" align="center" valign="bottom" style="padding:12pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b> <BR></b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;"><b> </b></font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="95" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1">&nbsp;</td>
<td colspan="7" width="368" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><i>Pharmaceuticals - 1.0%</i></font></p></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">1</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="252" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Afferent Milestone Interest</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">1,116,688</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="66" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">1</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="252" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Neurovance Milestone Interest</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">3,406,861</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
&nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">1</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="252" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">TargeGen Milestone Interest</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 2pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 2pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">137,447</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 2pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt;">
&nbsp;</td>
<td colspan="1" width="66" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="252" align="left" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><b>TOTAL MILESTONE INTERESTS<BR></b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">(Cost $7,503,366)</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">4,660,996</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt;">
&nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="252" bgcolor="#cceeff" align="left" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><b>TOTAL INVESTMENTS - 100.1%<BR></b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">(Cost $328,626,288)</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">466,979,662</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt;">
&nbsp;</td>
<td colspan="1" width="66" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="252" align="left" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><b>OTHER LIABILITIES IN EXCESS <BR></b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><b>OF ASSETS - (0.1)%</b></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">(628,858</font></p></td>
<td colspan="1" width="20" align="left" valign="bottom" style="padding:3pt .7pt 2.5pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">)</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="66" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="252" bgcolor="#cceeff" align="left" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><b>NET ASSETS - 100%</b></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" align="right" valign="bottom" style="padding:3pt .7pt 0pt 0pt; border:none; border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">$</font></p></td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom" style="padding:3pt .7pt 0pt 0pt; border:none; border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">466,350,804</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt; border:none; border-bottom:double windowtext 2.25pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
</table>

<p style="margin:22pt 0pt 0pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">(a)&nbsp;&nbsp;Security fair valued. See Investment Valuation and Fair Value Measurements.</font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">(b)&nbsp;&nbsp;Non-income producing security.</font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">(c)&nbsp;&nbsp;Affiliated issuers in which the Fund holds 5% or more of the voting securities (total market value of $3,855,410).</font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">(d)&nbsp;&nbsp;Foreign security.</font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">(e)&nbsp;&nbsp;Number of warrants to be determined at a future date.</font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">(f)&nbsp;&nbsp;American Depository Receipt</font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">(g)&nbsp;&nbsp;Security exempt from registration under Rule 144A of the Securities Act of 1933, as amended. These securities may be resold in transactions exempt from registration, normally to qualified institutional buyers.</font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times">The accompanying notes are an integral part of these financial statements.<br>16</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=18,FOLIO='16',FILE='17-24477-2.ca',USER='pvangb',CD='Nov 24 09:22 2017' -->
<br clear="all" style="page-break-before:always;">


<br clear="all" style="page-break-before:always;">
<!-- Document name: 17-24477-2.da-->
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 6pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:19pt;"><b>TEKLA LIFE SCIENCES INVESTORS</b></font></p>
<p style="margin:2pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:12pt;"><b>STATEMENT OF ASSETS AND LIABILITIES</b></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:11pt;"><i>SEPTEMBER 30, 2017</i></font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="7" width="363" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">ASSETS:</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="255" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Investments in unaffiliated issuers, at value <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">(cost $309,136,225)</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">$</font></p></td>
<td colspan="1" width="67" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">458,463,256</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="255" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Investments in affiliated issuers, at value <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">(cost $11,986,697)</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">3,855,410</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="255" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Milestone interests, at value <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">(cost $7,503,366)</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">4,660,996</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="255" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Total investments</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">466,979,662</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="255" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Cash</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">615,306</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="255" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Dividends and interest receivable</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">18,129</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="255" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Prepaid expenses</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">25,398</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="255" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Other assets (see Note 1)</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">693,984</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="255" align="left" valign="bottom" style="padding:2pt .7pt 2pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Total assets</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:2pt .7pt 2pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom" style="padding:2pt .7pt 2pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">468,332,479</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:2pt .7pt 2pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="7" width="363" bgcolor="#cceeff" align="left" valign="bottom" style="padding:6pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">LIABILITIES:</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="255" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Payable for investments purchased</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">1,310,395</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="255" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Accrued advisory fee</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">380,052</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="255" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Accrued investor support service fees</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">18,906</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="255" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Accrued shareholder reporting fees</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">86,613</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="255" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Accrued trustee fees</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">94</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="255" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Accrued other</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">185,615</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="255" align="left" valign="bottom" style="padding:2pt .7pt 2pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Total liabilities</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:2pt .7pt 2pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom" style="padding:2pt .7pt 2pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">1,981,675</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:2pt .7pt 2pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="7" width="363" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Commitments and Contingencies (see Note 1)</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="255" align="left" valign="bottom" style="padding:9pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">NET ASSETS</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" align="right" valign="bottom" style="padding:9pt .7pt 0pt 0pt; border:none; border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">$</font></p></td>
<td colspan="1" width="67" align="right" valign="bottom" style="padding:9pt .7pt 0pt 0pt; border:none; border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">466,350,804</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:9pt .7pt 0pt 0pt; border:none; border-bottom:double windowtext 2.25pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="7" width="363" bgcolor="#cceeff" align="left" valign="bottom" style="padding:6pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">SOURCES OF NET ASSETS:</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="255" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Shares of beneficial interest, par value $.01 per share, <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">unlimited number of shares authorized, amount paid<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">in on 21,572,492 shares issued and outstanding</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">$</font></p></td>
<td colspan="1" width="67" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">317,621,178</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="255" bgcolor="#cceeff" align="left" valign="bottom" style="padding:5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Accumulated net investment loss</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom" style="padding:5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">(22,500</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" align="left" valign="bottom" style="padding:5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">)</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="255" align="left" valign="bottom" style="padding:5pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Accumulated net realized gain on investments <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">and milestone interests</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom" style="padding:5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">10,398,752</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="255" bgcolor="#cceeff" align="left" valign="bottom" style="padding:5pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Net unrealized gain on investments and <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">milestone interests</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom" style="padding:5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">138,353,374</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="255" align="left" valign="bottom" style="padding:8pt .7pt 2pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Total net assets (equivalent to $21.62 per share <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">based on 21,572,492 shares outstanding)</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" align="right" valign="bottom" style="padding:8pt .7pt 2pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">$</font></p></td>
<td colspan="1" width="67" align="right" valign="bottom" style="padding:8pt .7pt 2pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">466,350,804</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:8pt .7pt 2pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
</table>

</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times">The accompanying notes are an integral part of these financial statements.<br>17</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=19,FOLIO='17',FILE='17-24477-2.da',USER='pvangb',CD='Nov 24 09:17 2017' -->
<br clear="all" style="page-break-before:always;">
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 6pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:19pt;"><b>TEKLA LIFE SCIENCES INVESTORS</b></font></p>
<p style="margin:2pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:12pt;"><b>STATEMENT OF OPERATIONS</b></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:11pt;"><i>YEAR ENDED SEPTEMBER 30, 2017</i></font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="7" width="363" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">INVESTMENT INCOME:</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="255" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Dividend income</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">$</font></p></td>
<td colspan="1" width="67" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">1,591,609</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="255" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Interest and other income</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">90,555</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="255" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Total investment income</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">1,682,164</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="7" width="363" bgcolor="#cceeff" align="left" valign="bottom" style="padding:8pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">EXPENSES:</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="255" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Advisory fees</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">4,305,299</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="255" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Shareholder reporting</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">232,760</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="255" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Investor support service fees</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">211,050</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="255" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Legal fees</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">201,202</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="255" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Trustees' fees and expenses</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">132,804</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="255" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Custodian fees</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">118,159</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="255" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Auditing fees</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">99,500</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="255" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Administration fees</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">87,802</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="255" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Transfer agent fees</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">53,075</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="255" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Other (see Note 2)</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">119,284</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="255" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Total expenses</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">5,560,935</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="255" bgcolor="#cceeff" align="left" valign="bottom" style="padding:10pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Net investment loss</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:10pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom" style="padding:10pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">(3,878,771</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" align="left" valign="bottom" style="padding:10pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">)</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="7" width="363" align="left" valign="bottom" style="padding:8pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">REALIZED AND UNREALIZED GAIN (LOSS):</font></p></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="7" width="363" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Net realized gain (loss) on:</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="255" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Investments in unaffiliated issuers</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">45,514,098</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="255" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Investments in affiliated issuers</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">(209,139</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">)</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="255" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Net realized gain</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">45,304,959</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="7" width="363" bgcolor="#cceeff" align="left" valign="bottom" style="padding:8pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Change in unrealized appreciation (depreciation)</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="255" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Investments in unaffiliated issuers</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">24,157,492</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="255" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Investments in affiliated issuers</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">2,852,004</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="255" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Milestone interests</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">119,993</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="255" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Change in unrealized appreciation (depreciation)</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">27,129,489</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="255" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Net realized and unrealized gain (loss)</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="21" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="67" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">72,434,448</font></p></td>
<td colspan="1" width="20" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="255" bgcolor="#cceeff" align="left" valign="bottom" style="padding:8pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Net increase in net assets resulting<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">from operations</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="21" bgcolor="#cceeff" align="right" valign="bottom" style="padding:8pt .7pt 0pt 0pt; border:none; border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">$</font></p></td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="bottom" style="padding:8pt .7pt 0pt 0pt; border:none; border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">68,555,677</font></p></td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:8pt .7pt 0pt 0pt; border:none; border-bottom:double windowtext 2.25pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
</table>

</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times">The accompanying notes are an integral part of these financial statements.<br>18</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=20,FOLIO='18',FILE='17-24477-2.da',USER='pvangb',CD='Nov 24 09:17 2017' -->
<br clear="all" style="page-break-before:always;">
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 6pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:19pt;"><b>TEKLA LIFE SCIENCES INVESTORS</b></font></p>
<p style="margin:2pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:12pt;"><b>STATEMENTS OF CHANGES IN NET ASSETS</b></font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="3" width="190" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="137" align="center" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Year ended<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">September 30, <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">2017</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="134" align="center" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">Year ended<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">September 30,<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">2016</font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="11" width="469" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">NET INCREASE (DECREASE) IN <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">NET ASSETS RESULTING FROM<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">OPERATIONS:</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="190" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Net investment loss</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="25" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">($</font></p></td>
<td colspan="1" width="76" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">3,878,771</font></p></td>
<td colspan="1" width="36" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">)</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="25" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">($</font></p></td>
<td colspan="1" width="73" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">3,790,651</font></p></td>
<td colspan="1" width="36" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">)</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="190" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Net realized gain</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="25" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="76" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">45,304,959</font></p></td>
<td colspan="1" width="36" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="25" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="73" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">4,851,698</font></p></td>
<td colspan="1" width="36" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="190" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Change in net unrealized appreciation <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">(depreciation)</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="25" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="76" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">27,129,489</font></p></td>
<td colspan="1" width="36" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="25" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="73" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">(12,972,671</font></p></td>
<td colspan="1" width="36" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">)</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="190" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Net increase (decrease) in net <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">assets resulting from operations</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="25" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="76" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">68,555,677</font></p></td>
<td colspan="1" width="36" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="25" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="73" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">(11,911,624</font></p></td>
<td colspan="1" width="36" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">)</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="11" width="469" align="left" valign="bottom" style="padding:7pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">DISTRIBUTIONS TO SHAREHOLDERS <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">FROM:</font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="190" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Net realized capital gains</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="25" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="76" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">(33,490,625</font></p></td>
<td colspan="1" width="36" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">)</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="25" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="73" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">(56,868,411</font></p></td>
<td colspan="1" width="36" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">)</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="190" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Total distributions</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="25" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="76" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">(33,490,625</font></p></td>
<td colspan="1" width="36" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">)</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="25" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="73" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">(56,868,411</font></p></td>
<td colspan="1" width="36" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">)</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="11" width="469" bgcolor="#cceeff" align="left" valign="bottom" style="padding:7pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">CAPITAL SHARE TRANSACTIONS:</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="190" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Reinvestment of distributions <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">(853,189 and 1,057,106 shares, <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">respectively)</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="25" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="76" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">16,719,637</font></p></td>
<td colspan="1" width="36" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="25" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="73" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">20,912,776</font></p></td>
<td colspan="1" width="36" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="190" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Fund shares repurchased (24,167<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">and 0 shares, respectively) <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">(see Note 1)</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="25" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="76" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">(406,764</font></p></td>
<td colspan="1" width="36" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">)</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="25" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="73" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">&#151;</font></p></td>
<td colspan="1" width="36" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="190" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Total capital share transactions</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="25" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="76" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">16,312,873</font></p></td>
<td colspan="1" width="36" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="25" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="73" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">20,912,776</font></p></td>
<td colspan="1" width="36" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="190" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Net increase (decrease) in net <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">assets</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="25" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="76" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">51,377,925</font></p></td>
<td colspan="1" width="36" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="25" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="73" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">(47,867,259</font></p></td>
<td colspan="1" width="36" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">)</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="11" width="469" align="left" valign="bottom" style="padding:7pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">NET ASSETS:</font></p></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="190" bgcolor="#cceeff" align="left" valign="bottom" style="padding:6pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Beginning of year</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="25" bgcolor="#cceeff" valign="bottom" style="padding:6pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="76" bgcolor="#cceeff" align="right" valign="bottom" style="padding:6pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">414,972,879</font></p></td>
<td colspan="1" width="36" bgcolor="#cceeff" valign="bottom" style="padding:6pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="25" bgcolor="#cceeff" valign="bottom" style="padding:6pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="73" bgcolor="#cceeff" align="right" valign="bottom" style="padding:6pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">462,840,138</font></p></td>
<td colspan="1" width="36" bgcolor="#cceeff" valign="bottom" style="padding:6pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="190" align="left" valign="bottom" style="padding:5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">End of year</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="25" align="right" valign="bottom" style="padding:5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">$</font></p></td>
<td colspan="1" width="76" align="right" valign="bottom" style="padding:5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">466,350,804</font></p></td>
<td colspan="1" width="36" valign="bottom" style="padding:5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="25" align="right" valign="bottom" style="padding:5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">$</font></p></td>
<td colspan="1" width="73" align="right" valign="bottom" style="padding:5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">414,972,879</font></p></td>
<td colspan="1" width="36" valign="bottom" style="padding:5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="190" bgcolor="#cceeff" align="left" valign="bottom" style="padding:1pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Accumulated net investment loss <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">included in net assets at end of year</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="25" bgcolor="#cceeff" align="right" valign="bottom" style="padding:1pt .7pt 0pt 0pt; border:none; border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">($</font></p></td>
<td colspan="1" width="76" bgcolor="#cceeff" align="right" valign="bottom" style="padding:1pt .7pt 0pt 0pt; border:none; border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">22,500</font></p></td>
<td colspan="1" width="36" bgcolor="#cceeff" align="left" valign="bottom" style="padding:1pt .7pt 0pt 0pt; border:none; border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">) <sup>(a)</sup></font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="25" bgcolor="#cceeff" align="right" valign="bottom" style="padding:1pt .7pt 0pt 0pt; border:none; border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">($</font></p></td>
<td colspan="1" width="73" bgcolor="#cceeff" align="right" valign="bottom" style="padding:1pt .7pt 0pt 0pt; border:none; border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">2,726,499</font></p></td>
<td colspan="1" width="36" bgcolor="#cceeff" align="left" valign="bottom" style="padding:1pt .7pt 0pt 0pt; border:none; border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">) <sup>(a)</sup></font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
</table>

<p style="margin:10pt 0pt 0pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">(a)&nbsp;&nbsp;Reflects reclassifications to the Fund's capital accounts to reflect income and gains available for distribution under income tax regulations.</font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times">The accompanying notes are an integral part of these financial statements.<br>19</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=21,FOLIO='19',FILE='17-24477-2.da',USER='pvangb',CD='Nov 24 08:43 2017' -->
<br clear="all" style="page-break-before:always;">


<br clear="all" style="page-break-before:always;">
<!-- Document name: 17-24477-2.ea-->
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 6pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:19pt;"><b>TEKLA LIFE SCIENCES INVESTORS</b></font></p>
<p style="margin:2pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:12pt;"><b>FINANCIAL HIGHLIGHTS</b></font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="3" width="158" valign="bottom" style="padding:0pt .7pt 2.5pt 0pt;">
&nbsp;</td>
<td colspan="1">&nbsp;</td>
<td colspan="19" width="429" align="center" valign="bottom" style="padding:0pt .7pt 2.5pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">For the years ended September 30,</font></p></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="158" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="80" align="center" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">2017</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="78" align="center" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">2016</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="78" align="center" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">2015</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="83" align="center" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">2014</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="78" align="center" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">2013</font></p></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="23" width="587" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;"><b>OPERATING PERFORMANCE FOR A <BR></b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;"><b>SHARE OUTSTANDING THROUGHOUT <BR></b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;"><b>EACH YEAR</b></font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="158" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Net asset value per share, beginning of year</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="20" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="34" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">20.00</font></p></td>
<td colspan="1" width="26" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="34" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">23.51</font></p></td>
<td colspan="1" width="24" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="34" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">23.37</font></p></td>
<td colspan="1" width="24" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="34" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">20.16</font></p></td>
<td colspan="1" width="29" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="34" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">15.74</font></p></td>
<td colspan="1" width="24" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="158" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Net investment loss <sup>(1)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="34" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(0.18</font></p></td>
<td colspan="1" width="26" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">)</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="34" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(0.19</font></p></td>
<td colspan="1" width="24" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">)</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="34" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(0.25</font></p></td>
<td colspan="1" width="24" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">)</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="34" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(0.23</font></p></td>
<td colspan="1" width="29" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">)</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="34" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(0.22</font></p></td>
<td colspan="1" width="24" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">)</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="158" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Net realized and unrealized gain (loss)</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="34" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">3.39</font></p></td>
<td colspan="1" width="26" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="34" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(0.47</font></p></td>
<td colspan="1" width="24" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">)</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="34" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">2.48</font></p></td>
<td colspan="1" width="24" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="34" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">5.71</font></p></td>
<td colspan="1" width="29" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="34" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">5.94</font></p></td>
<td colspan="1" width="24" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="158" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Total increase (decrease) from <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">investment operations</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="34" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">3.21</font></p></td>
<td colspan="1" width="26" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="34" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(0.66</font></p></td>
<td colspan="1" width="24" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">)</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="34" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">2.23</font></p></td>
<td colspan="1" width="24" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="34" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">5.48</font></p></td>
<td colspan="1" width="29" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="34" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">5.72</font></p></td>
<td colspan="1" width="24" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="23" width="587" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Distributions to shareholders from:</font></p></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="158" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Net realized capital gains</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="34" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(1.59</font></p></td>
<td colspan="1" width="26" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">)</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="34" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(2.85</font></p></td>
<td colspan="1" width="24" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">)</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="34" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(2.09</font></p></td>
<td colspan="1" width="24" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">)</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="34" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(1.70</font></p></td>
<td colspan="1" width="29" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">)</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="34" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(1.30</font></p></td>
<td colspan="1" width="24" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">)</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="158" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Total distributions</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="34" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(1.59</font></p></td>
<td colspan="1" width="26" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">)</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="34" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(2.85</font></p></td>
<td colspan="1" width="24" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">)</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="34" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(2.09</font></p></td>
<td colspan="1" width="24" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">)</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="34" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(1.70</font></p></td>
<td colspan="1" width="29" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">)</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
&nbsp;</td>
<td colspan="1" width="34" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(1.30</font></p></td>
<td colspan="1" width="24" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">)</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="158" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Increase resulting from shares repurchased <sup>(1)</sup></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="34" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="26" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;"><sup>(2)</sup></font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="34" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="24" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="34" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="24" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="34" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="29" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="34" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="24" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="158" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Change due to rights offering</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="34" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="26" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="34" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="24" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="34" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="24" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="34" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(0.57</font></p></td>
<td colspan="1" width="29" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">)<sup>(3)</sup></font></p></td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="34" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="24" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="158" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Net asset value per share, end of year</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="34" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">21.62</font></p></td>
<td colspan="1" width="26" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="34" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">20.00</font></p></td>
<td colspan="1" width="24" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="34" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">23.51</font></p></td>
<td colspan="1" width="24" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="34" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">23.37</font></p></td>
<td colspan="1" width="29" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="34" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">20.16</font></p></td>
<td colspan="1" width="24" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="158" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Per share market value, end of year</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="20" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="34" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">21.48</font></p></td>
<td colspan="1" width="26" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="34" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">18.73</font></p></td>
<td colspan="1" width="24" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="34" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">22.51</font></p></td>
<td colspan="1" width="24" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="34" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">22.10</font></p></td>
<td colspan="1" width="29" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="34" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">19.25</font></p></td>
<td colspan="1" width="24" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="158" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Total investment return at market value</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="34" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">24.26</font></p></td>
<td colspan="1" width="26" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">%</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="34" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(4.66</font></p></td>
<td colspan="1" width="24" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">%)</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="34" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">9.92</font></p></td>
<td colspan="1" width="24" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">%</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="34" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">24.20</font></p></td>
<td colspan="1" width="29" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">%</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="34" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">34.96</font></p></td>
<td colspan="1" width="24" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">%</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="158" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Total investment return at net asset value</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="34" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">17.12</font></p></td>
<td colspan="1" width="26" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">%</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="34" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(2.52</font></p></td>
<td colspan="1" width="24" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">%)</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="34" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">8.56</font></p></td>
<td colspan="1" width="24" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">%</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="34" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">25.40</font></p></td>
<td colspan="1" width="29" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">%</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="34" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">38.19</font></p></td>
<td colspan="1" width="24" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">%</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="23" width="587" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;"><b>RATIOS</b></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="158" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Expenses to average net assets</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="34" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">1.32</font></p></td>
<td colspan="1" width="26" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">%</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="34" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">1.27</font></p></td>
<td colspan="1" width="24" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">%</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="34" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">1.21</font></p></td>
<td colspan="1" width="24" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">%</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="34" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">1.34</font></p></td>
<td colspan="1" width="29" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">%</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="34" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">1.47</font></p></td>
<td colspan="1" width="24" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">%</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="158" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Expenses to average net assets with waiver</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="34" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="26" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="34" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="24" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="34" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">1.17</font></p></td>
<td colspan="1" width="24" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">%</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="34" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">1.32</font></p></td>
<td colspan="1" width="29" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">%</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="34" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="24" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="158" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Net investment loss to average net assets</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="34" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(0.92</font></p></td>
<td colspan="1" width="26" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">%)</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="34" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(0.92</font></p></td>
<td colspan="1" width="24" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">%)</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="34" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(0.91</font></p></td>
<td colspan="1" width="24" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">%)</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="34" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(1.07</font></p></td>
<td colspan="1" width="29" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">%)</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="34" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(1.26</font></p></td>
<td colspan="1" width="24" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">%)</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="23" width="587" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;"><b>SUPPLEMENTAL DATA</b></font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="158" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Net assets at end of year (in millions)</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="20" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="34" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">466</font></p></td>
<td colspan="1" width="26" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="34" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">415</font></p></td>
<td colspan="1" width="24" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="34" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">463</font></p></td>
<td colspan="1" width="24" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="34" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">444</font></p></td>
<td colspan="1" width="29" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="34" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">302</font></p></td>
<td colspan="1" width="24" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="158" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Portfolio turnover rate</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="34" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">43.08</font></p></td>
<td colspan="1" width="26" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">%</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="34" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">30.99</font></p></td>
<td colspan="1" width="24" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">%</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="34" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">45.94</font></p></td>
<td colspan="1" width="24" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">%</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="34" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">30.62</font></p></td>
<td colspan="1" width="29" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">%</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="34" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">42.23</font></p></td>
<td colspan="1" width="24" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">%</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
</table>

<p style="margin:9pt 0pt 0pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(1)&nbsp;&nbsp;Computed using average shares outstanding.</font></p>
<p style="margin:4pt 0pt 0pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(2)&nbsp;&nbsp;Rounds to less than $0.005 per share.</font></p>
<p style="margin:4pt 0pt 0pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(3)&nbsp;&nbsp;The rights offering shares were issued at a subscription price of $19.750 which was less than the Fund's net asset value of $22.78 on June 27, 2014 thus creating a dilution effect on the net asset value per share.</font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times">The accompanying notes are an integral part of these financial statements.<br>20</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=22,FOLIO='20',FILE='17-24477-2.ea',USER='bjonesc',CD='Nov 23 01:53 2017' -->
<br clear="all" style="page-break-before:always;">


<br clear="all" style="page-break-before:always;">
<!-- Document name: 17-24477-2.fa-->
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 6pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:19pt;"><b>TEKLA LIFE SCIENCES INVESTORS</b></font></p>
<p style="margin:2pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:12pt;"><b>NOTES TO FINANCIAL STATEMENTS</b></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:11pt;"><i>SEPTEMBER 30, 2017</i></font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><i>(1)&nbsp;&nbsp;Organization and Significant Accounting Policies</i></font></p>
<p style="margin:0pt 0pt 6pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Tekla Life Sciences Investors (the Fund) is a Massachusetts business trust formed on February 20, 1992, and registered under the Investment Company Act of 1940 as a non-diversified closed-end management investment company. The Fund commenced operations on May 8, 1992. The Fund's investment objective is long-term capital appreciation through investment in U.S. and foreign companies in the life sciences industry (including biotechnology, pharmaceutical, diagnostics, managed healthcare and medical equipment, hospitals, healthcare information technology and services, devices and supplies), agriculture and environmental management. The Fund invests primarily in securities of public and private companies that are believed by the Fund's Investment Adviser, Tekla Capital Management LLC (the Adviser), to have significant potential for above-average growth. The Fund may invest up to 20% of its net assets in securities of foreign issuers, expected to be located primarily in Western Europe, Canada and Japan, and securities of U.S. issuers that are traded primarily in foreign markets.</font></p>
<p style="margin:0pt 0pt 6pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">The preparation of these financial statements requires the use of certain estimates by management in determining the Fund's assets, liabilities, revenues and expenses. Actual results could differ from these estimates and such differences could be material. The following is a summary of significant accounting policies followed by the Fund, which are in conformity with accounting principles generally accepted in the United States of America (GAAP). The Fund is an investment company and follows accounting and reporting guidance in the Financial Accounting Standards Board Accounting Standards Codification 946. Events or transactions occurring after September 30, 2017, through the date that the financial statements were issued, have been evaluated in the preparation of these financial statements.</font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><i>Investment Valuation</i></font></p>
<p style="margin:0pt 0pt 6pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Shares of publicly traded companies listed on national securities exchanges or trading in the over-the-counter market are typically valued at the last sale price, as of the close of trading, generally 4 p.m., Eastern time. The Board of Trustees of the Fund (the Trustees) has established and approved fair valuation policies and procedures with respect to securities for which quoted prices may not be available or which do not reflect fair value. Convertible bonds, corporate and government bonds are valued using a third-party pricing service. Convertible bonds are valued using this pricing service only on days when there is no sale reported. Restricted securities of companies that are publicly traded are typically valued based on the closing market quote on the valuation date adjusted for the impact of the restriction as determined in good faith by the Adviser also using fair valuation policies and procedures approved by the Trustees described below. Non-exchange traded warrants of publicly traded companies are generally valued using the Black-Scholes model, which incorporates both observable and unobservable inputs. Short-term investments with a maturity of 60 days or less are generally valued at amortized cost, which approximates fair value.</font></p>
<p style="margin:0pt 0pt 6pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Convertible preferred shares, warrants or convertible note interests in private companies, milestone interests, and other restricted securities, as well as shares of publicly traded companies for which market quotations are not readily available, such as stocks for which trading has been halted or for which there are no current day sales, or which do not reflect fair value, are typically valued in good faith, based upon the recommendations made by the Adviser pursuant to fair valuation policies and procedures approved by the Trustees.</font></p>
<p style="margin:0pt 0pt 6pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">The Adviser has a Valuation Sub-Committee comprised of senior management which reports to the Valuation Committee of the Board at least quarterly. Each fair value determination is </font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times"><br>21</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=23,FOLIO='21',FILE='17-24477-2.fa',USER='pvangb',CD='' -->
<br clear="all" style="page-break-before:always;">
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 6pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:19pt;"><b>TEKLA LIFE SCIENCES INVESTORS</b></font></p>
<p style="margin:2pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:12pt;"><b>NOTES TO FINANCIAL STATEMENTS</b></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:11pt;"><i>SEPTEMBER 30, 2017</i></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">(continued)</font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 6pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">based on a consideration of relevant factors, including both observable and unobservable inputs. Observable and unobservable inputs the Adviser considers may include (i) the existence of any contractual restrictions on the disposition of securities; (ii) information obtained from the company, which may include an analysis of the company's financial statements, the company's products or intended markets or the company's technologies; (iii) the price of the same or similar security negotiated at arm's length in an issuer's completed subsequent round of financing; (iv) the price and extent of public trading in similar securities of the issuer or of comparable companies; or (v) a probability and time value adjusted analysis of contractual terms. Where available and appropriate, multiple valuation methodologies are applied to confirm fair value. Significant unobservable inputs identified by the Adviser are often used in the fair value determination. A significant change in any of these inputs may result in a significant change in the fair value measurement. Due to the uncertainty inherent in the valuation process, such estimates of fair value may differ significantly from the values that would have been used had a ready market for the investments existed, and differences could be material. Additionally, changes in the market environment and other events that may occur over the life of the investments may cause the gains or losses ultimately realized on these investments to be different from the valuations used at the date of these financial statements.</font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><i>Milestone Interests</i></font></p>
<p style="margin:0pt 0pt 6pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">The Fund holds financial instruments which reflects the current value of future milestone payments the Fund may receive as a result of contractual obligations from other parties. The value of such payments are adjusted to reflect the estimated risk based on the relative uncertainty of both the timing and the achievement of individual milestones. A risk to the Fund is that the milestones will not be achieved and no payment will be received by the Fund. The milestone interests were received as part of the proceeds from the sale of three private companies. Any payments received are treated as a reduction of the cost basis of the milestone interest with payments received in excess of the cost basis treated as a realized gain. The contractual obligations with respect to the Afferent Milestone Interest, Neurovance Milestone Interest and the TargeGen Milestone Interest provide for payments at various stages of the development of Afferent's, Neurovance's and TargeGen's principal product candidate as of the date of the sale.</font></p>
<p style="margin:0pt 0pt 6pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">The following is a summary of the impact of the milestone interests on the financial statements as of and for the year ended September 30, 2017:</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="3" width="272" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 1pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Statement of Assets and Liabilities, Milestone interests, at value</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 1pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">$</font></p></td>
<td colspan="1" width="51" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 1pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">4,660,996</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 1pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="272" align="left" valign="bottom" style="padding:0pt .7pt 1pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Statement of Assets and Liabilities, Net unrealized loss on<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">milestone interests</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="20" align="right" valign="bottom" style="padding:0pt .7pt 1pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">$</font></p></td>
<td colspan="1" width="51" align="right" valign="bottom" style="padding:0pt .7pt 1pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">(2,842,370</font></p></td>
<td colspan="1" width="19" align="left" valign="bottom" style="padding:0pt .7pt 1pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">)</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="272" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 1pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Statement of Operations, Change in unrealized appreciation (depreciation)<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">on milestone interests</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 1pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">$</font></p></td>
<td colspan="1" width="51" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 1pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">119,993</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 1pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
</table>

<p style="margin:6pt 0pt 0pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><i>Other Assets</i></font></p>
<p style="margin:0pt 0pt 6pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Other assets in the Statement of Assets and Liabilities consists of amounts due to the Fund at various times in the future in connection with the sale of investments in four private companies.</font></p>
<p style="margin:6pt 0pt 0pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><i>Investment Transactions and Income</i></font></p>
<p style="margin:0pt 0pt 6pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Investment transactions are recorded on a trade date basis. Gains and losses from sales of investments are recorded using the "identified cost" method. Interest income is recorded on the accrual basis, adjusted for amortization of premiums and accretion of discounts. Dividend income </font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times"><br>22</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=24,FOLIO='22',FILE='17-24477-2.fa',USER='pvangb',CD='' -->
<br clear="all" style="page-break-before:always;">
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 6pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:19pt;"><b>TEKLA LIFE SCIENCES INVESTORS</b></font></p>
<p style="margin:2pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:12pt;"><b>NOTES TO FINANCIAL STATEMENTS</b></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:11pt;"><i>SEPTEMBER 30, 2017</i></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">(continued)</font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 6pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">is recorded on the ex-dividend date, less any foreign taxes withheld. Upon notification from issuers, some of the dividend income received may be redesignated as a reduction of cost of the related investment if it represents a return of capital.</font></p>
<p style="margin:0pt 0pt 6pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">The aggregate cost of purchases and proceeds from sales of investment securities (other than short-term investments) for the year ended September 30, 2017 totaled $174,386,780 and $185,929,260, respectively.</font></p>
<p style="margin:6pt 0pt 0pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><i>Repurchase Agreements</i></font></p>
<p style="margin:0pt 0pt 6pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">In managing short-term investments the Fund may from time to time enter into transactions in repurchase agreements. In a repurchase agreement, the Fund's custodian takes possession of the underlying collateral securities from the counterparty, the market value of which is at least equal to the principal, including accrued interest, of the repurchase transaction at all times. In the event of default or bankruptcy by the other party to the agreement, realization and/or retention of the collateral by the Fund may be delayed. The Fund may enter into repurchase transactions with any broker, dealer, registered clearing agency or bank. Repurchase agreement transactions are not counted for purposes of the limitations imposed on the Fund's investment in debt securities.</font></p>
<p style="margin:6pt 0pt 0pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><i>Distribution Policy</i></font></p>
<p style="margin:0pt 0pt 6pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Pursuant to a Securities and Exchange Commission exemptive order, the Fund may make periodic distributions that include capital gains as frequently as 12 times in any one taxable year in respect of its common shares, and the Fund has implemented a managed distribution policy (the Policy) providing for quarterly distributions at a rate set by the Board of Trustees. Under the current Policy, the Fund intends to make quarterly distributions at a rate of 2% of the Fund's net assets to shareholders of record. The Fund intends to use net realized capital gains when making quarterly distributions, if available, but the Policy would result in a return of capital to shareholders if the amount of the distribution exceeds the Fund's net investment income and realized capital gains. If taxable income and net long-term realized gains exceed the amount required to be distributed under the Policy, the Fund will at a minimum make distributions necessary to comply with the requirements of the Internal Revenue Code. The Policy has been established by the Trustees and may be changed by them without shareholder approval. The Trustees regularly review the Policy and the frequency and rate of distribution considering the purpose and effect of the Policy, the financial market environment, and the Fund's income, capital gains and capital available to pay distributions.</font></p>
<p style="margin:0pt 0pt 6pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">The Fund's policy is to declare quarterly distributions in stock. The distributions are automatically paid in newly-issued full shares of the Fund unless otherwise instructed by the shareholder. Fractional shares will generally be settled in cash, except for registered shareholders with book entry accounts of the Fund's transfer agent who will have whole and fractional shares added to their accounts. The Fund's transfer agent delivers an election card and instructions to each registered shareholder in connection with each distribution. The number of shares issued will be determined by dividing the dollar amount of the distribution by the lower of net asset value or market price on the pricing date. If a shareholder elects to receive a distribution in cash, rather than in shares, the shareholder's relative ownership in the Fund will be reduced. The shares reinvested will be valued at the lower of the net asset value or market price on the pricing date. Distributions in stock will not relieve shareholders of any federal, state or local income taxes that may be payable on such distributions. Additional distributions, if any, made to satisfy </font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times"><br>23</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=25,FOLIO='23',FILE='17-24477-2.fa',USER='pvangb',CD='' -->
<br clear="all" style="page-break-before:always;">
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 6pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:19pt;"><b>TEKLA LIFE SCIENCES INVESTORS</b></font></p>
<p style="margin:2pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:12pt;"><b>NOTES TO FINANCIAL STATEMENTS</b></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:11pt;"><i>SEPTEMBER 30, 2017</i></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">(continued)</font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 6pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">requirements of the Internal Revenue Code may be paid in stock, as described above, or in cash.</font></p>
<p style="margin:6pt 0pt 0pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><i>Share Repurchase Program</i></font></p>
<p style="margin:0pt 0pt 6pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">In March 2017, the Trustees approved the renewal of the repurchase program to allow the Fund to repurchase up to 12% of its outstanding shares in the open market for a one year period ending July 14, 2018. Prior to this renewal, in March 2016, the Trustees approved the renewal of the share repurchase program to allow the Fund to repurchase up to 12% of its outstanding shares for a one year period ending July 10, 2017. The share repurchase program is intended to enhance shareholder value and potentially reduce the discount between the market price of the Fund's shares and the Fund's net asset value.</font></p>
<p style="margin:0pt 0pt 6pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">During the year ended September 30, 2017 the Fund repurchased 24,167 shares at a total cost of $406,764. The weighted average discount per share between the cost of repurchase and net asset value applicable to such shares at the date of repurchase was 8.33%. During the year ended September 30, 2016, the Fund did not repurchase any shares through the repurchase program.</font></p>
<p style="margin:6pt 0pt 0pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><i>Federal Taxes</i></font></p>
<p style="margin:0pt 0pt 6pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">It is the Fund's policy to comply with the requirements of the Internal Revenue Code applicable to regulated investment companies and to distribute to its shareholders substantially all of its taxable income and its net realized capital gains, if any. Therefore, no Federal income or excise tax provision is required.</font></p>
<p style="margin:0pt 0pt 6pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">As of September 30, 2017, the Fund had no uncertain tax positions that would require financial statement recognition or disclosure. The Fund's federal tax returns are subject to examination by the Internal Revenue Service for a period of three years.</font></p>
<p style="margin:6pt 0pt 0pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><i>Distributions</i></font></p>
<p style="margin:0pt 0pt 6pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">The Fund records all distributions to shareholders on the ex-dividend date. Such distributions are determined in conformity with income tax regulations, which may differ from GAAP. These differences include temporary and permanent differences from losses on wash sale transactions, installment sale adjustments and ordinary loss netting to reduce short term capital gains. Reclassifications are made to the Fund's capital accounts to reflect income and gains available for distribution under income tax regulations. At September 30, 2017, the Fund reclassified $6,582,770 from accumulated net realized gain on investment and $6,582,770 to undistributed net investment income for current period book/tax differences.</font></p>
<p style="margin:0pt 0pt 6pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">The tax basis components of distributable earnings and the tax cost as of September 30, 2017 were as follows:</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="3" width="161" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Cost of investments for tax purposes</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="23" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="56" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">325,891,050</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="161" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Gross tax unrealized appreciation</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="23" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="56" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">188,840,947</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="161" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Gross tax unrealized depreciation</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="23" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">($</font></p></td>
<td colspan="1" width="56" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">47,752,335</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">)</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="161" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Net tax unrealized appreciation on investments</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="23" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="56" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">141,088,612</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="161" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Undistributed ordinary income</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="23" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="56" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">7,641,014</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
</table>

</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times"><br>24</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=26,FOLIO='24',FILE='17-24477-2.fa',USER='pvangb',CD='' -->
<br clear="all" style="page-break-before:always;">
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 6pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:19pt;"><b>TEKLA LIFE SCIENCES INVESTORS</b></font></p>
<p style="margin:2pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:12pt;"><b>NOTES TO FINANCIAL STATEMENTS</b></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:11pt;"><i>SEPTEMBER 30, 2017</i></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">(continued)</font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">The Fund has designated the distributions for its taxable years ended September 30, 2017 and 2016 as follows:</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="3" width="170" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Distributions paid from:</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="80" align="center" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">2017</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="80" align="center" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">2016</font></p></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="170" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Ordinary income (includes short-term capital gain)</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="52" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">1,096,494</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="52" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="170" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Long-term capital gain</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="20" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="52" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">32,394,131</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="52" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">56,868,411</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
</table>

<p style="margin:12pt 0pt 0pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><i>Commitments and Contingencies</i></font></p>
<p style="margin:0pt 0pt 6pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Under the Fund's organizational documents, its officers and Trustees may be indemnified against certain liabilities and expenses arising out of the performance of their duties to the Fund. Additionally, in the normal course of business, the Fund enters into agreements with service providers that may contain indemnification clauses. The Fund's maximum exposure under these agreements is unknown as this would involve future claims that may be made against the Fund that have not yet occurred. However, based on experience, the Fund expects the risk of loss to be remote.</font></p>
<p style="margin:6pt 0pt 0pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><i>Investor Support Services</i></font></p>
<p style="margin:0pt 0pt 6pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">The Fund has retained Destra Capital Investment LLC (Destra) to provide investor support services in connection with the ongoing operation of the Fund. The Fund pays Destra a fee in an annual amount equal to 0.05% of the average aggregate daily value of the Fund's Managed Assets from January 1, 2017 through the remaining term of the investor support services agreement.</font></p>
<p style="margin:6pt 0pt 0pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><i>(2)&nbsp;&nbsp;Investment Advisory and Other Affiliated Fees</i></font></p>
<p style="margin:0pt 0pt 6pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">The Fund has entered into an Investment Advisory Agreement (the Advisory Agreement) with the Adviser. Pursuant to the terms of the Advisory Agreement, the Fund pays the Adviser a monthly fee at the rate when annualized of (i) 2.50% of the average net assets for the month of its venture capital and other restricted securities up to 25% of net assets and (ii) for all other net assets, 0.98% of the average net assets up to $250 million, 0.88% of the average net assets for the next $250 million, 0.80% of the average net assets for the next $500 million and 0.70% of the average net assets thereafter. The aggregate fee would not exceed a rate when annualized of 1.36%.</font></p>
<p style="margin:0pt 0pt 6pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">The Fund has entered into a Services Agreement (the Agreement) with the Adviser. Pursuant to the terms of the Agreement, the Fund reimburses the Adviser for certain services related to a portion of the payment of salary and provision of benefits to the Fund's Chief Compliance Officer. During the year ended September 30, 2017, these payments amounted to $37,657 and are included in the Other category of expenses in the Statement of Operations, together with insurance and other expenses incurred to unaffiliated entities. Expenses incurred pursuant to the Agreement as well as certain expenses paid for by the Adviser are allocated to the Fund in an equitable fashion as approved by the Trustees of the Fund who are also officers of the Adviser.</font></p>
<p style="margin:0pt 0pt 6pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">The Fund pays compensation to Independent Trustees in the form of a retainer, attendance fees, and additional compensation to Board and Committee chairpersons. The Fund does not pay compensation directly to Trustees or officers of the Fund who are also officers of the Adviser.</font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times"><br>25</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=27,FOLIO='25',FILE='17-24477-2.fa',USER='pvangb',CD='' -->
<br clear="all" style="page-break-before:always;">
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 6pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:19pt;"><b>TEKLA LIFE SCIENCES INVESTORS</b></font></p>
<p style="margin:2pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:12pt;"><b>NOTES TO FINANCIAL STATEMENTS</b></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:11pt;"><i>SEPTEMBER 30, 2017</i></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">(continued)</font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><i>(3)&nbsp;&nbsp;Other Transactions with Affiliates</i></font></p>
<p style="margin:0pt 0pt 6pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">An affiliate company is a company in which the Fund holds 5% or more of the voting securities. Transactions involving such companies during the year ended September 30, 2017 were as follows:</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="3" width="83" align="left" valign="bottom" style="padding:6pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Affiliated Companies</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="89" align="center" valign="bottom" style="padding:6pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Begining<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Value as of<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">September 30,<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">2016</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="81" align="center" valign="bottom" style="padding:6pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Purchases at<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Cost</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="97" align="center" valign="bottom" style="padding:6pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Proceeds<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">from Sales</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="94" align="center" valign="bottom" style="padding:6pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Net Realized<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Gain/(Loss)<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">on sale of<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Affiliated<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Companies</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="99" align="center" valign="bottom" style="padding:6pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Change in<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Unrealized<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Appreciation/<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Depreciation</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="99" align="center" valign="bottom" style="padding:6pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Ending Value<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">as of<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">September 30,<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">2017</font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="83" bgcolor="#cceeff" align="left" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">ARCA Biopharma, Inc.</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" align="right" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="61" bgcolor="#cceeff" align="right" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">2,458,019</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="81" bgcolor="#cceeff" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="97" bgcolor="#cceeff" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="94" bgcolor="#cceeff" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="23" bgcolor="#cceeff" align="right" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">($</font></p></td>
<td colspan="1" width="57" bgcolor="#cceeff" align="right" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">1,533,220</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" align="left" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">)</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" align="right" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="61" bgcolor="#cceeff" align="right" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">924,799</font></p></td>
<td colspan="1" width="18" bgcolor="#cceeff" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="83" align="left" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">EBI Life Sciences, Inc.</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="61" align="right" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">13,102</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="81" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="97" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="94" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="23" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="57" align="right" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="61" align="right" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">13,102</font></p></td>
<td colspan="1" width="18" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="83" bgcolor="#cceeff" align="left" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Euthymics <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Biosciences, Inc.</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="61" bgcolor="#cceeff" align="right" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">2,862</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" align="right" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="53" bgcolor="#cceeff" align="right" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">37,604</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="97" bgcolor="#cceeff" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="94" bgcolor="#cceeff" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="23" bgcolor="#cceeff" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="57" bgcolor="#cceeff" align="right" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(40,466</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" align="left" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">)</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="61" bgcolor="#cceeff" align="right" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="18" bgcolor="#cceeff" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="83" align="left" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Insightra Medical, Inc.</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="61" align="right" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">9,017</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="53" align="right" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">3,589</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="23" align="right" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(</font></p></td>
<td colspan="1" width="55" align="right" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$14,988</font></p></td>
<td colspan="1" width="19" align="left" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">)</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" align="right" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(</font></p></td>
<td colspan="1" width="55" align="right" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$3,998,891</font></p></td>
<td colspan="1" width="19" align="left" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">)</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="23" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="57" align="right" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">4,001,583</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="61" align="right" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="18" align="left" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">*</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="83" bgcolor="#cceeff" align="left" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Neurovance, Inc.</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="61" bgcolor="#cceeff" align="right" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">2,960,342</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="53" bgcolor="#cceeff" align="right" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">576,071</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="23" bgcolor="#cceeff" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="55" bgcolor="#cceeff" align="right" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(11,433,437</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" align="left" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">)</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="55" bgcolor="#cceeff" align="right" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">7,592,874</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="23" bgcolor="#cceeff" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="57" bgcolor="#cceeff" align="right" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">304,150</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="61" bgcolor="#cceeff" align="right" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="18" bgcolor="#cceeff" align="left" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">*</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="83" align="left" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Palyon Medical <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Corporation</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="61" align="right" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">0</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="53" align="right" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="23" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="55" align="right" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="55" align="right" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(3,384,844</font></p></td>
<td colspan="1" width="19" align="left" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">)</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="23" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="57" align="right" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">3,384,844</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="61" align="right" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="18" align="left" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">*</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="83" bgcolor="#cceeff" align="left" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Veniti, Inc.</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="61" bgcolor="#cceeff" align="right" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">6,174,813</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="53" bgcolor="#cceeff" align="right" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">7,583</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="23" bgcolor="#cceeff" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="55" bgcolor="#cceeff" align="right" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="55" bgcolor="#cceeff" align="right" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="23" bgcolor="#cceeff" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="57" bgcolor="#cceeff" align="right" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(3,264,887</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" align="left" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">)</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="61" bgcolor="#cceeff" align="right" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">2,917,509</font></p></td>
<td colspan="1" width="18" bgcolor="#cceeff" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="83" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="20" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="61" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">11,618,155</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="53" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">624,847</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="23" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">($</font></p></td>
<td colspan="1" width="55" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">11,448,425</font></p></td>
<td colspan="1" width="19" align="left" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">)</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="55" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">209,139</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="23" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="57" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">2,852,004</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="61" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">3,855,410</font></p></td>
<td colspan="1" width="18" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
</table>

<p style="margin:3pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">*&nbsp;&nbsp;Not an affiliate as of September 30, 2017.</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="3" width="83" align="left" valign="bottom" style="padding:12pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Affiliated Companies</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="77" align="center" valign="bottom" style="padding:12pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Shares as of<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">September 30,<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">2017</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="78" align="center" valign="bottom" style="padding:12pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Dividend<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Income<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">from<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Affiliated<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Companies</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="87" align="center" valign="bottom" style="padding:12pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Capital Gain<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Distributions<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">from Affiliated<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Companies</font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="83" bgcolor="#cceeff" align="left" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">ARCA Biopharma, Inc.</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="61" bgcolor="#cceeff" align="right" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">1,135,718</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="78" bgcolor="#cceeff" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="87" bgcolor="#cceeff" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="83" align="left" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">EBI Life Sciences, Inc.</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="8" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="61" align="right" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">2,568,939</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="78" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="87" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="83" bgcolor="#cceeff" align="left" valign="top" style="padding:4pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Euthymics <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Biosciences, Inc.</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="top" style="padding:4pt .7pt 0pt 0pt;">
</td>
<td colspan="1" width="61" bgcolor="#cceeff" align="right" valign="top" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">2,862,324</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="top" style="padding:4pt .7pt 0pt 0pt;">
</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="78" bgcolor="#cceeff" valign="top" style="padding:4pt .7pt 0pt 0pt;">
</td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="87" bgcolor="#cceeff" valign="top" style="padding:4pt .7pt 0pt 0pt;">
</td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="83" align="left" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Insightra Medical, Inc.</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="8" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="61" align="right" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="78" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="87" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="83" bgcolor="#cceeff" align="left" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Neurovance, Inc.</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="61" bgcolor="#cceeff" align="right" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="78" bgcolor="#cceeff" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="87" bgcolor="#cceeff" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="83" align="left" valign="top" style="padding:4pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Palyon Medical <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Corporation</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="8" valign="top" style="padding:4pt .7pt 0pt 0pt;">
</td>
<td colspan="1" width="61" align="right" valign="top" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="8" valign="top" style="padding:4pt .7pt 0pt 0pt;">
</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="78" valign="top" style="padding:4pt .7pt 0pt 0pt;">
</td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="87" valign="top" style="padding:4pt .7pt 0pt 0pt;">
</td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="83" bgcolor="#cceeff" align="left" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Veniti, Inc.</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="61" bgcolor="#cceeff" align="right" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">4,629,922</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="78" bgcolor="#cceeff" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="87" bgcolor="#cceeff" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="83" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="8" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
&nbsp;</td>
<td colspan="1" width="61" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">11,196,903</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="50" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">0</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="59" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">0</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
</table>

<p style="margin:6pt 0pt 0pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><i>(4)&nbsp;&nbsp;Fair Value Measurements</i></font></p>
<p style="margin:0pt 0pt 6pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">The Fund uses a three-tier hierarchy to prioritize the assumptions, referred to as inputs, used in valuation techniques to measure fair value. The three-tier hierarchy of inputs is summarized in the three broad levels. Level 1 includes quoted prices in active markets for identical investments. Level 2 includes prices determined using other significant observable inputs (including quoted prices for similar investments, interest rates, credit risk, etc.). The independent pricing vendor may value bank loans and debt securities at an evaluated bid price by employing methodologies that utilize actual market transactions, broker-supplied valuations, and/or other methodologies designed to identify the market value for such securities and such securities are considered Level 2 in the fair value hierarchy. Level 3 includes prices determined using significant unobservable inputs (including the Fund's own assumptions in determining the </font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times"><br>26</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=28,FOLIO='26',FILE='17-24477-2.fa',USER='pvangb',CD='' -->
<br clear="all" style="page-break-before:always;">
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 6pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:19pt;"><b>TEKLA LIFE SCIENCES INVESTORS</b></font></p>
<p style="margin:2pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:12pt;"><b>NOTES TO FINANCIAL STATEMENTS</b></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:11pt;"><i>SEPTEMBER 30, 2017</i></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">(continued)</font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 6pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">fair value of investments). These inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities.</font></p>
<p style="margin:0pt 0pt 6pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">For the year ended September 30, 2017, there was a transfer between Level 1 and 2, Level 3 and 2 and no other transfers between Levels. The amount of transfers between Level 1 and Level 2 was $1,926,708. The investment was transferred from Level 1 to Level 2 due to a trading restriction and the value is being supported by significant observable inputs. The amount of transfers between Level 3 and Level 2 was $2,260,108. The investment was transferred from Level 3 to Level 2 due to an initial public offering. The Fund accounts for transfers between Levels at the beginning of the period.</font></p>
<p style="margin:0pt 0pt 6pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">The following is a summary of the levels used as of September 30, 2017 to value the Fund's net assets.</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="3" width="122" align="left" valign="bottom" style="padding:6pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Assets at Value</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="84" align="center" valign="bottom" style="padding:6pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Level 1</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="80" align="center" valign="bottom" style="padding:6pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Level 2</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="80" align="center" valign="bottom" style="padding:6pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Level 3</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="84" align="center" valign="bottom" style="padding:6pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Total</font></p></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="19" width="474" bgcolor="#cceeff" align="left" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Convertible Preferred and Warrants</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="122" align="left" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Biotechnology</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="20" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="56" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">463,500</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="80" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="20" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="52" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">4,596,436</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="56" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">5,059,936</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="122" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Health Care Equipment &amp; Supplies</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="56" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="80" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">3,782,642</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="56" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">3,782,642</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="122" align="left" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Life Sciences Tools &amp; Services</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="56" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="80" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">3,361,069</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="56" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">3,361,069</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="122" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Pharmaceuticals</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="56" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="80" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">900,000</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="56" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">900,000</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="19" width="474" align="left" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Convertible Notes and Non-Convertible Notes</font></p></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="122" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Health Care Equipment &amp; Supplies</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="56" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="80" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">154,983</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="56" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">154,983</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="122" align="left" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Pharmaceuticals</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="56" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="80" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">0</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="56" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">0</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="19" width="474" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Common Stocks and Warrants</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="122" align="left" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Biotechnology</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="56" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">342,831,723</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="52" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">863,748</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">140,479</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="56" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">343,835,950</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="122" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Health Care Equipment &amp; Supplies</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="56" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">20,341,949</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">284,445</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="56" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">20,626,394</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="122" align="left" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Health Care Providers &amp; Services</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="56" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">322,963</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="56" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">322,963</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="122" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Life Sciences Tools &amp; Services</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="56" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">26,705,121</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="56" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">26,705,121</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="122" align="left" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Pharmaceuticals</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="56" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">35,738,568</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">1,568,612</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">138,636</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="56" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">37,445,816</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="122" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Exchange Traded Fund</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="56" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">10,514,792</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="56" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">10,514,792</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="122" align="left" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Short-Term Investment</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="56" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">9,609,000</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="56" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">9,609,000</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="19" width="474" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Milestone Interest</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="122" align="left" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Pharmaceuticals</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="56" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">4,660,996</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="56" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">4,660,996</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="122" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Other Assets</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="56" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">693,984</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="56" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">693,984</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="122" align="left" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Total</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="20" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="56" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">436,595,653</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="52" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">12,041,360</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="52" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">19,036,633</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="56" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">467,673,646</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
</table>

</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times"><br>27</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=29,FOLIO='27',FILE='17-24477-2.fa',USER='pvangb',CD='' -->
<br clear="all" style="page-break-before:always;">
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 6pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:19pt;"><b>TEKLA LIFE SCIENCES INVESTORS</b></font></p>
<p style="margin:2pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:12pt;"><b>NOTES TO FINANCIAL STATEMENTS</b></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:11pt;"><i>SEPTEMBER 30, 2017</i></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">(continued)</font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">The following is a reconciliation of Level 3 assets for which significant unobservable inputs were used to determine fair value.</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="3" width="64" align="left" valign="bottom" style="padding:6pt .7pt 2pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Level 3 Assets</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="89" align="center" valign="bottom" style="padding:6pt .7pt 2pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Balance as of <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">September 30,<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">2016</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="106" align="center" valign="bottom" style="padding:6pt .7pt 2pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Net realized <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">gain (loss) and <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">change in <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">unrealized <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">appreciation <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(depreciation)</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="81" align="center" valign="bottom" style="padding:6pt .7pt 2pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Cost of <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">purchases <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">and <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">conversions</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="97" align="center" valign="bottom" style="padding:6pt .7pt 2pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Proceeds<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">from sales <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">and <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">conversions</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="90" align="center" valign="bottom" style="padding:6pt .7pt 2pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Net <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">transfers<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">in <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(out of)<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Level 3</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="103" align="center" valign="bottom" style="padding:6pt .7pt 2pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Balance<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">as of <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">September 30,<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">2017</font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="27" width="670" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Convertible <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Preferred and <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Warrants</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="64" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Biotechnology</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="20" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="61" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">1,845,795</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="23" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">($</font></p></td>
<td colspan="1" width="64" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">785</font></p></td>
<td colspan="1" width="19" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">)</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="53" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">2,751,426</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="97" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="90" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="23" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="61" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">4,596,436</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="64" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Health Care <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Equipment &amp; <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Supplies</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="61" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">11,980,833</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="23" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="64" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(8,479,780</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">)</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="53" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">281,788</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="23" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">($</font></p></td>
<td colspan="1" width="55" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">199</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">)</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="90" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="23" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="61" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">3,782,642</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="64" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Life Sciences <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Tools &amp; <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Services</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="61" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">4,641,917</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="23" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="64" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(122,158</font></p></td>
<td colspan="1" width="19" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">)</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="53" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">71,670</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="23" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="55" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(1,230,360</font></p></td>
<td colspan="1" width="19" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">)</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="90" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="23" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="61" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">3,361,069</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="64" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Pharmaceuticals</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="61" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">4,662,008</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="23" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="64" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">5,655,332</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="53" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">908,708</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="23" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="55" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(10,326,048</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">)</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="90" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="23" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="61" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">900,000</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="27" width="670" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Convertible and <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Non-Convertible <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Notes</font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="64" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Health Care <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Equipment &amp; <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Supplies</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="61" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">0</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="23" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="64" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(179,616</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">)</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="53" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">349,590</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="23" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="55" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(14,991</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">)</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="90" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="23" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="61" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">154,983</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="64" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Pharmaceuticals</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="61" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">561,304</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="23" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="64" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">1,088,904</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="53" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">41,067</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="23" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="55" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(1,691,275</font></p></td>
<td colspan="1" width="19" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">)</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="90" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="23" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="61" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">0</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="27" width="670" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Common Stocks and <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Warrants</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="64" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Biotechnology</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="61" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">126,674</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="23" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="64" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">13,475</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="53" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">2,260,438</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="23" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="55" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="23" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">($</font></p></td>
<td colspan="1" width="48" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">2,260,108</font></p></td>
<td colspan="1" width="19" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">)</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="23" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="61" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">140,479</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="64" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Health Care <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Equipment &amp; <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Supplies</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="61" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">214,150</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="23" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="64" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">70,295</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="53" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="23" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="55" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="23" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="48" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="23" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="61" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">284,445</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="64" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Health Care <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Providers &amp; <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Services</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="61" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">126,667</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="23" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="64" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">196,296</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="53" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="23" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="55" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="23" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="48" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="23" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="61" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">322,963</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="64" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Pharmaceuticals</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="61" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">64,304</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="23" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="64" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">73,538</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="53" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">794</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="23" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="55" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="23" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="48" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="23" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="61" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">138,636</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="27" width="670" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Milestone Interests</font></p></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="64" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Pharmaceuticals</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="61" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">1,123,203</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="23" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="64" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">119,994</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="53" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">3,417,799</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="23" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="55" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="23" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="48" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="23" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="61" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">4,660,996</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="64" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Other Assets</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="61" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">374,787</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="23" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="64" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="53" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">512,579</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="23" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">($</font></p></td>
<td colspan="1" width="55" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">193,382</font></p></td>
<td colspan="1" width="19" align="left" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">)</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="23" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="48" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&#151;</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="23" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="61" align="right" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">693,984</font></p></td>
<td colspan="1" width="19" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="64" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Total</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="61" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">25,721,642</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="23" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">($</font></p></td>
<td colspan="1" width="64" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">1,564,505</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">)</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="53" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">10,595,859</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="23" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">($</font></p></td>
<td colspan="1" width="55" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">13,456,255</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">)</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="23" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">($</font></p></td>
<td colspan="1" width="48" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">2,260,108</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">)</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="23" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="61" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">19,036,633</font></p></td>
<td colspan="1" width="19" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="23" width="559" align="left" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Net change in unrealized appreciation (depreciation) from <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">investments still held as of September 30, 2017</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="23" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">($</font></p></td>
<td colspan="1" width="61" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">8,501,737</font></p></td>
<td colspan="1" width="19" align="left" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">)</font></p></td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
</table>

</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times"><br>28</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=30,FOLIO='28',FILE='17-24477-2.fa',USER='pvangb',CD='' -->
<br clear="all" style="page-break-before:always;">
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 6pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:19pt;"><b>TEKLA LIFE SCIENCES INVESTORS</b></font></p>
<p style="margin:2pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:12pt;"><b>NOTES TO FINANCIAL STATEMENTS</b></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:11pt;"><i>SEPTEMBER 30, 2017</i></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">(continued)</font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">The following is a quantitative disclosure about significant unobservable inputs used in the determination of the fair value of Level 3 assets.</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="3" width="110" valign="bottom" style="padding:6pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="107" align="center" valign="bottom" style="padding:6pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Fair Value at<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">September 30,<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">2017</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="157" align="center" valign="bottom" style="padding:6pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Valuation Technique</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="159" align="center" valign="bottom" style="padding:6pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Unobservable Input</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="203" align="center" valign="bottom" style="padding:6pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Range<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(Weighted Average)</font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="110" bgcolor="#cceeff" align="left" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Private Companies<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">and Other Restricted<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Securities</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="26" bgcolor="#cceeff" align="right" valign="top" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="top" style="padding:0pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">563,417<BR></font></td>
<td colspan="1" width="14" bgcolor="#cceeff" valign="top" style="padding:0pt .7pt 0pt 0pt;">
</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="157" bgcolor="#cceeff" align="left" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;"><BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Income approach,<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Black-Scholes</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="159" bgcolor="#cceeff" align="left" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;"><BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Discount for lack <BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">of marketability</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="203" bgcolor="#cceeff" align="left" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;"><BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">20%-50% (23.49%)<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;"> &nbsp;&nbsp;</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="110" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="26" valign="top" style="padding:2.5pt .7pt 0pt 0pt;">
</td>
<td colspan="1" width="67" align="right" valign="top" style="padding:2.5pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">9,639,381<BR></font></td>
<td colspan="1" width="14" valign="top" style="padding:2.5pt .7pt 0pt 0pt;">
</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="157" align="left" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Probability-weighed<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">expected return model</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="159" align="left" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Discount rate<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Price to sales multiple</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="203" align="left" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">15.39-60.56% (23.82%)<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;"> 1.31x-10.90x (3.96x)</font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="110" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="26" bgcolor="#cceeff" valign="top" style="padding:2.5pt .7pt 0pt 0pt;">
</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="top" style="padding:2.5pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">3,293,339<BR></font></td>
<td colspan="1" width="14" bgcolor="#cceeff" valign="top" style="padding:2.5pt .7pt 0pt 0pt;">
</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="157" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Market approach,<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">recent transaction</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="159" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(a)<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;"> &nbsp;&nbsp;</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="203" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">N/A<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;"> &nbsp;&nbsp;</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="110" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="26" valign="top" style="padding:4pt .7pt 0pt 0pt;">
</td>
<td colspan="1" width="67" align="right" valign="top" style="padding:4pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">322,963<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;"><BR></font></td>
<td colspan="1" width="14" valign="top" style="padding:4pt .7pt 0pt 0pt;">
</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="157" align="left" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Market comparable<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;"> &nbsp;&nbsp;<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;"> &nbsp;&nbsp;</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="159" align="left" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Discount for lack<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">of marketability<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Price to earnings multiple</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="203" align="left" valign="bottom" style="padding:4pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">50%<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;"><BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">17.00x</font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="110" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="26" bgcolor="#cceeff" valign="top" style="padding:2.5pt .7pt 0pt 0pt;">
</td>
<td colspan="1" width="67" bgcolor="#cceeff" align="right" valign="top" style="padding:2.5pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">5,217,533<BR></font></td>
<td colspan="1" width="14" bgcolor="#cceeff" valign="top" style="padding:2.5pt .7pt 0pt 0pt;">
</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="157" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Probability adjusted<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">value</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="159" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Probability of events<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Timing of events</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="203" bgcolor="#cceeff" align="left" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">10%-98% (61.66%)<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;"> 0.25-7.50 (2.33) years</font></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="110" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="26" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="67" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">19,036,633</font></p></td>
<td colspan="1" width="14" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="3" width="157" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="159" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="203" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1">&nbsp;</td>
</tr>
</table>

<p style="margin:3pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">(a)&nbsp;&nbsp;The valuation technique used as a basis to approximate fair value of these investments is based upon subsequent financing rounds. There is no quantitative information as these methods of measure are investment specific.</font></p>
<p style="margin:6pt 0pt 0pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><i>(5) Private Companies and Other Restricted Securities</i></font></p>
<p style="margin:0pt 0pt 4pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">The Fund may invest in private companies and other restricted securities if these securities would currently comprise 40% or less of net assets. The value of these securities represented 4% of the Fund's net assets at September 30, 2017.</font></p>
<p style="margin:0pt 0pt 4pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">At September 30, 2017 the Fund had a commitment of $900,000 relating to additional investments in one private company.</font></p>
<p style="margin:0pt 0pt 4pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">The following table details the acquisition date, cost, carrying value per unit, and value of the Fund's private companies and other restricted securities at September 30, 2017. The Fund on its own does not have the right to demand that such securities be registered.</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="3" width="159" align="left" valign="bottom" style="padding:6pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Security (#)</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="76" align="center" valign="bottom" style="padding:6pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Acquisition<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Date</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="80" align="center" valign="bottom" style="padding:6pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Cost</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="88" align="center" valign="bottom" style="padding:6pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Carrying Value<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">per Unit</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="80" align="center" valign="bottom" style="padding:6pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Value</font></p></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="159" bgcolor="#cceeff" align="left" valign="bottom" style="padding:9pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Afferent Milestone Interest</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="76" bgcolor="#cceeff" align="left" valign="bottom" style="padding:9pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">7/27/16</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" align="right" valign="bottom" style="padding:9pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="52" bgcolor="#cceeff" align="right" valign="bottom" style="padding:9pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">1,123,622</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:9pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" align="right" valign="bottom" style="padding:9pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="60" bgcolor="#cceeff" align="right" valign="bottom" style="padding:9pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">1,116,688.42</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:9pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" align="right" valign="bottom" style="padding:9pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="52" bgcolor="#cceeff" align="right" valign="bottom" style="padding:9pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">1,116,688</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:9pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="19" width="499" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">AlterG, Inc.</font></p></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="159" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Series C Cvt. Pfd</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="76" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">4/12/13</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">1,427,310</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="60" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">0.37</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">865,133</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="159" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Cvt. Promissory Note</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="76" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">9/8/17</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">12,336</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="60" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">100.00</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">12,336</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="159" bgcolor="#cceeff" align="left" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Amphivena Therapeutics, Inc. Series B Cvt. Pfd</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="76" bgcolor="#cceeff" align="left" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">7/17/17</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" bgcolor="#cceeff" align="right" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">2,100,000</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="60" bgcolor="#cceeff" align="right" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">1.50</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" bgcolor="#cceeff" align="right" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">2,100,000</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="19" width="499" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">BioClin Therapeutics, Inc.</font></p></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="159" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Series A Cvt. Pfd</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="76" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">1/19/16, 10/24/16</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">750,495</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="60" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">0.65</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">750,001</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="159" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Series B Cvt. Pfd</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="76" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">3/3/17</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">333,333</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="60" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">0.75</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">333,333</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="19" width="499" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">CardioKinetix, Inc.</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="159" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Series C Cvt. Pfd</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="76" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">5/22/08</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">1,653,409</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="60" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">0.00</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">0</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="159" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Series D Cvt. Pfd</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="76" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">12/10/10</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">546,109</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="60" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">0.00</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">0</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="159" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Series E Cvt. Pfd</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="76" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">9/14/11</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">1,254,131</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="60" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">0.00</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">0</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="159" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Series F Cvt. Pfd</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="76" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">12/04/14</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">1,645,495</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="60" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">0.00</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">0</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="159" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Cvt. Promissory Note</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="76" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">6/20/17</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">51,741</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="60" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">0.00</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">0</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="159" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Warrants (expiration 12/11/19)</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="76" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">12/10/09, 2/11/10</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">123</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="60" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">0.00</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">0</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="159" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Warrants (expiration 6/03/20)</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="76" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">6/03/10, 9/01/10</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">123</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="60" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">0.00</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">0</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="159" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Warrants (expiration 8/15/24)</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="76" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">8/15/14</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">136</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="60" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">0.00</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">0</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
</table>

</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times"><br>29</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=31,FOLIO='29',FILE='17-24477-2.fa',USER='pvangb',CD='' -->
<br clear="all" style="page-break-before:always;">
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 6pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:19pt;"><b>TEKLA LIFE SCIENCES INVESTORS</b></font></p>
<p style="margin:2pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:12pt;"><b>NOTES TO FINANCIAL STATEMENTS</b></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:11pt;"><i>SEPTEMBER 30, 2017</i></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">(continued)</font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="3" width="159" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Security (#)</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="76" align="center" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Acquisition<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Date</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="80" align="center" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Cost</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="88" align="center" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Carrying Value<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">per Unit</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="80" align="center" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Value</font></p></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="159" bgcolor="#cceeff" align="left" valign="bottom" style="padding:9pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Cercacor Laboratories, Inc. Common</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="76" bgcolor="#cceeff" align="left" valign="bottom" style="padding:9pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">3/31/98</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" align="right" valign="bottom" style="padding:9pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="52" bgcolor="#cceeff" align="right" valign="bottom" style="padding:9pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">0</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:9pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" align="right" valign="bottom" style="padding:9pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="60" bgcolor="#cceeff" align="right" valign="bottom" style="padding:9pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">2.19</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:9pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" align="right" valign="bottom" style="padding:9pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="52" bgcolor="#cceeff" align="right" valign="bottom" style="padding:9pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">284,302</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:9pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="159" align="left" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">EBI Life Sciences, Inc. Series A Cvt. Pfd</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="76" align="left" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">12/29/11&dagger;</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" align="right" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">13,597</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="60" align="right" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">0.01</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" align="right" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">13,102</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="19" width="499" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Euthymics Biosciences, Inc.</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="159" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Series A Cvt. Pfd</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="76" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">7/14/10 - 5/21/12</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">2,637,247</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="60" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">0.00</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">0</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="159" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Cvt. Promissory Note</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="76" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">5/22/17</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">26,940</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="60" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">0.00</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">0</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="159" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Cvt. Promissory Note</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="76" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">7/17/17</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">8,975</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="60" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">0.00</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">0</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="159" bgcolor="#cceeff" align="left" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">GenomeDx Biosciences, Inc. Series C Cvt. Pfd</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="76" bgcolor="#cceeff" align="left" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">2/22/16</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" bgcolor="#cceeff" align="right" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">1,401,589</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="60" bgcolor="#cceeff" align="right" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">1.50</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" bgcolor="#cceeff" align="right" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">1,400,000</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="19" width="499" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">IlluminOss Medical, Inc.</font></p></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="159" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Series AA Cvt. Pfd</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="76" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">1/21/16</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">956,841</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="60" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">0.00</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">0</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="159" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Junior Preferred Cvt. Pfd</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="76" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">1/21/16</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">1,561,759</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="60" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">0.00</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">0</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="159" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Cvt. Promissory Note</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="76" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">3/28/17</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">285,385</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="60" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">50.00</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">142,647</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="159" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Warrants (expiration 3/31/27)</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="76" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">3/28/17</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">45</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="60" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">0.00</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">0</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="159" bgcolor="#cceeff" align="left" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">InnovaCare Health, Inc. Common</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="76" bgcolor="#cceeff" align="left" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">12/21/12&dagger;</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" bgcolor="#cceeff" align="right" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">643,527</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="60" bgcolor="#cceeff" align="right" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">2.18</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" bgcolor="#cceeff" align="right" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">322,963</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="19" width="499" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Labcyte, Inc.</font></p></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="159" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Series C Cvt. Pfd</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="76" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">7/18/05</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">1,284,768</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="60" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">1.26</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">3,081,980</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="159" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Series D Cvt. Pfd</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="76" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">12/21/12</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">68,643</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="60" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">1.38</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">147,906</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="159" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Series E Cvt. Pfd</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="76" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">3/27/17</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">70,827</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="60" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">1.61</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">131,183</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="19" width="499" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Milestone Pharmaceuticals, Inc.</font></p></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="159" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Series C Cvt. Pfd</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="76" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">7/17/17</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">900,000</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="60" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">1.37</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">900,000</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="159" align="left" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Neurovance Milestone Interest</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="76" align="left" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">3/20/17</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" align="right" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">3,414,295</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="60" align="right" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">3,406,861</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" align="right" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">3,406,861</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="159" bgcolor="#cceeff" align="left" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Ovid Therapeutics Inc. Common</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="76" bgcolor="#cceeff" align="left" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">8/7/15</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" bgcolor="#cceeff" align="right" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">1,500,844</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="60" bgcolor="#cceeff" align="right" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">7.71</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" bgcolor="#cceeff" align="right" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">863,748</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="159" align="left" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">TargeGen Milestone Interest</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="76" align="left" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">7/20/10</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" align="right" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">2,965,449</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="60" align="right" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">137,447</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" align="right" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">137,447</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="159" bgcolor="#cceeff" align="left" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">TherOx, Inc. Common</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="76" bgcolor="#cceeff" align="left" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">9/11/00, 7/8/05</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" bgcolor="#cceeff" align="right" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">2,388,426</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="60" bgcolor="#cceeff" align="right" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">0.02</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" bgcolor="#cceeff" align="right" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">143</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="19" width="499" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Tibion Corporation</font></p></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="159" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Series B Cvt. Pfd</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="76" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">2/23/11</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">905,158</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="60" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">0.00</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">0</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="159" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Non-Cvt. Promissory Note</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="76" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">7/12/12</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">238,497</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="60" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">0.00</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">0</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="159" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Non-Cvt. Promissory Note</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="76" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">4/12/13</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">28,211</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="60" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">0.00</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">0</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="159" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Warrants (expiration 10/30/17)</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="76" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">10/30/12</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">0</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="60" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">0.00</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">0</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="159" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Warrants (expiration 11/28/17)</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="76" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">11/28/12</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">0</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="60" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">0.00</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">0</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="19" width="499" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Veniti, Inc.</font></p></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="159" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Series A Cvt. Pfd</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="76" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">2/28/11</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">2,276,891</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="60" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">0.60</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">1,563,620</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="159" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Series B Cvt. Pfd</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="76" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">5/24/13</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">1,199,887</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="60" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">0.63</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">823,516</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="159" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Series C Cvt. Pfd</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="76" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">12/12/14</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">821,337</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="60" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">0.74</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">530,373</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="159" align="left" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">Verona Pharma plc Common</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="76" align="left" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">4/27/17</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" align="right" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">1,759,826</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="60" align="right" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">1.69</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="20" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" align="right" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">1,568,612</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:3pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="159" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="76" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="52" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">38,257,327</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="3" width="88" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="20" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">$</font></p></td>
<td colspan="1" width="52" bgcolor="#cceeff" align="right" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">20,495,894</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:2.5pt .7pt 0pt 0pt; border:none; border-top:solid windowtext 1pt;border-bottom:double windowtext 2.25pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
</table>

<p style="margin:3pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&nbsp;&nbsp;(#)&nbsp;&nbsp;See Schedule of Investments and corresponding footnotes for more information on each issuer.</font></p>
<p style="margin:0pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:7pt;">&nbsp;&nbsp;&dagger;&nbsp;&nbsp;Interest received as part of a corporate action for a previously owned security.</font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times"><br>30</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=32,FOLIO='30',FILE='17-24477-2.fa',USER='pvangb',CD='' -->
<br clear="all" style="page-break-before:always;">


<br clear="all" style="page-break-before:always;">
<!-- Document name: 17-24477-2.ga-->
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:11pt;"><b>REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</b></font></p>
<p style="margin:6pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><i>To the Board of Trustees and Shareholders of Tekla Life Sciences Investors:</i></font></p>
<p style="margin:4pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">We have audited the accompanying statement of assets and liabilities of Tekla Life Sciences Investors (the "Fund"), including the schedule of investments, as of September 30, 2017, the related statement of operations for the year then ended, the statements of changes in net assets for each of the two years in the period then ended, and the financial highlights for each of the five years in the period then ended. These financial statements and financial highlights are the responsibility of the Fund's management. Our responsibility is to express an opinion on these financial statements and financial highlights based on our audits.</font></p>
<p style="margin:4pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements and financial highlights are free of material misstatement. The Fund is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. Our audits included consideration of internal control over financial reporting as a basis for designing audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Fund's internal control over financial reporting. Accordingly, we express no such opinion. An audit also includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements, assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. Our procedures included confirmation of securities owned as of September 30, 2017, by correspondence with the custodian and brokers; where replies were not received from brokers, we performed other auditing procedures. We believe that our audits provide a reasonable basis for our opinion.</font></p>
<p style="margin:4pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">In our opinion, such financial statements and financial highlights referred to above present fairly, in all material respects, the financial position of Tekla Life Sciences Investors as of September 30, 2017, the results of its operations for the year then ended, the changes in its net assets for each of the two years in the period then ended, and the financial highlights for each of the five years in the period then ended, in conformity with accounting principles generally accepted in the United States of America.</font></p>
<p style="margin:6pt 0pt 0pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">DELOITTE &amp; TOUCHE LLP<BR>Boston, Massachusetts<BR>November 20, 2017</font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times"><br>31</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=33,FOLIO='31',FILE='17-24477-2.ga',USER='bjonesc',CD='Nov 23 01:53 2017' -->
<br clear="all" style="page-break-before:always;">
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 6pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:19pt;"><b>TEKLA LIFE SCIENCES INVESTORS</b></font></p>
<p style="margin:2pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:12pt;"><b>TRUSTEES</b></font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="3" width="118" align="center" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Name, Address</b><b><sup>1<BR></sup></b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>and Date of Birth</b></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="163" align="center" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Position(s) Held with<BR></b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Fund, Term of Office</b><b><sup>2</sup></b><b> and<BR></b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Length of Time Served</b></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="3076" align="center" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Principal Occupation(s)<BR></b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>During Past 5 Years and<BR></b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Other Directorship(s) Held</b></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="106" align="center" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Number of<BR></b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Portfolios in Fund<BR></b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Complex Overseen<BR></b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>by Trustee</b></font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="15" width="3463" align="center" valign="bottom" style="padding:6pt .7pt 3pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b><i>Independent Trustees:</i></b></font></p></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="118" align="left" valign="top" style="padding:1pt .7pt 6pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Michael W. Bonney<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">8/1958</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="163" align="left" valign="top" style="padding:1pt .7pt 6pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Trustee (since 2011)</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="3076" align="left" valign="top" style="padding:1pt .7pt 6pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Chief Executive Officer and Chairman of the Board of Trustees, Kaleido Biosciences (since 2017); Partner, Third Rock Ventures (2016); Chief Executive Officer and Director, Cubist Pharmaceuticals, Inc. (2012-2015); President, Chief Executive Officer and Director, Cubist Pharmaceuticals, Inc. (2002-2012); Director, Magenta Therapeutics (since 2016); Director, Global Blood Therapeutics (since 2016); Director, Revolution Medicine (since 2016); Director, Celgene Corporation (since 2015); Director, Whitehead Institute (since 2015); Director, Alnylam Pharmaceuticals, Inc. (since 2014); Director, Gulf of Maine Research Institute (since 2015); Director, NPS Pharmaceuticals, Inc. (2012-2015); Chairman of the Board of Trustees, Bates College (since 2010); Board member of Pharmaceutical Research and Manufacturers of America (PhRMA) (2009-2014) Trustee, Bates College (since 2002).</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="8" valign="top" style="padding:1pt .7pt 6pt 0pt;">
</td>
<td colspan="1" width="90" align="right" valign="top" style="padding:1pt .7pt 6pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">4</font></p></td>
<td colspan="1" width="8" valign="top" style="padding:1pt .7pt 6pt 0pt;">
</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="118" align="left" valign="top" style="padding:1pt .7pt 6pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Rakesh K. Jain, Ph.D.<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">12/1950</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="163" align="left" valign="top" style="padding:1pt .7pt 6pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Trustee (since 2007)</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="3076" align="left" valign="top" style="padding:1pt .7pt 6pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Director, Steele Lab of Tumor Biology at Massachusetts General Hospital (since 1991); A.W. Cook Professor of Tumor Biology (Radiation Oncology) at Harvard Medical School (since 1991); Ad hoc Consultant/Scientific Advisory Board Member for pharmaceutical/biotech companies (various times since 2002); Ad hoc Consultant, Gershon Lehman Group (since 2004); Director, Co-Founder, XTuit Pharmaceuticals, Inc. (since 2012).</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="8" valign="top" style="padding:1pt .7pt 6pt 0pt;">
</td>
<td colspan="1" width="90" align="right" valign="top" style="padding:1pt .7pt 6pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">4</font></p></td>
<td colspan="1" width="8" valign="top" style="padding:1pt .7pt 6pt 0pt;">
</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="118" align="left" valign="top" style="padding:1pt .7pt 6pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Oleg M. Pohotsky, M.B.A, J.D.<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">3/1947</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="163" align="left" valign="top" style="padding:1pt .7pt 6pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Trustee (since 2000)<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Chairman (since 2012)</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="3076" align="left" valign="top" style="padding:1pt .7pt 6pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Consultant and Managing Partner, Right Bank Partners (since 2002); Adviser, Board Advisers, Kaufman &amp; Co. LLC (since 2008); Director, AvangardCo Investment Holdings (since 2011); Director, The New America High Income Fund, Inc. (since 2013).</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="8" valign="top" style="padding:1pt .7pt 6pt 0pt;">
</td>
<td colspan="1" width="90" align="right" valign="top" style="padding:1pt .7pt 6pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">4</font></p></td>
<td colspan="1" width="8" valign="top" style="padding:1pt .7pt 6pt 0pt;">
</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
</table>

</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times"><br>32</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=34,FOLIO='32',FILE='17-24477-2.ga',USER='bjonesc',CD='Nov 23 01:53 2017' -->
<br clear="all" style="page-break-before:always;">
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 6pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:19pt;"><b>TEKLA LIFE SCIENCES INVESTORS</b></font></p>
<p style="margin:2pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:12pt;"><b>TRUSTEES</b></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">(continued)</font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="3" width="118" align="center" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Name, Address</b><b><sup>1<BR></sup></b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>and Date of Birth</b></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="163" align="center" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Position(s) Held with<BR></b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Fund, Term of Office</b><b><sup>2</sup></b><b> and<BR></b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Length of Time Served</b></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="3076" align="center" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Principal Occupation(s)<BR></b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>During Past 5 Years and<BR></b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Other Directorship(s) Held</b></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="106" align="center" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Number of<BR></b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Portfolios in Fund<BR></b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Complex Overseen<BR></b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>by Trustee</b></font></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="118" align="left" valign="top" style="padding:7pt .7pt 6pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">William S. Reardon<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">6/1946</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="163" align="left" valign="top" style="padding:7pt .7pt 6pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Trustee (since 2010)</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="3076" align="left" valign="top" style="padding:7pt .7pt 6pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Certified Public Accountant (until 2017); Independent Consultant (since 2002); Director, Idera Pharmaceuticals, Inc (since 2002); Director, Synta Pharmaceuticals, Inc. (2004-2016).</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="8" valign="top" style="padding:7pt .7pt 6pt 0pt;">
</td>
<td colspan="1" width="90" align="right" valign="top" style="padding:7pt .7pt 6pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">4</font></p></td>
<td colspan="1" width="8" valign="top" style="padding:7pt .7pt 6pt 0pt;">
</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="118" align="left" valign="top" style="padding:1pt .7pt 6pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Uwe E. Reinhardt, Ph.D.<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">9/1937 (deceased 11/2017)</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="163" align="left" valign="top" style="padding:1pt .7pt 6pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Trustee (since 1998)</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="3076" align="left" valign="top" style="padding:1pt .7pt 6pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Professor of Economics, Princeton University (since 1968); Director, Boston Scientific Corporation (2002-2015); Director, Amerigroup, Inc. (2002-2012).</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="8" valign="top" style="padding:1pt .7pt 6pt 0pt;">
</td>
<td colspan="1" width="90" align="right" valign="top" style="padding:1pt .7pt 6pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">4</font></p></td>
<td colspan="1" width="8" valign="top" style="padding:1pt .7pt 6pt 0pt;">
</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="118" align="left" valign="top" style="padding:1pt .7pt 6pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Lucinda H. Stebbins, CPA<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">11/1945</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="163" align="left" valign="top" style="padding:1pt .7pt 6pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Trustee (since 2006)</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="3076" align="left" valign="top" style="padding:1pt .7pt 6pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Independent Consultant, Deutsche Bank (2004-2015); Director, Bald Peak Land Company, Inc. (2008-2014); Director, Solstice Home Care, Inc. (since 2014)</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="8" valign="top" style="padding:1pt .7pt 6pt 0pt;">
</td>
<td colspan="1" width="90" align="right" valign="top" style="padding:1pt .7pt 6pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">4</font></p></td>
<td colspan="1" width="8" valign="top" style="padding:1pt .7pt 6pt 0pt;">
</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="118" align="left" valign="bottom" style="padding:6pt .7pt 3pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b><i>Interested Trustee:</i></b></font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="163" valign="bottom" style="padding:6pt .7pt 3pt 0pt;">
&nbsp;</td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="3076" valign="bottom" style="padding:6pt .7pt 3pt 0pt;">
&nbsp;</td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="106" valign="bottom" style="padding:6pt .7pt 3pt 0pt;">
&nbsp;</td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="118" align="left" valign="top" style="padding:1pt .7pt 6pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Daniel R Omstead, Ph.D.<sup>3<BR></sup></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">7/1953</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="163" align="left" valign="top" style="padding:1pt .7pt 6pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">President (since 2001);Trustee (since 2003)</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="3076" align="left" valign="top" style="padding:1pt .7pt 6pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">President of the Fund, Tekla Healthcare Investors (HQH) (since 2001),Tekla Healthcare Opportunities Fund (THQ) (since 2014) and Tekla World Healthcare Fund (THW) (since 2015); President, Chief Executive Officer and Managing Member of Tekla Capital Management LLC (since 2002); Celladon Corporation (2012-2014); Concentric Medical, Inc. (2008-2012); Dynex Corporation (since 2011); EBI Life Sciences, Inc. (since 2015); Euthymics Biosciences, Inc. (since 2015); GenomeDx Biosciences Inc. (since 2016); IlluminOss Medical, Inc. (since 2011); Insightra Medical, Inc. (since 2015); Magellan Diagnostics, Inc. (2006-2016); Neurovance, Inc. (since 2015); Palyon Medical Corporation (2009 2015); Tibion Corporation (2011-2013) and Veniti, Inc. (since 2015).</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="8" valign="top" style="padding:1pt .7pt 6pt 0pt;">
</td>
<td colspan="1" width="90" align="right" valign="top" style="padding:1pt .7pt 6pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">4</font></p></td>
<td colspan="1" width="8" valign="top" style="padding:1pt .7pt 6pt 0pt;">
</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
</table>

<p style="margin:0pt 0pt 3pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><sup>1</sup>&nbsp;&nbsp;The Address for each Trustee is: Tekla Life Sciences Investors, 100 Federal Street, 19th Floor, Boston, Massachusetts, 02110, 617-772-8500.</font></p>
<p style="margin:0pt 0pt 3pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><sup>2</sup>&nbsp;&nbsp;Each Trustee currently is serving a three year term.</font></p>
<p style="margin:0pt 0pt 3pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><sup>3</sup>&nbsp;&nbsp;Trustee considered to be an "interested person" within the meaning of the Investment Company Act of 1940, as amended (the "1940 Act"), through position or affiliation with the Adviser.</font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times"><br>33</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=35,FOLIO='33',FILE='17-24477-2.ga',USER='bjonesc',CD='Nov 23 01:53 2017' -->
<br clear="all" style="page-break-before:always;">
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 6pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:19pt;"><b>TEKLA LIFE SCIENCES INVESTORS</b></font></p>
<p style="margin:2pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:12pt;"><b>OFFICERS</b></font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="3" width="104" align="center" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Name, Address</b><b><sup>1<BR></sup></b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>and Date of Birth</b></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="140" align="center" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Position(s) Held with<BR></b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Fund, Term of Office</b><b><sup>2</sup></b><b> and<BR></b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Length of Time Served</b></font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="2312" align="center" valign="bottom" style="padding:0pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>Principal Occupation(s) During Past 5 Years</b></font></p></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="104" align="left" valign="top" style="padding:7pt .7pt 6pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Daniel R. Omstead, Ph.D.<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">7/1953</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="140" align="left" valign="top" style="padding:7pt .7pt 6pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">President (since 2001);<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Trustee (since 2003)</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="2312" align="left" valign="top" style="padding:7pt .7pt 6pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">President of the Fund HQH (since 2001),THQ (since 2014) and THW (since 2015); President, Chief Executive Officer and Managing Member of Tekla Capital Management LLC (since 2002); Celladon Corporation (2012-2014); Concentric Medical, Inc. (2008-2012); Dynex Corporation (since 2011); EBI Life Sciences, Inc. (since 2015); Euthymics Biosciences, Inc. (since 2015); GenomeDx Biosciences Inc. (since 2016); IlluminOss Medical, Inc. (since 2011); Insightra Medical, Inc. (since 2015); Magellan Diagnostics, Inc. (2006-2016); Neurovance, Inc. (since 2015); Palyon Medical Corporation (2009 2015); Tibion Corporation (2011-2013) and Veniti, Inc. (since 2015).</font></p></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="104" align="left" valign="top" style="padding:7pt .7pt 6pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Laura Woodward, CPA<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">11/1968</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="140" align="left" valign="top" style="padding:7pt .7pt 6pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Chief Compliance Officer, Secretary<BR></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">and Treasurer (since 2009)</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="2312" align="left" valign="top" style="padding:7pt .7pt 6pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Chief Compliance Officer, Secretary and Treasurer, the Fund, HQH (since 2009), THQ (since 2014) and THW (since 2015); Chief Compliance Officer and Vice President of Fund Administration, Tekla Capital Management LLC (since 2009); Senior Manager, PricewaterhouseCoopers LLP (1990-2009).</font></p></td>
<td colspan="1">&nbsp;</td>
</tr>
</table>

<p style="margin:0pt 0pt 3pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><sup>1</sup>&nbsp;&nbsp;The Address for each officer is: Tekla Life Sciences Investors; 100 Federal Street, 19th Floor, Boston, Massachusetts, 02110, 617-772-8500.</font></p>
<p style="margin:0pt 0pt 3pt 0pt;" align="left"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><sup>2</sup>&nbsp;&nbsp;Each officer serves in such capacity for an indefinite period of time at the pleasure of the Trustees.</font></p>
<p style="margin:4pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:9pt;">The Fund's Statement of Additional Information includes additional information about the Fund's Trustees and is available without charge, upon request by calling (617) 772-8500 or writing to Tekla Capital Management LLC at 100 Federal, 19th Floor, Boston, MA 02110.</font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times"><br>34</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=36,FOLIO='34',FILE='17-24477-2.ga',USER='bjonesc',CD='Nov 23 01:53 2017' -->
<br clear="all" style="page-break-before:always;">
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 6pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:19pt;"><b>TEKLA LIFE SCIENCES INVESTORS</b></font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>ANNUAL MEETING REPORT:</b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"> An Annual Meeting of Shareholders was held on June 15, 2017. Shareholders voted to elect Trustees of the Fund to hold office for a term of three years or until their respective successors shall have been duly elected and qualified. The following votes were cast with respect to each of the nominees:</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td colspan="3" width="119" valign="bottom" style="padding:2pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="68" align="center" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">For</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="61" align="center" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Withheld</font></p></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="119" bgcolor="#cceeff" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Oleg Pohotsky, MBA, J.D.</font></p></td>
<td colspan="1" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">18,714,751</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="45" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">552,967</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
<tr>
<td colspan="3" width="119" align="left" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">William S. Reardon</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">18,766,073</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="45" align="right" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">501,645</font></p></td>
<td colspan="1" width="8" valign="bottom" style="padding:0pt .7pt 0pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8">&nbsp;</td>
</tr>
</table>

<p style="margin:6pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Oleg Pohotsky, MBA, J.D. and William S. Reardon, were elected to serve until the 2020 Annual Meeting.</font></p>
<p style="margin:6pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Trustees serving until the 2018 Annual Meeting are Daniel R. Omstead, Ph.D. and Lucinda H. Stebbins, CPA.</font></p>
<p style="margin:6pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Trustees serving until the 2019 Annual Meeting are Michael W. Bonney, Rakesh K. Jain, Ph.D. and Uwe E. Reinhardt, Ph. D.</font></p>
<p style="margin:6pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Shareholders ratified the appointment of Deloitte &amp; Touche LLP as the independent registered public accountants of the Fund for the fiscal year ending September 30, 2017 by the following votes:</font></p>
<table border="0" cellspacing="0" cellpadding="0">
<tr>
<td colspan="3" width="119" align="center" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">For</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="68" align="center" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Against</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="61" align="center" valign="bottom" style="padding:2pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Abstain</font></p></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
&nbsp;</td>
<td colspan="1" width="103" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">18,852,213</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">190,061</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
&nbsp;</td>
<td colspan="1" width="45" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">225,445</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
</table>

<p style="margin:6pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Shareholders opposed a shareholder proposal regarding annual terms of trustees by the following votes:</font></p>
<table border="0" cellspacing="0" cellpadding="0">
<tr>
<td colspan="3" width="64" align="center" valign="bottom" style="padding:6pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">For</font></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="64" align="center" valign="bottom" style="padding:6pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Against</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="58" align="center" valign="bottom" style="padding:6pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Abstain</font></p></td>
<td colspan="1">&nbsp;</td>
<td colspan="3" width="68" align="center" valign="bottom" style="padding:6pt .7pt 0pt 0pt; border:none; border-bottom:solid windowtext 1pt;">
<p style="margin:0pt 0pt 0pt 0pt"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Non-Votes</font></p></td>
<td colspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
&nbsp;</td>
<td colspan="1" width="48" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
<font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">2,992,916</font></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
&nbsp;</td>
<td colspan="1" width="48" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">4,988,619</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
&nbsp;</td>
<td colspan="1" width="42" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">432,040</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
&nbsp;</td>
<td colspan="1" width="52" bgcolor="#cceeff" align="right" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt; white-space:nowrap"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">10,854,144</font></p></td>
<td colspan="1" width="8" bgcolor="#cceeff" valign="bottom" style="padding:0pt .7pt 2pt 0pt;">
&nbsp;</td>
<td colspan="1" width="8" bgcolor="#cceeff">&nbsp;</td>
</tr>
</table>

<p style="margin:4pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>FOR MORE INFORMATION:</b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"> A description of the Fund's proxy voting policies and procedures and information on how the Fund voted proxies relating to portfolio securities during the most recent 12-month period ended June 30 is available (i) without charge, upon request by calling 1-800-451-2597; (ii) by writing to Tekla Capital Management LLC at 100 Federal Street, 19th Floor, Boston, MA 02110; (iii) on the Fund's website at www.teklacap.com; and (iv) on the SEC's website at http://www.sec.gov.</font></p>
<p style="margin:4pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">The Fund's complete Schedule of Investments for the first and third quarters of its fiscal year will be filed quarterly with the SEC on Form N-Q. This Schedule of Investments will also be available on the Fund's website at www.teklacap.com, or the SEC's website at http://www.sec.gov. The Fund's Form N-Q may be reviewed and copied at the SEC's Public Reference Room in Washington, DC or by calling 1-800-SEC-0330.</font></p>
<p style="margin:4pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">You can find information regarding the Fund at the Fund's website, www.teklacap.com. The Fund regularly posts information to its website, including information regarding daily share pricing and distributions and press releases, and maintains links to the Fund's SEC filings. The Fund currently publishes and distributes quarterly fact cards, including performance, portfolio and sector information for each fiscal quarter. These fact cards will be available on the Fund's website and by request from the Fund's marketing and investor support services agent, Destra Capital Investments, at 1-877-855-3434.</font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times"><br>35</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=37,FOLIO='35',FILE='17-24477-2.ga',USER='bjonesc',CD='Nov 23 01:53 2017' -->
<br clear="all" style="page-break-before:always;">
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 6pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:19pt;"><b>TEKLA LIFE SCIENCES INVESTORS</b></font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>FEDERAL TAX INFORMATION (unaudited):</b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"> Certain information for the Fund is required to be provided to shareholders based on the Fund's income and distributions for the taxable year ended December 31, 2017. In February 2018, shareholders will receive Form 1099-DIV, which will include their share of qualified dividends and capital gains and return of capital distributed during the calendar year 2017. Shareholders are advised to check with their tax advisors for information on the treatment of these amounts on their individual tax returns.</font></p>
<p style="margin:4pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">For corporate shareholders, 0.00% of ordinary income dividends paid by the Fund qualified for the dividends received deduction during the period July 31, 2017 to September 30, 2017.</font></p>
<p style="margin:4pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;">Under Section 854(b)(2) of the Code, the Fund designated $0 as qualified dividends for the year ended September 30, 2017.</font></p>
<p style="margin:4pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>DISTRIBUTION POLICY:</b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"> The Fund has a fixed distribution policy as described in the Notes to Financial Statements. For more information contact your financial adviser.</font></p>
<p style="margin:4pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>SHARE REPURCHASE PROGRAM:</b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"> In March 2017, the Trustees approved the renewal of the repurchase program to allow the Fund to repurchase up to 12% of its outstanding shares in the open market for a one year period ending July 14, 2018.</font></p>
<p style="margin:4pt 0pt 0pt 0pt;"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"><b>PORTFOLIO MANAGEMENT:</b></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:8pt;"> Daniel R. Omstead, Ph.D., Jason C. Akus, M.D./M.B.A., Timothy Gasperoni, M.B.A, Ph.D., Christian M. Richard, M.B.A, M.S., Henry Skinner Ph.D., Christopher Abbott, Robert Benson, CFA, CAIA, Amanda Birdsey-Benson, Ph.D. and Alan Kwan, M.B.A, Ph.D. are members of a team that analyzes investments on behalf of the Fund. Dr. Omstead exercises ultimate decision making authority with respect to investments.</font></p>
</div>
<div style="margin:8pt 0pt 8pt 0pt;">
</div>
<p align="center"><font size="2" face="Times New Roman PS, Times New Roman, Times"><br>36</font></p>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=38,FOLIO='36',FILE='17-24477-2.ga',USER='bjonesc',CD='Nov 23 01:53 2017' -->
<br clear="all" style="page-break-before:always;">


<br clear="all" style="page-break-before:always;">
<!-- Document name: 17-24477-2.za-->
<div style="margin:8pt 0pt 8pt 0pt;">
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:16pt;"><b>TEKLA LIFE SCIENCES INVESTORS</b></font></p>
<p style="margin:7pt 0pt 6pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">New York Stock Exchange Symbol: HQL<BR>NAV Symbol: XHQLX</font></p>
<p style="margin:7pt 0pt 6pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">100 Federal Street, 19th Floor<BR>Boston, Massachusetts 02110<BR>(617) 772-8500<BR>www.teklacap.com</font></p>
<p style="margin:5pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><b>Officers</b></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Daniel R. Omstead, Ph.D., President<BR>Laura Woodward, CPA, Chief Compliance Officer,<BR>Secretary and Treasurer</font></p>
<p style="margin:5pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><b>Trustees</b></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Michael W. Bonney<BR>Rakesh K. Jain, Ph.D.<BR>Daniel R. Omstead, Ph.D.<BR>Oleg M. Pohotsky, M.B.A., J.D.<BR>William S. Reardon<BR>Uwe E. Reinhardt, Ph.D.<BR>Lucinda H. Stebbins, CPA</font></p>
<p style="margin:5pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><b>Investment Adviser</b></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Tekla Capital Management LLC</font></p>
<p style="margin:5pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><b>Administrator &amp; Custodian</b></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">State Street Bank and Trust Company</font></p>
<p style="margin:5pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><b>Transfer Agent</b></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Computershare, Inc.</font></p>
<p style="margin:5pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><b>Legal Counsel</b></font></p>
<p style="margin:0pt 0pt 11pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Dechert LLP</font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Shareholders with questions regarding share transfers may call</font></p>
<p style="margin:0pt 0pt 7pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:14pt;"><b>1-800-426-5523</b></font></p>
<p style="margin:0pt 0pt 0pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">Daily net asset value may be obtained from<BR>our website (</font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;"><i>www.teklacap.com</i></font><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:10pt;">) or by calling</font></p>
<p style="margin:0pt 0pt 7pt 0pt;" align="center"><font face="Times New Roman PS Std, Times New Roman PS, Times New Roman, Times" style="font-size:14pt;"><b>617-772-8500</b></font></p>
</div>
<hr size="3" width="100%" noshade color="gray" align="center">
<!-- SEQ.=39,FOLIO='',FILE='17-24477-2.za',USER='bjonesc',CD='Nov 23 01:53 2017' -->
<br clear="all" style="page-break-before:always;">


<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Item 2.&#160; CODE OF ETHICS.</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>As of the end of the period covered by this report, the Registrant has adopted a code of ethics that applies to the Registrant&#146;s principal executive officer, principal financial officer, principal accounting officer or controller, or persons performing similar functions, regardless of whether these individuals are employed by the Registrant or a third party.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>No disclosures are required by this Item.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>During the period covered by this report, the Registrant did not make any substantive amendment to the code of ethics.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>During the period covered by this report, the Registrant did not grant any waiver, including any implicit waiver, from any provision of the code of ethics.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(e)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Not applicable.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(f)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>A copy of the Registrant&#146;s code is filed as Exhibit&nbsp;1 to this Form&nbsp;N-CSR.&#160; Copies of the Code will also be made available, free of charge, upon request, by writing or calling Tekla Capital Management LLC at 100 Federal Street, 19<font size="1" style="font-size:8.0pt;position:relative;top:-3.0pt;">th</font>&#160;Floor, Boston, MA 02110, 617-772-8500.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">ITEM 3. AUDIT COMMITTEE FINANCIAL EXPERT.</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The Registrant&#146;s Board of Trustees has determined that the Registrant has at least one audit committee financial expert serving on its audit committee.&#160; The audit committee financial expert is Oleg M. Pohotsky.&#160; He is &#147;independent&#148; for the purposes of Item 3.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">ITEM 4. PRINCIPAL ACCOUNTANT FEES AND SERVICES.</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .75in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Audit Fees.&#160; The aggregate fees billed in each of the last two fiscal years for professional services rendered by the principal accountant for the audit of the Registrant&#146;s annual financial statements or services that are normally provided by the accountant in connection with statutory and regulatory filings or engagements for those fiscal years were $111,240 for the fiscal year ended September&nbsp;30, 2017 and $108,000 for the fiscal year ended September&nbsp;30, 2016.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .75in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Audit Related Fees.&#160; The Registrant was not billed any fees in each of the last two fiscal years ended September&nbsp;30 for assurance and related services by the principal accountant that are reasonably related to the performance of the audit of the Registrant&#146;s financial statements and not otherwise included above.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .75in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Tax Fees.&#160; The aggregate fees billed in each of the last two fiscal years for professional services rendered by the principal accountant for tax compliance, tax advice, and tax planning were $5,500 for the fiscal year ended September&nbsp;30, 2017 and $4,650 for the fiscal year ended September&nbsp;30, 2016.&#160; The nature of the services comprising the fees disclosed under this category was tax compliance.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .75in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>All Other Fees.&#160; The aggregate fees billed in each of the last two fiscal years ended September&nbsp;30 for products and services provided by the principal accountant, other than the services reported in paragraphs (a)&nbsp;through (c)&nbsp;of this Item were $0 for the fiscal year ended September&nbsp;30, 2017 and $0 for the fiscal year ended September&nbsp;30, 2016.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .75in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(e)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>(1)&nbsp; Pre-approval Policies and Procedures.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .75in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Pursuant to the Registrant&#146;s Audit Committee Charter (&#147;Charter&#148;), the Audit Committee is responsible for approving in advance the firm to be employed as</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\109925\17-24477-1\task8658105\24477-1-ga.htm',USER='109925',CD='Dec  3 16:34 2017' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .75in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">the Registrant&#146;s independent auditor.&#160; In addition, the Charter provides that the Audit Committee is responsible for approving any and all proposals by the Registrant, its investment adviser or their affiliated persons or any entity controlling, controlled by, or under common control with the adviser that provides services to the Registrant to employ the independent auditor to render permissible non-audit services related directly to the operations and financial reporting of the Registrant.&#160; In determining whether to pre-approve non-audit services, the Audit Committee considers whether such services are consistent with the independent auditor&#146;s independence.&#160; The Charter further permits the Audit Committee to delegate to one or more of its members authority to pre-approve permissible non-audit services to the registrant, provided that any pre-approval determination of a delegate is for services with an estimated budget of less than $15,000.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .75in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(2)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>None of the services described in each of paragraphs (b)&nbsp;through (d)&nbsp;of this Item were approved by the Audit Committee pursuant to paragraph (c)(7)(i)(C)&nbsp;of Rule&nbsp;2-01 of Regulation S-X. All services described in paragraphs (b)&nbsp;though (d)&nbsp;of the NCSR were approved in advance by the Audit Committee of each Fund.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .75in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(f)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Not applicable.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .75in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(g)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>None.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .75in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(h)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Not applicable.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">ITEM 5.&#160; AUDIT COMMITTEE OF LISTED REGISTRANTS.</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The Registrant has a separately-designated standing Audit Committee established in accordance with Section&nbsp;3(a)(58)(A)&nbsp;of the Securities Exchange Act (15 U.S.C. 78c(a)(58)(A)).&#160; The members of the Audit Committee are Oleg M. Pohotsky, Uwe E. Reinhardt (deceased 11/2017), Lucinda H. Stebbins and William S. Reardon.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">ITEM 6.&#160; INVESTMENTS.</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The Registrant&#146;s Schedule of Investments is included as part of the Report to Shareholders filed under Item 1 of this form.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">ITEM 7.&#160; DISCLOSURE OF PROXY VOTING POLICIES AND PROCEDURES FOR CLOSED-END MANAGEMENT INVESTMENT COMPANIES.</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The Registrant has adopted the following proxy voting policies and procedures.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">PROXY VOTING POLICIES AND PROCEDURES</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><u><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Policy</font></u></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The following are the policies and procedures adopted and implemented by Tekla Capital Management LLC (&#147;TCM&#148;) for voting proxies with respect to portfolio securities held by Tekla Healthcare Investors, Tekla Life Sciences Investors, Tekla Healthcare Opportunities Fund and Tekla World Healthcare Fund (each a &#147;Fund&#148; and collectively the &#147;Funds&#148;). The policies and procedures are reasonably designed to ensure that proxies are voted in the best interest of the Funds and the Funds&#146; shareholders, in accordance with TCM&#146;s fiduciary duties and Rule&nbsp;206(4)-6 under the Investment Advisers Act of 1940 (the &#147;Investment Advisers Act&#148;). TCM considers the &#147;best interests&#148; of the Funds and their shareholders to mean their best long-term economic interests.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">TCM shall vote proxies for the exclusive benefit, and in the best economic interest, of the Funds and their shareholders. Such exercise of voting rights shall be subject to the same standard of care as is generally applicable to TCM&#146;s performance of its duties, as set forth in the advisory agreements with the Funds. The policies and procedures contained herein are designed to be guidelines, however each vote is ultimately cast on a case-by-case basis, taking into consideration the relevant facts and circumstances at the time of the vote. Any material conflicts that may arise will be resolved in the best interests of the Funds and their shareholders.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">A proxy committee has been designated and is responsible for administering and overseeing the proxy voting process. The committee consists of the President of TCM, TCM&#146;s Chief Compliance Officer (&#147;CCO&#148;), and the analyst responsible for oversight of the company that is the subject of the proxy.&#160; The committee considers proxy questions and determines the vote on behalf of the Funds.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\109925\17-24477-1\task8658105\24477-1-ga.htm',USER='109925',CD='Dec  3 16:34 2017' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><u><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Procedures</font></u></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Logistics</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">TCM&#146;s CCO shall be responsible for maintaining the proxy log, monitoring corporate actions and confirming the timely voting of proxies. The proxy log shall contain the following information, in accordance with Form&nbsp;N-PX:</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.25in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>the name of the issuer;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.25in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>the exchange ticker symbol, if available;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.25in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>the CUSIP number, if available;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.25in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>the shareholder meeting date;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.25in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>a brief identification of the matter voted on;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.25in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>whether the matter was proposed by the issuer or a security holder;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.25in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>whether TCM cast its vote on the matter;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.25in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>how TCM cast its vote on the matter (for, against, abstain; for or withhold regarding the election of directors); and</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.25in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>whether TCM cast its vote for or against management;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">TCM&#146;s CCO shall also record whether any conflicts of interest have been identified and, if so, what action was taken to resolve the conflict with respect to each vote cast and each abstention.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Substantive Voting Decisions</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">TCM&#146;s substantive voting decisions turn on the particular facts and circumstances of each proxy vote. The following is a list of common proxy vote issues and TCM&#146;s standard considerations when determining how to vote such proxies.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">Routine Matters/Corporate Administrative Items</font></i>. After an initial review, TCM generally votes with management on routine matters related to the operation of the issuer that are not expected to have a significant economic impact on the issuer and/or its shareholders.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">Potential for Major Economic Impact</font></i>. TCM may review and analyze on a case-by-case basis, non-routine proposals that are more likely to affect the structure and operation of the issuer and to have a greater impact on the value of the investment.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">Corporate Governance</font></i>. TCM may review and consider corporate governance issues related to proxy matters and generally supports proposals that foster good corporate governance practices.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">Special Interest Issues</font></i>. TCM may consider: (i)&nbsp;the long-term benefit to shareholders of promoting corporate accountability and responsibility on social issues; (ii)&nbsp;management&#146;s responsibility with respect to special interest issues; (iii)&nbsp;any economic costs and restrictions on management; and (iv)&nbsp;the responsibility of TCM to vote proxies for the greatest long-term shareholder value.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">Limitations on Director Tenure and Retirement</font></i>. TCM may consider: (i)&nbsp;a reasonable retirement age for directors, <i>e.g.</i> 70 or 72; (ii)&nbsp;the introduction of new perspectives on the board; and (iii)&nbsp;the arbitrary nature of such limitations and the possibility of detracting from the board&#146;s stability and continuity.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">Directors&#146; Minimum Stock Ownership</font></i>. TCM may consider: (i)&nbsp;the benefits of additional vested interest; (ii)&nbsp;the ability of a director to serve a company well regardless of the extent of his or her share ownership; and (iii)&nbsp;the impact of limiting the number of persons qualified to be directors.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">D&amp;O Indemnification and Liability Protection</font></i>. TCM may consider: (i)&nbsp;indemnifying directors for acts conducted in the normal course of business; (ii)&nbsp;limiting liability for monetary damages for violating the duty of care; (iii)&nbsp;expanding coverage beyond legal expenses to acts that represent more serious violations of fiduciary obligation than carelessness (<i>e.g.</i> negligence);and (iv)&nbsp;providing expanded coverage in cases when a director&#146;s legal defense was unsuccessful if the director was found to have acted in good faith and in a manner that he or she reasonably believed was in the best interests of the issuer.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">Director Nominations in Contested Elections</font></i>. TCM may consider: (i)&nbsp;long-term financial performance of the issuer relative to its industry; (ii)&nbsp;management&#146;s track record; (iii)&nbsp;background to proxy contest; (iv)&nbsp;qualifications of both slates of nominees; (v)&nbsp;evaluations of what each side is offering shareholders as well as the likelihood that the proposed objectives and goals can be met; and (vi)&nbsp;stock ownership positions.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\109925\17-24477-1\task8658105\24477-1-ga.htm',USER='109925',CD='Dec  3 16:34 2017' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">Cumulative Voting</font></i>. TCM may consider: (i)&nbsp;the ability of significant stockholders to elect a director of their choosing; (ii)&nbsp;the ability of minority shareholders to concentrate their support in favor of a director or directors of their choosing; and (iii)&nbsp;the potential to limit the ability of directors to work for all shareholders.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">Classified Boards</font></i>.&#160; TCM may consider: (i)&nbsp;providing continuity; (ii)&nbsp;promoting long-term planning; and (iii)&nbsp;guarding against unwanted takeovers.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">Poison Pills</font></i>. TCM may consider: (i)&nbsp;TCM&#146;s position on supporting proposals to require a shareholder vote on other shareholder rights plans; (ii)&nbsp;ratifying or redeeming a poison pill in the interest of protecting the value of the issuer; and (iii)&nbsp;other alternatives to prevent a takeover at a price demonstrably below the true value of the issuer.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">Fair Price Provisions</font></i>. TCM may consider: (i)&nbsp;the vote required to approve the proposed acquisition; (ii)&nbsp;the vote required to repeal the fair price provision; (iii)&nbsp;the mechanism for determining fair price; and (iv)&nbsp;whether these provisions are bundled with other anti-takeover measures (<i>e.g.</i>, supermajority voting requirements) that may entrench management and discourage attractive tender offers.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">Equal Access</font></i>. TCM may consider: (i)&nbsp;the opportunity for significant shareholders of the issuer to evaluate and propose voting recommendations on proxy proposals and director nominees, and to nominate candidates to the board; and (ii)&nbsp;the added complexity and burden.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">Charitable Contributions</font></i>. TCM may consider: (i)&nbsp;the potential benefits to shareholders; (ii)&nbsp;the potential to detract the issuer&#146;s resources from more direct uses of increasing shareholder value; and (iii)&nbsp;the responsibility of shareholders to make individual contributions.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">Stock Authorizations</font></i>: TCM may consider: (i)&nbsp;the need for the increase; (ii)&nbsp;the percentage increase with respect to the existing authorization; (iii)&nbsp;voting rights of the stock; and (iv)&nbsp;overall capitalization structures.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">Preferred Stock</font></i>. TCM may consider: (i)&nbsp;whether the new class of preferred stock has unspecified voting, conversion, dividend distribution, and other rights; (ii)&nbsp;whether the issuer expressly states that the stock will not be used as a takeover defense or carry superior voting rights; (iii)&nbsp;whether the issuer specifies the voting, dividend, conversion, and other rights of such stock and the terms of the preferred stock appear reasonable; and (iv)&nbsp;whether the stated purpose is to raise capital or make acquisitions in the normal course of business.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">Director Compensation</font></i>. TCM may consider: (i)&nbsp;whether director shares are at the same market risk as those of the shareholders; and (ii)&nbsp;how option programs for outside directors compare with the standards of internal programs.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">Golden and Tin Parachutes</font></i>. TCM may consider: (i)&nbsp;whether they will be submitted for shareholder approval; and (ii)&nbsp;the employees covered by the plan and the quality of management.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">Compensation. </font></i>TCM may consider: (i)&nbsp;Whether the company has an independent compensation committee; (ii)&nbsp;whether the compensation committee engaged independent consultants; (iii)&nbsp;whether the compensation committee has lapsed or waived equity vesting restrictions; and (iv)&nbsp;whether the company has adopted or extended a Golden Parachute without shareholder approval. TCM will generally support annual advisory votes on executive compensation.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Limitations</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">TCM may abstain from voting a proxy if it concludes that the effect on shareholders&#146; economic interests or the value of the portfolio holding is indeterminable or insignificant. TCM may abstain from voting a proxy if it concludes that the cost of voting is disproportionate to the economic impact the vote would have on the portfolio holdings. With respect to certain privately held companies, TCM may not have the opportunity to vote or may have a limitation on its ability to vote. For example, in certain cases a company may be permitted by its charter or other governing documents to take action without a shareholder meeting and with written consent of fewer than all shareholders.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Conflicts of Interest</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman"><font style="font-size:10.0pt;">The Proxy Committee identifies any potential conflicts of interest.&#160; Each potential conflict must be addressed in a manner which will be in the best interest of the Funds and their shareholders. If any potential conflict is identified the Proxy Committee consults with the Funds&#146; counsel.&#160; Where conflicts of interest arise between clients and TCM, TCM may convene an ad-hoc committee to debate the</font>  </font>conflict and to give a ruling on a preferred course of action. If the ad-hoc committee determines that TCM has a conflict of interest in any instance, TCM&#146;s CCO shall disclose the conflict to the Board and seek voting instructions.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">TCM may cause the proxies to be voted in accordance with the recommendations of an independent third party service provider that TCM may use to assist in voting proxies.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\109925\17-24477-1\task8658105\24477-1-ga.htm',USER='109925',CD='Dec  3 16:34 2017' -->


<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Disclosure</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The following disclosure shall be provided in connection with these policies and procedures:</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .25in;text-indent:-.25in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>TCM shall provide a description or a copy of these policies and procedures to the Boards of Trustees of the Funds annually and upon request.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .25in;text-indent:-.25in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>TCM shall make available to the Funds its proxy voting records, for inclusion on the Funds&#146; Form&nbsp;N-PX.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .25in;text-indent:-.25in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>TCM shall include its proxy voting policies and procedures in its annual filing on Form&nbsp;N-CSR.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .25in;text-indent:-.25in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>TCM shall cause the Funds&#146; shareholder reports to include a statement that a copy of these policies and procedures is available upon request (i)&nbsp;by calling a toll-free number; (ii)&nbsp;on the Funds&#146; website, (if the Funds choose); and (iii)&nbsp;on the SEC&#146;s website.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .25in;text-indent:-.25in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>TCM shall cause the Funds&#146; annual and semi-annual reports to include a statement that information is available regarding how the Funds voted proxies during the most recent twelve-month period (i)&nbsp;without charge, upon request, either by calling a toll-free number or on or through the Funds&#146; website, or both; and (ii)&nbsp;on the SEC&#146;s website.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Recordkeeping</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">TCM shall maintain records of proxies voted in accordance with Section&nbsp;204-2 of the Advisers Act, including proxy statements, a record of each vote cast, and a copy of any document created by the Adviser that was material to making a decision of how to vote the proxy, or that memorializes the basis for the Adviser&#146;s decision on how to vote the proxy. TCM shall also maintain a copy of its policies and procedures and each written request from a client for proxy voting records and the Adviser&#146;s written response to any client request, either written or oral, for such records. Proxy statements that are filed on EDGAR shall be considered maintained by TCM. All such records shall be maintained for a period of five years in an easily accessible place, the first two years in the offices of TCM.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">ITEM 8.&#160; PORTFOLIO MANAGERS OF CLOSED-END MANAGEMENT INVESTMENT COMPANIES.</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)&nbsp;(1)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>As of December&nbsp;5, 2017, Daniel R. Omstead, Ph.D., Jason C. Akus, M.D./M.B.A., Timothy Gasperoni, Ph.D, M.B.A., Christian M. Richard, M.S, M.B.A, Henry Skinner, Ph.D, Amanda Birdsey-Benson, Ph.D., Alan Kwan, Ph.D, M.B.A., Christopher Abbott and Robert Benson, CFA<font size="1" style="font-size:6.5pt;position:relative;top:-3.0pt;">&#174;</font>, CAIA are members of a team that analyzes investments on behalf of the Registrant.&#160; Dr.&nbsp;Omstead exercises ultimate decision making authority with respect to investments.&#160; Dr.&nbsp;Omstead also performs other duties including management of the investment adviser and makes investments on behalf of Tekla Healthcare Investors (&#147;HQH&#148;), Tekla Healthcare Opportunities Fund (&#147;THQ&#148;) and Tekla World Healthcare Fund (&#147;THW&#148;).&#160; The date each team member joined the portfolio management team and each team member&#146;s business experience for at least the last five years is included below.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Daniel R. Omstead, Ph.D. is President and Chief Executive Officer of the investment adviser and has been employed by the investment adviser of the Registrant since 2000. He is also President of the Registrant, HQH, THQ and THW.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Jason C. Akus, M.D./M.B.A., is Senior Vice President, Research of the investment adviser and is responsible for investment research and due diligence in the biotechnology, medical device, and diagnostic areas. Dr.&nbsp;Akus joined the investment adviser of the Registrant in 2001.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Timothy Gasperoni, Ph.D., M.B.A. is Senior Vice President, Research of TCM. He&nbsp;was previously a Senior Analyst and Founding Member of Sabby Capital and was a Partner and Senior Analyst at Crosswind Investments, LLC.&nbsp; He joined TCM in 2015.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Christian M. Richard, M.S., M.B.A is Senior Vice President, Research of TCM. He&nbsp;was previously a Partner/Head of Research for Merlin Biomed Private Equity/Merlin.&nbsp;He joined TCM in 2015.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Henry Skinner, Ph.D., is Senior Vice President, Venture of TCM. He was previously Vice President and Deputy Head and Managing Director of the Novartis Venture Fund. He joined TCM in October&nbsp;2017.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Amanda Birdsey-Benson, Ph.D. is Senior Analyst of TCM. She was previously an analyst for R.A. Capital Management.&nbsp; She joined TCM in 2014.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Alan Kwan, Ph.D., M.B.A. is Senior Analyst of TCM. He was previously a Principal Investigator at GlaxoSmithKline, plc. He joined TCM in 2014.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Christopher Abbott, is Senior Analyst.&#160; Previously, Mr.&nbsp;Abbott spent 8 years at Leerink Partners where he was a Vice President on the Equity Research team covering the Healthcare IT and Healthcare Supply Chain group.&#160; He joined TCM in 2016.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Robert Benson, CFA</font><font size="1" style="font-size:6.5pt;position:relative;top:-3.0pt;">&#174;</font>, CAIA, is Senior Analyst, Research. Previously, Mr.&nbsp;Benson spent 12 years at State Street Global Advisors (SSgA) where he performed quantitative research for asset allocation, equities, and alternatives teams.&#160; He joined TCM in 2016.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)&nbsp;(2)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The following table lists the number and types of other accounts and assets under management in those accounts advised by the Registrant&#146;s portfolio management team as of the end of the Registrant&#146;s fiscal year.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\105435\17-24477-1\task8658795\24477-1-gc.htm',USER='105435',CD='Dec  5 01:54 2017' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="22%" valign="bottom" style="padding:0in 0in 0in 0in;width:22.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">REGISTERED</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="15%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:15.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="22%" valign="bottom" style="padding:0in 0in 0in 0in;width:22.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">INVESTMENT</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="15%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:15.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="22%" valign="bottom" style="padding:0in 0in 0in 0in;width:22.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">PORTFOLIO</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">COMPANY</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="15%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:15.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">ASSETS</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">POOLED</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">ASSETS</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">OTHER</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">ASSETS</font></b></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="22%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:22.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">MANAGER</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="10%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">ACCOUNTS</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="15%" colspan="2" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:15.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">MANAGED</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="10%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">ACCOUNTS</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="10%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">MANAGED</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="10%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">ACCOUNTS</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="10%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">MANAGED</font></b></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="22%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:22.0%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Daniel R. Omstead</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="13%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:13.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2,758 million</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="22%" valign="top" style="padding:0in 0in 0in 0in;width:22.0%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Jason C. Akus</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="13%" valign="bottom" style="padding:0in 0in 0in 0in;width:13.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2,758 million</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="22%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:22.0%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Christian M. Richard</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="13%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:13.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2,758 million</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="22%" valign="top" style="padding:0in 0in 0in 0in;width:22.0%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Timothy Gasperoni</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="13%" valign="bottom" style="padding:0in 0in 0in 0in;width:13.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2,758 million</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="22%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:22.0%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Henry Skinner</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="13%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:13.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2,758 million</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="22%" valign="top" style="padding:0in 0in 0in 0in;width:22.0%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Amanda Birdsey-Benson</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="13%" valign="bottom" style="padding:0in 0in 0in 0in;width:13.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2,758 million</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="22%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:22.0%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Alan Kwan</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="13%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:13.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2,758 million</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="22%" valign="top" style="padding:0in 0in 0in 0in;width:22.0%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Christopher Abbott</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="13%" valign="bottom" style="padding:0in 0in 0in 0in;width:13.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2,758 million</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="22%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:22.0%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Robert Benson</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="13%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:13.86%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2,758 million</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">None of the funds or other accounts are subject to a performance-based advisory fee.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Each member of the portfolio management team may perform investment management services for other accounts similar to those provided to the Registrant and the investment action for each account may differ. The portfolio management team may discover an investment opportunity that may be suitable for more than one account. However, the investment opportunity may be limited so that all accounts may not be able to fully participate or an investment opportunity or&nbsp;investment allocation&nbsp;may be allocated to just one account or may be allocated between accounts at different levels based on an investment decision made by the investment team.&nbsp; The investment team may subsequently make investment decisions that result in&nbsp;investment levels that make the accounts&nbsp;more differentiated or, conversely, more closely&nbsp;or completely aligned.&nbsp;&nbsp;Such investment decisions may occur within a day or two.&nbsp;&nbsp;In addition, the investment adviser may receive different compensation from each account. In that case, the portfolio management team may have an incentive to direct investments to an account that could result in higher fees for the investment adviser. The registrant has adopted procedures designed to allocate investments fairly across multiple accounts.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Additionally, a portfolio manager may be perceived to have a conflict of interest if he has other executive management responsibilities.&#160; In addition to managing the Registrant, HQH, THQ and THW, Dr.&nbsp;Omstead is the President of the investment adviser of the Registrant.&#160; Dr.&nbsp;Omstead periodically discusses the amount of time he allocates to each of his responsibilities with the Registrant&#146;s Board of Trustees.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The portfolio management team&#146;s management of personal accounts may also present certain conflicts of interest.&#160; The Registrant has adopted a code of ethics designed to address these potential conflicts.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)&nbsp;(3)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>As of September&nbsp;30, 2017, portfolio manager compensation is comprised of a base salary and discretionary compensation as described below.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">Base Salary Compensation</font></i>.&#160; The team members receive a base salary compensation linked to individual experience and responsibilities. The amount of base salary is reviewed annually.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">Discretionary Compensation</font></i>.&#160; Discretionary Compensation is in the form of a cash bonus, paid annually, which may be up to 60% of the team member&#146;s base salary. Several factors affect discretionary compensation, which can vary by team member and circumstances. The discretionary compensation component is determined based on factors including investment performance of accounts managed by the team predominantly relative to the S&amp;P 500 Index and a blended consideration of appropriate healthcare indicies and related performance metrics during the Fund&#146;s fiscal year, performance of specific investments proposed by the individual, financial performance of the investment adviser and a qualitative assessment of the individual overall contribution to the investment team and to the investment adviser. Discretionary compensation is evaluated annually after the completion of the Registrant&#146;s fiscal year.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\105435\17-24477-1\task8658795\24477-1-gc.htm',USER='105435',CD='Dec  5 01:54 2017' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)&nbsp;(4)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>As of September&nbsp;30, 2017, the dollar range of Registrant&#146;s shares beneficially owned by the portfolio managers are as follows as of the end of the Registrant&#146;s fiscal year:</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="21%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:21.5%;">
<p style="margin:0in 0in .0001pt;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">PORTFOLIO&nbsp;MANAGER</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="75%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:75.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">DOLLAR&nbsp;RANGE&nbsp;OF&nbsp;SHARES&nbsp;BENEFICIALLY&nbsp;OWNED</font></b></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="21%" valign="top" style="padding:0in 0in 0in 0in;width:21.5%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="75%" valign="bottom" style="padding:0in 0in 0in 0in;width:75.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="21%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:21.5%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Daniel R.   Omstead</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="75%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:75.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">over $1,000,000</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="21%" valign="top" style="padding:0in 0in 0in 0in;width:21.5%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Jason C. Akus</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="75%" valign="bottom" style="padding:0in 0in 0in 0in;width:75.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">none</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="21%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:21.5%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Christian M. Richard</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="75%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:75.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">none</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="21%" valign="top" style="padding:0in 0in 0in 0in;width:21.5%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Timothy Gasperoni</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="75%" valign="bottom" style="padding:0in 0in 0in 0in;width:75.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">none</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="21%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:21.5%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Henry Skinner</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="75%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:75.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">none</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="21%" valign="top" style="padding:0in 0in 0in 0in;width:21.5%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Amanda Birdsey-Benson</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="75%" valign="bottom" style="padding:0in 0in 0in 0in;width:75.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">none</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="21%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:21.5%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Alan Kwan</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="75%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:75.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">none</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="21%" valign="top" style="padding:0in 0in 0in 0in;width:21.5%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Christopher Abbott</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="75%" valign="bottom" style="padding:0in 0in 0in 0in;width:75.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">none</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="21%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:21.5%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Robert Benson</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="75%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:75.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">none</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .25in;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)&nbsp;N/A.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">ITEM 9.&#160; PURCHASES OF EQUITY SECURITIES BY CLOSED-END MANAGEMENT INVESTMENT COMPANY AND AFFILIATED PURCHASERS.</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="41%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:41.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Period</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="12%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:12.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">(a)&nbsp;Total&nbsp;No.<br>   of&nbsp;Shares<br>   Purchased&nbsp;(1)</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:12.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">(b)&nbsp;Average<br>   Price&nbsp;Paid&nbsp;per<br>   Share</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="12%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:12.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">(c)&nbsp;Total&nbsp;No.<br>   of&nbsp;Shares<br>   Purchased&nbsp;as<br>   Part&nbsp;of<br>   Publicly<br>   Announced&nbsp;Plans<br>   or&nbsp;Programs</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="12%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:12.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">(d)&nbsp;Maximum&nbsp;No.<br>   of&nbsp;Shares&nbsp;that<br>   May&nbsp;Yet&nbsp;Be<br>   Purchased&nbsp;Under<br>   the&nbsp;Plans&nbsp;or<br>   Programs</font></b></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="41%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:41.0%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Month   #1 (Oct.&nbsp;1, 2016 &#151; Oct.&nbsp;31, 2016)</font></b></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">2,489,216</font></b></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="41%" valign="top" style="padding:0in 0in 0in 0in;width:41.0%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Month   #2 (Nov.&nbsp;1, 2016 &#151; Nov.&nbsp;30, 2016)</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">24,167</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">$</font></b></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">16.81</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">24,167</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">2,465,049</font></b></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="41%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:41.0%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Month   #3 (Dec.&nbsp;1, 2016 &#151; Dec.&nbsp;31, 2016)</font></b></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">2,465,049</font></b></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="41%" valign="top" style="padding:0in 0in 0in 0in;width:41.0%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Month   #4 (Jan.&nbsp;1, 2017 &#151; Jan.&nbsp;31, 2017)</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">2,465,049</font></b></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="41%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:41.0%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Month   #5 (Feb.&nbsp;1, 2017 &#151; Feb.&nbsp;28, 2017)</font></b></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">2,465,049</font></b></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="41%" valign="top" style="padding:0in 0in 0in 0in;width:41.0%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Month   #6 (Mar.&nbsp;1, 2017 &#151; Mar.&nbsp;31, 2017)</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">2,465,049</font></b></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="41%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:41.0%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Month   #7 (Apri. 1, 2017&#151; Apri. 30, 2017)</font></b></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">2,465,049</font></b></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="41%" valign="top" style="padding:0in 0in 0in 0in;width:41.0%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Month   #8 (May&nbsp;1, 2017&#151; May&nbsp;31, 2017)</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">2,465,049</font></b></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="41%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:41.0%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Month   #9 (June&nbsp;1, 2017&#151; June&nbsp;30, 2017)</font></b></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">2,465,049</font></b></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="41%" valign="top" style="padding:0in 0in 0in 0in;width:41.0%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Month   #10 (Jul.&nbsp;1, 2017&#151; Jul.&nbsp;31, 2017)</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">2,563,522</font></b></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="41%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:41.0%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Month   #11 (Aug.&nbsp;1, 2017&#151; Aug.&nbsp;31, 2017)</font></b></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">2,563,522</font></b></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="41%" valign="top" style="padding:0in 0in 0in 0in;width:41.0%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Month   #12 (Sep.&nbsp;1, 2017&#151; Sep.&nbsp;30, 2017)</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">2,563,522</font></b></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="41%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:41.0%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Total</font></b></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">24,167</font></b></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">$</font></b></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:10.86%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">16.81</font></b></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">24,167</font></b></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="1" width="25%" noshade align="left" style="color:black;"></div>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(1)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>On June&nbsp;30, 2011, the share repurchase program was announced, which has been subsequently reviewed and approved by the Board of Trustees.&nbsp;On March&nbsp;24, 2016, the Trustees approved the renewal of the share repurchase program, allowing the Registrant to repurchase up to 12% of its outstanding shares in the open market for a one year period ending July&nbsp;10, 2017. On March&nbsp;23, 2017, the Trustees approved the renewal of the share repurchase program, allowing the Registrant to repurchase up to 12% of its outstanding shares in the open market for a one year period ending July&nbsp;14, 2018.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\105435\17-24477-1\task8658795\24477-1-gc.htm',USER='105435',CD='Dec  5 01:54 2017' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">ITEM 10. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS.</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">There have been no material changes to the procedures by which the shareholders may recommend nominees to the registrant&#146;s Board of Trustees, where those changes were implemented after the registrant last provided disclosure in response to the requirements of Item 407(c)(2)(iv)&nbsp;of Regulation S-K (17 CFR229.407) (as required by Item 22(b)(15) of Schedule 14A (17 CFR240.14a-101)), or this Item.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">ITEM 11. CONTROLS AND PROCEDURES.</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 57.0pt;text-indent:-21.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>In the opinion of the principal executive officer and principal financial officer, based on their evaluation which took place within 90 days of this filing, the Registrant&#146;s disclosure controls and procedures are adequately designed and are operating effectively to ensure (i)&nbsp;that material information relating to the Registrant, including its consolidated subsidiaries, is made known to them by others within those entities, particularly during the period in which this report is being prepared; and (ii)&nbsp;that information required to be disclosed by the registrant on Form&nbsp;N-CSR is recorded, processed, summarized and reported within the time period specified in the Securities and Exchange Commission&#146;s rules&nbsp;and forms.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 58.5pt;text-indent:-22.5pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>There were no changes in the Registrant&#146;s internal control over financial reporting that occurred during the Registrant&#146;s most recent fiscal half-year that have materially affected or that are reasonably likely to materially affect the Registrant&#146;s internal control over financial reporting.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">ITEM 12. EXHIBITS.</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)&nbsp;(1)&nbsp;The Code of Ethics that is the subject of the disclosure required by Item 2 is attached hereto (Exhibit&nbsp;1).</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)&nbsp;(2)&nbsp;Separate certifications of the Principal Executive and Financial Officers as required by Rule&nbsp;30a-2(a)&nbsp;under the 1940 Act and Section&nbsp;302 of the Sarbanes-Oxley Act of 2002 are attached hereto (Exhibit&nbsp;2 and 3).</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)&nbsp;(3)&nbsp;Notice to Fund&#146;s shareholders in accordance with Investment Company Act Section&nbsp;19(a)&nbsp;and Rule&nbsp;19a-1 (Exhibit&nbsp;4).</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Certifications pursuant to Section&nbsp;906 of the Sarbanes-Oxley Act of 2002 are attached hereto (Exhibit&nbsp;5).</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\105435\17-24477-1\task8658795\24477-1-gc.htm',USER='105435',CD='Dec  5 01:54 2017' -->


<br clear="all" style="page-break-before:always;">
<div>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">SIGNATURES</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:48.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, there unto duly authorized.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="10%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:10.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(Registrant)</font></p>    </td>
<td width="89%" colspan="3" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:89.16%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">TEKLA LIFE   SCIENCES INVESTORS</font></p>    </td>   </tr>
<tr>
<td width="21%" colspan="3" valign="top" style="padding:0in 0in 0in 0in;width:21.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="78%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:78.34%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="21%" colspan="3" valign="top" style="padding:0in 0in 0in 0in;width:21.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">By (Signature and Title)*</font></p>    </td>
<td width="78%" colspan="2" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:78.34%;">
<p style="margin:0in 0in .0001pt 30.25pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">/s/ Daniel R.   Omstead</font></p>    </td>   </tr>
<tr>
<td width="21%" colspan="3" valign="top" style="padding:0in 0in 0in 0in;width:21.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="78%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:78.34%;">
<p style="margin:0in 0in .0001pt 20.2pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Daniel R.   Omstead, President</font></p>    </td>   </tr>
<tr>
<td width="21%" colspan="3" valign="top" style="padding:0in 0in 0in 0in;width:21.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="78%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:78.34%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="5%" valign="top" style="padding:0in 0in 0in 0in;width:5.76%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Date:</font></p>    </td>
<td width="20%" colspan="3" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:20.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">12/5/17</font></p>    </td>
<td width="74%" valign="top" style="padding:0in 0in 0in 0in;width:74.26%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr height="0">
<td width="41" style="border:none;"></td>
<td width="36" style="border:none;"></td>
<td width="77" style="border:none;"></td>
<td width="29" style="border:none;"></td>
<td width="526" style="border:none;"></td>   </tr> </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:48.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="21%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:21.42%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">By (Signature and   Title)*</font></p>    </td>
<td width="78%" colspan="2" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:78.58%;">
<p style="margin:0in 0in .0001pt 30.25pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">/s/ Laura   Woodward</font></p>    </td>   </tr>
<tr>
<td width="21%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:21.42%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="78%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:78.58%;">
<p style="margin:0in 0in .0001pt 20.2pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Laura Woodward,   Treasurer</font></p>    </td>   </tr>
<tr>
<td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="93%" colspan="3" valign="top" style="padding:0in 0in 0in 0in;width:93.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Date:</font></p>    </td>
<td width="19%" colspan="2" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:19.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">12/5/17</font></p>    </td>
<td width="74%" valign="top" style="padding:0in 0in 0in 0in;width:74.34%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr height="0">
<td width="44" style="border:none;"></td>
<td width="108" style="border:none;"></td>
<td width="30" style="border:none;"></td>
<td width="526" style="border:none;"></td>   </tr> </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="1" width="25%" noshade align="left" style="color:black;"></div>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">* Print the name and title of each signing officer under his or her signature.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\109925\17-24477-1\task8658105\24477-1-jc.htm',USER='109925',CD='Dec  3 16:38 2017' -->

</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.CODEETH
<SEQUENCE>2
<FILENAME>a17-24477_1ex99dcodeeth.htm
<DESCRIPTION>EX-99.CODEETH
<TEXT>


<html>
<head>



  </head>
<body link=blue lang="EN-US">
<div style="font-family:Times New Roman;">
<p align="right" style="font-weight:bold;margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;">Exhibit 99.CODEETH</font></b></p>
<p align="left" style="font-weight:bold;margin:0in 0in .0001pt;text-align:left;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></b></p>
<p align="left" style="font-weight:bold;margin:0in 0in .0001pt;text-align:left;text-decoration:underline;"><b><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">Exhibit&nbsp;1</font></u></b></p>
<p align="left" style="font-weight:bold;margin:0in 0in .0001pt;text-align:left;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></b></p>
<p align="left" style="font-weight:bold;margin:0in 0in .0001pt;text-align:left;text-decoration:underline;"><b><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">Sarbanes-Oxley Code of Ethics</font></u></b></p>
<p align="left" style="font-weight:bold;margin:0in 0in .0001pt;text-align:left;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></b></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Introduction</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The Board of Trustees of Tekla Life Sciences Investors, Tekla Healthcare Investors, Tekla Healthcare Opportunities Fund and Tekla World Healthcare Fund (each a &#147;Fund&#148;) has established this Code of Ethics (&#147;Code&#148;) in accordance with the Sarbanes-Oxley Act of 2002 and the rules&nbsp;promulgated thereunder. This Code does not supersede or otherwise affect the separate code of ethics that the Fund and its investment adviser have adopted pursuant to Rule&nbsp;17j-1 under the Investment Company Act of 1940, as amended (&#147;1940 Act&#148;).</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">This Code is designed to deter wrongdoing and promote: (i)&nbsp;honest and ethical conduct, including the ethical handling of actual or apparent conflicts of interest between personal and professional relationships; (ii)&nbsp;full, fair, accurate, timely, and understandable disclosure in reports and documents that the Fund files with, or submits to, the Securities and Exchange Commission (&#147;SEC&#148;) and in other public communications made by the Fund; (iii)&nbsp;compliance with applicable governmental laws, rules, and regulations; (iv)&nbsp;the prompt internal reporting of violations of the Code to an appropriate person or persons; and (v)&nbsp;accountability for adherence to the Code. The Code applies to the Funds&#146; President, Treasurer, Secretary and Assistant Treasurer (collectively, &#147;Covered Officers,&#148; each of whom is set forth in Exhibit&nbsp;A).</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">A.</font></b><b><font size="1" style="font-size:8.5pt;font-weight:bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font></b><b><font size="2" style="font-size:10.0pt;font-weight:bold;">Principles of Honest and Ethical Conduct</font></b></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1<i>. </i>General Objectives</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The Fund expects all Covered Officers to adhere to the highest possible standards of honest and ethical conduct. All Covered Officers are expected to handle actual or apparent conflicts of interest between personal and professional relationships in a manner that is above reproach, and to place the interests of the Fund above their own personal interests.</font></p>
<p style="margin:0in 0in .0001pt .25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2. Conflicts of Interest</font></p>
<p style="margin:0in 0in .0001pt .25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">All Covered Officers should be scrupulous in avoiding a conflict of interest with regard to the Fund&#146;s interests. A conflict of interest occurs when an individual&#146;s private interest interferes in any way with the interests of the Fund. This includes any specific situation or transaction that the Trustees of the Fund who are not interested persons as defined in the 1940 Act, would consider to create the appearance of a conflict of interest. A conflict situation can arise when a Covered Officer takes actions or has interests that may make it difficult to perform his or her work for the Fund objectively and effectively.&#160; Conflicts of interest also arise when a Covered Officer, or a member of his or her family, receives improper benefits as a result of his or her position with the Fund, whether such benefits are received from the Fund or a third party.&#160; Any conflict of interest that arises in a specific situation or transaction must be disclosed by the Covered Officer and resolved before taking any action.</font></p>
<p style="margin:0in 0in .0001pt .25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Conflicts of interest may not always be evident, and Covered Officers should consult with the Funds&#146; Chief Compliance Officer or the Funds&#146; legal counsel if they are uncertain about any situation.</font></p>
<p style="margin:0in 0in .0001pt .25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Examples of possible conflicts of interest include:</font></p>
<p style="margin:0in 0in .0001pt .25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<h5 style="font-weight:normal;margin:0in 0in .0001pt .75in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">i)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><i><font size="2" style="font-size:10.0pt;font-style:italic;">Outside Employment or Activities</font></i><font size="2" style="font-size:10.0pt;">.&#160; Covered Officers may not engage in any outside employment or activity that interferes with their performance or responsibilities to the </font></h5>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\105348\17-24476-1\task8657652\24476-1-mm.htm',USER='105348',CD='Dec  2 06:44 2017' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<h5 style="font-weight:normal;margin:0in 0in .0001pt .75in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h5>
<h5 style="font-weight:normal;margin:0in 0in .0001pt .75in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Fund or is otherwise in conflict with or prejudicial to the Fund.&#160; A Covered Officer must disclose to the Funds&#146; Chief Compliance Officer any outside employment or activity that may constitute a conflict of interest and obtain the Funds&#146; Chief Compliance Officer&#146;s approval before engaging in any such employment or activity.</font></h5>
<h5 style="font-weight:normal;margin:0in 0in .0001pt .75in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></h5>
<p style="margin:0in 0in .0001pt .75in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">ii)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><i><font size="2" style="font-size:10.0pt;font-style:italic;">Gifts.</font></i><font size="2" style="font-size:10.0pt;">Covered Officers may not accept gifts or other items of more than small value, consistent with industry standards from any person or entity that does business with or on behalf of the Fund.</font></p>
<p style="margin:0in 0in .0001pt .75in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .75in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">iii)</font><i><font size="1" style="font-size:3.0pt;font-style:italic;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font></i><i><font size="2" style="font-size:10.0pt;font-style:italic;">Other Situations.</font></i><font size="2" style="font-size:10.0pt;">&#160; Because other conflicts of interest may arise, it would be impractical to attempt to list all possible situations in this Code. If a proposed transaction or situation raises questions or doubts, a Covered Officer should consult with the Funds&#146; Chief Compliance Officer before engaging in the transaction or activity.</font></p>
<p style="margin:0in 0in .0001pt .75in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1.</font><font size="1" style="font-size:8.5pt;">&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Corporate Opportunities</font></p>
<p style="margin:0in 0in .0001pt .25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Covered Officers may not exploit for their own personal gain, or for the personal gain or their family members or relatives, opportunities that are discovered through the use of Fund property, information, or position, unless the opportunity is first disclosed fully in writing to the Board of Trustees and the Board of Trustees declines to pursue such opportunity.</font></p>
<p style="margin:0in 0in .0001pt .25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .5in;text-indent:-.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">B.</font></b><font size="1" style="font-size:8.5pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><font size="2" style="font-size:10.0pt;font-weight:bold;">Full, Fair, Accurate, Timely, and Understandable Disclosure in Fund Disclosure and Reporting Documents</font></b></p>
<p style="margin:0in 0in .0001pt .5in;text-indent:-.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">As registered investment companies, it is of critical importance that the Funds&#146; public communications, reports, and filings contain full, fair, accurate, timely, and understandable disclosure. Accordingly, Covered Officers are expected to consider it central to their roles as officers of the Funds to promote full, fair, accurate, timely, and understandable disclosure in the Funds&#146; public communications and reports, and in the documents that the Funds file with, or submits to, the Securities and Exchange Commission (the &#147;SEC&#148;).</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Depending on his or her position with the Funds, a Covered Officer may be called upon to provide necessary information to make the Funds&#146; public reports, communications, and SEC filings and submissions complete, fair, and understandable. The Funds expect Covered Officers to take this responsibility very seriously and to provide prompt and accurate answers to inquiries related to the Funds&#146; public disclosure requirements. Covered Officers may be asked to certify the accuracy of all responses and information provided for inclusion in the Funds&#146; public reports, communications, and SEC filings and submissions.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">C.</font></b><b><font size="1" style="font-size:8.5pt;font-weight:bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font></b><b><font size="2" style="font-size:10.0pt;font-weight:bold;">Compliance with Applicable Governmental Rules&nbsp;and Regulations</font></b></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">As registered investment companies, the Funds are subject to regulation by the SEC and must comply with Federal securities laws and regulations, as well as other applicable laws.&#160; The Funds insist on strict compliance with the spirit and the letter of these laws and regulations. Each Covered Officer shall cooperate with Fund counsel, the Funds&#146; independent accountants, and the Funds&#146; other service providers with the goal of maintaining the Funds&#146; material compliance with applicable governmental rules&nbsp;and regulations.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The Funds expect their Covered Officers to comply with all laws, rules, and regulations applicable to the Funds&#146; operations and business. Covered Officers should seek guidance whenever they are in doubt as to the applicability of any law, rule, or regulation, or regarding any </font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\105348\17-24476-1\task8657652\24476-1-mm.htm',USER='105348',CD='Dec  2 06:44 2017' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">contemplated course of action. Covered Officers should also make use of the various guidelines which the Funds and their service providers have prepared on specific laws and regulations.&#160; If in doubt on a course of action, a good guideline is &#147;always ask first, act later&#148; &#151; if you are unsure of what to do in any situation, seek guidance before you act.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Covered Officers are encouraged to attend courses and seminars for the purpose of keeping themselves apprised of developments relating to those governmental statutes, rules, and regulations applicable to the Funds.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Upon obtaining knowledge of any material violation of any applicable law, rule, or regulation by the Funds or a person acting with or on behalf of the Fund, a Covered Officer shall report such violation to the Funds&#146; Chief Compliance Officer, Fund counsel, or both. (See Section&nbsp;VI of the Code for a discussion of reporting Code violations.) Each Covered Officer shall cooperate or take such steps as may be necessary or appropriate to remedy any such material violation.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">D.</font></b><b><font size="1" style="font-size:8.5pt;font-weight:bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font></b><b><font size="2" style="font-size:10.0pt;font-weight:bold;">Confidentiality</font></b></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Covered Officers must maintain the confidentiality of information entrusted to them by the Funds, except when disclosure is authorized by Fund counsel or required by laws or regulations. Whenever possible, Covered Officers should consult with Fund counsel if they believe they have a legal obligation to disclose confidential information. Confidential information includes all non-public information that might be of use to competitors, or harmful to the Funds or their shareholders, if disclosed. The obligation to preserve confidential information continues even after employment as a Covered Officer ends.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .5in;text-indent:-.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">E.</font></b><b><font size="1" style="font-size:8.5pt;font-weight:bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font></b><b><font size="2" style="font-size:10.0pt;font-weight:bold;">Prompt Internal Reporting of Violations of the Code; Evaluation of Possible Violations; Determination of Sanctions</font></b></p>
<p style="margin:0in 0in .0001pt .5in;text-indent:-.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>
<p style="margin:0in 0in .0001pt .5in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1.</font><font size="1" style="font-size:8.5pt;">&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Reporting to the Funds&#146; Chief Compliance Officer</font></p>
<p style="margin:0in 0in .0001pt .5in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">A Covered Officer shall promptly report knowledge of, or information concerning, any material violation of this Code to the Funds&#146; Chief Compliance Officer. Any such report shall preferably be in writing, and shall describe in reasonable detail the conduct that such Covered Officer believes to have violated this Code. The Funds&#146; Chief Compliance Officer shall also have the authority to draft a report of a suspected material violation of the Code, if no written report is made by a Covered Officer.</font></p>
<p style="margin:0in 0in .0001pt .5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .5in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.</font><font size="1" style="font-size:8.5pt;">&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Evaluation of Reports</font></p>
<p style="margin:0in 0in .0001pt .5in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The Funds&#146; Chief Compliance Officer shall then consult with Fund counsel to the extent necessary to determine whether the reported conduct actually violates the Code. If it is determined that there has been a violation of the Code, the Funds&#146; Chief Compliance Officer will determine (in consultation with Fund counsel) whether the violation has had or may have, in the reasonable judgment of the Funds&#146; Chief Compliance Officer, a material adverse impact upon the Fund.</font></p>
<p style="margin:0in 0in .0001pt .5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .75in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">i</font><font size="1" style="font-size:8.5pt;">&#160;&#160;&#160;&#160;&#160;&#160; </font><i><font size="2" style="font-size:10.0pt;font-style:italic;">No Material Adverse Impact on the Funds.</font></i><font size="2" style="font-size:10.0pt;">&#160; If the Funds&#146; Chief Compliance Officer determines that the violation has not caused a material adverse impact upon the Fund, the Funds&#146; Chief Compliance Officer shall determine what sanctions, if any, may be appropriate for the violation. (See G of this Code for a discussion of possible sanctions.)</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\105348\17-24476-1\task8657652\24476-1-mm.htm',USER='105348',CD='Dec  2 06:44 2017' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt .75in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .75in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">ii</font><font size="1" style="font-size:8.5pt;">&#160;&#160;&#160;&#160;&#160; </font><i><font size="2" style="font-size:10.0pt;font-style:italic;">Material Adverse Impact on the Funds</font></i><font size="2" style="font-size:10.0pt;">.&#160; If the Funds&#146; Chief Compliance Officer determines that the violation has caused a material adverse impact upon the Fund, the Funds&#146; Chief Compliance Officer shall promptly notify the Board of such violation. The Board shall be entitled to consult with independent legal counsel to determine whether the violation actually has had a material adverse impact upon the Fund; to formulate sanctions, if any, appropriate for the violation; or for any other purpose that the Board, in its business judgment, determines to be necessary or advisable. (See G of this Code for a discussion of possible sanctions.)</font></p>
<p style="margin:0in 0in .0001pt .75in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .5in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3.</font><font size="1" style="font-size:8.5pt;">&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Periodic Reports by the Funds&#146; Chief Compliance Officer to Board of Trustees.</font></p>
<p style="margin:0in 0in .0001pt .5in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The Funds&#146; Chief Compliance Officer shall report to the Board at each regularly scheduled Board meeting all violations of this Code (whether or not they caused a material adverse impact upon the Fund) and all sanctions imposed.</font></p>
<p style="margin:0in 0in .0001pt .5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">F.</font></b><b><font size="1" style="font-size:8.5pt;font-weight:bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font></b><b><font size="2" style="font-size:10.0pt;font-weight:bold;">Waivers of Provisions of the Code</font></b></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>
<p style="margin:0in 0in .0001pt .5in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1.</font><font size="1" style="font-size:8.5pt;">&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Waivers.</font></p>
<p style="margin:0in 0in .0001pt .5in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">A Covered Officer may request a waiver of a provision of this Code if there is a reasonable likelihood that a contemplated action would be a material departure from a provision of the Code. Waivers will not be granted except under extraordinary or special circumstances.</font></p>
<p style="margin:0in 0in .0001pt .5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The process of requesting a waiver shall consist of the following steps:</font></p>
<p style="margin:0in 0in .0001pt .5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 1.0in;text-indent:-18.35pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">i.</font><font size="1" style="font-size:8.5pt;">&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">The Covered Officer shall set forth a request for waiver in writing and submit such request to the Funds&#146; Chief Compliance Officer. The request shall describe the conduct, activity, or transaction for which the Covered Officer seeks a waiver, and shall briefly explain the reason for engaging in the conduct, activity, or transaction.</font></p>
<p style="margin:0in 0in .0001pt 1.0in;text-indent:-18.35pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 1.0in;text-indent:-18.35pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">ii.</font><font size="1" style="font-size:8.5pt;">&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">The determination with respect to the waiver shall be made in a timely fashion by the Funds&#146; Chief Compliance Officer, in consultation with Fund counsel, and submitted to the Board for ratification.</font></p>
<p style="margin:0in 0in .0001pt 1.0in;text-indent:-18.35pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 1.0in;text-indent:-18.35pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">iii.</font><font size="1" style="font-size:8.5pt;">&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">The decision with respect to the waiver request shall be documented and kept in the Fund&#146;s records for the appropriate period mandated by applicable law or regulation.</font></p>
<p style="margin:0in 0in .0001pt 1.0in;text-indent:-18.35pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .5in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.</font><font size="1" style="font-size:8.5pt;">&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Disclosure of Waivers.</font></p>
<p style="margin:0in 0in .0001pt .5in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">To the extent required by applicable law, waivers (including &#147;implicit waivers&#148;) shall be publicly disclosed on a timely basis. An &#147;implicit waiver&#148; is defined as the Fund&#146;s failure to take action within a reasonable period of time regarding a material departure from a provision of the Code that has been made known to an &#147;executive officer&#148; of the Fund. For this purpose, an &#147;executive officer&#148; is a Fund&#146;s President or Chief Executive Officer, Vice President (who is in charge of a principal policymaking function), or any other person who performs similar policymaking functions for the Fund. For the purpose of determining whether an &#147;implicit waiver&#148; has occurred, if a material departure from a provision of the Code is known only by the Covered Officer who has caused the material departure, the material departure will not be considered to have been made known to an executive officer of the Fund.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\105348\17-24476-1\task8657652\24476-1-mm.htm',USER='105348',CD='Dec  2 06:44 2017' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">G.</font></b><b><font size="1" style="font-size:8.5pt;font-weight:bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font></b><b><font size="2" style="font-size:10.0pt;font-weight:bold;">Accountability for Adherence to the Code</font></b></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The matters covered in this Code are of the utmost importance to the Fund and its shareholders, and are essential to the Fund&#146;s ability to conduct its business in accordance with its stated values. Covered Officers are expected to adhere to these rules&nbsp;in carrying out their duties for the Fund.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The Fund will, if appropriate, take action against any Covered Officer whose actions are found to violate this Code. Sanctions for violations of the Code may include, among other things, a requirement that the violator undergo training related to the violation, a letter of sanction, the imposition of a monetary penalty, and/or suspension or termination of the employment of the violator. Where the Fund has suffered a loss because of violations of this Code or applicable laws, regulations, or rules, it may pursue its remedies against the individuals or entities responsible.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">H.</font></b><b><font size="1" style="font-size:8.5pt;font-weight:bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font></b><b><font size="2" style="font-size:10.0pt;font-weight:bold;">Recordkeeping</font></b></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>
<p style="margin:0in 0in .0001pt .5in;text-indent:-.25in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">1.</font></b><font size="1" style="font-size:8.5pt;">&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">General.</font></p>
<p style="margin:0in 0in .0001pt .5in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The Fund requires accurate recording and reporting of information in order to make responsible business decisions. All of the Fund&#146;s books, records, accounts and financial statements must be maintained in reasonable detail, must appropriately reflect the Fund&#146;s transactions and must conform both to applicable legal requirements and to the Fund&#146;s system of internal controls.</font></p>
<p style="margin:0in 0in .0001pt .5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .5in;text-indent:-.25in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">2.</font></b><font size="1" style="font-size:8.5pt;">&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Code of Ethics Records.</font></p>
<p style="margin:0in 0in .0001pt .5in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">A copy of this Code, any amendments hereto, and any reports or other records created in relation to waivers of or amendments to provisions of this Code shall be kept as records of the Fund for six years from the end of the fiscal year in which such document was created. Such records shall be furnished to the SEC or its staff upon request.</font></p>
<p style="margin:0in 0in .0001pt .5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">I.</font></b><b><font size="1" style="font-size:8.5pt;font-weight:bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font></b><b><font size="2" style="font-size:10.0pt;font-weight:bold;">Amendments to the Code</font></b></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The Covered Officers and the Funds&#146; Chief Compliance Officer are encouraged to recommend improvements to this Code to the Board, and the Board may amend the Code in its discretion. In connection with any amendment to the Code, the Funds&#146; Chief Compliance Officer shall prepare a brief description of the amendment, in order that this description may be disclosed in accordance with applicable law and regulations.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\105348\17-24476-1\task8657652\24476-1-mm.htm',USER='105348',CD='Dec  2 06:44 2017' -->

<br clear="all" style="page-break-before:always;">
<div>
<p align="left" style="margin:0in 0in .0001pt;text-align:left;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="left" style="margin:0in 0in .0001pt;text-align:left;text-autospace:none;text-decoration:underline;"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">Exhibit&nbsp;A: Covered Officers</font></u></p>
<p align="left" style="margin:0in 0in .0001pt;text-align:left;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Daniel R. Omstead, President</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Laura Woodward, Treasurer and Secretary</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\105348\17-24476-1\task8657652\24476-1-mm.htm',USER='105348',CD='Dec  2 06:44 2017' -->

</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.CERT
<SEQUENCE>3
<FILENAME>a17-24477_1ex99dcert.htm
<DESCRIPTION>EX-99.CERT
<TEXT>


<html>
<head>




  </head>
<body link=blue lang="EN-US">
<div style="font-family:Times New Roman;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Exhibit&nbsp;99.CERT</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">EXHIBIT&nbsp;2: CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">I,&nbsp;&nbsp;&nbsp;Daniel R. Omstead, certify that:</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>I have reviewed this report on Form&nbsp;N-CSR of TEKLA LIFE SCIENCES INVESTORS;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations, changes in net assets, and cash flows (if the financial statements are required to include a statement of cash flows) of the registrant as of, and for, the periods presented in this report;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">4.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The registrant&#146;s other certifying officer(s)&nbsp;and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Rule&nbsp;30a-3(c)&nbsp;under the Investment Company Act of 1940) and internal control over financial reporting (as defined in Rule&nbsp;30a-3(d)&nbsp;under the Investment Company Act of 1940) for the Registrant and have:</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:-22.5pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:-22.5pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:-22.5pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Evaluated the effectiveness of the registrant&#146;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of a date within 90 days prior to the filing date of this report based on such evaluation; and</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:-22.5pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Disclosed in this report any change in the registrant&#146;s internal control over financial reporting that occurred during the second fiscal quarter of the period covered by this report that has materially affected, or is reasonably likely to materially affect, the registrant&#146;s internal control over financial reporting; and</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">5.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The registrant&#146;s other certifying officer(s)&nbsp;and I have disclosed to the registrant&#146;s auditors and the audit committee of the registrant&#146;s board of directors (or persons performing the equivalent functions):</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:-22.5pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#146;s ability to record, process, summarize, and report financial information; and</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:-22.5pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#146;s internal control over financial reporting.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="5%" valign="top" style="padding:0in 0in 0in 0in;width:5.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Date:</font></p>    </td>
<td width="40%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:40.26%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">12/5/17</font></p>    </td>
<td width="4%" valign="top" style="padding:0in 0in 0in 0in;width:4.76%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">/s/ Daniel R. Omstead</font></p>    </td>   </tr>
<tr>
<td width="50%" colspan="3" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Name: Daniel R. Omstead</font></p>    </td>   </tr>
<tr>
<td width="50%" colspan="3" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Title: President</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\105435\17-24477-1\task8658795\24477-1-mo.htm',USER='105435',CD='Dec  5 02:00 2017' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">EXHIBIT&nbsp;3: CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">I,&nbsp;&nbsp;&nbsp;Laura Woodward, certify that:</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>I have reviewed this report on Form&nbsp;N-CSR of TEKLA LIFE SCIENCES INVESTORS;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations, changes in net assets, and cash flows (if the financial statements are required to include a statement of cash flows) of the registrant as of, and for, the periods presented in this report;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">4.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The registrant&#146;s other certifying officer(s)&nbsp;and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Rule&nbsp;30a-3(c)&nbsp;under the Investment Company Act of 1940) and internal control over financial reporting (as defined in Rule&nbsp;30a-3(d)&nbsp;under the Investment Company Act of 1940) for the Registrant and have:</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:-22.5pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:-22.5pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:-22.5pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Evaluated the effectiveness of the registrant&#146;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of a date within 90 days prior to the filing date of this report based on such evaluation; and</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:-22.5pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Disclosed in this report any change in the registrant&#146;s internal control over financial reporting that occurred during the second fiscal quarter of the period covered by this report that has materially affected, or is reasonably likely to materially affect, the registrant&#146;s internal control over financial reporting; and</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">5.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The registrant&#146;s other certifying officer(s)&nbsp;and I have disclosed to the registrant&#146;s auditors and the audit committee of the registrant&#146;s board of directors (or persons performing the equivalent functions):</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:-22.5pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#146;s ability to record, process, summarize, and report financial information; and</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.0in;text-indent:-22.5pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#146;s internal control over financial reporting.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="5%" valign="top" style="padding:0in 0in 0in 0in;width:5.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Date:</font></p>    </td>
<td width="40%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:40.26%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">12/5/17</font></p>    </td>
<td width="4%" valign="top" style="padding:0in 0in 0in 0in;width:4.76%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">/s/ Laura Woodward</font></p>    </td>   </tr>
<tr>
<td width="50%" colspan="3" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Name: Laura Woodward</font></p>    </td>   </tr>
<tr>
<td width="50%" colspan="3" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Title: Treasurer</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\105435\17-24477-1\task8658795\24477-1-mo.htm',USER='105435',CD='Dec  5 02:00 2017' -->

</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.SECTION 19(A)
<SEQUENCE>4
<FILENAME>a17-24477_1ex99dsection19a.htm
<DESCRIPTION>EX-99.SECTION 19(A)
<TEXT>


<html>
<head>



  </head>
<body link=blue lang="EN-US">
<div style="font-family:Times New Roman;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Exhibit&nbsp;99.Section&nbsp;19(a)</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">EXHIBIT&nbsp;4: SECTION&nbsp;19(a)&nbsp;NOTICE TO FUND&#146;S SHAREHOLDERS</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">TEKLA LIFE SCIENCES INVESTORS</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Notification of Sources of Distribution</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Distribution Paid Date:&nbsp;June&nbsp;30, 2017</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Distribution Amount Per Common Share:&nbsp;&nbsp;$0.41</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The following table sets forth the estimated amounts of the current distribution, paid June&nbsp;30, 2017, and the cumulative distributions paid this fiscal year-to-date from the following sources: net investment income, net realized short-term capital gains, net realized long-term capital gains, and return of capital or other capital source. All amounts are expressed per common share.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="33%" valign="bottom" style="padding:0in 0in 0in 0in;width:33.5%;">
<p style="margin:0in 0in .0001pt;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="12%" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="15%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:15.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="16%" valign="bottom" style="padding:0in 0in 0in 0in;width:16.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Percentage</font></b></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="33%" valign="bottom" style="padding:0in 0in 0in 0in;width:33.5%;">
<p style="margin:0in 0in .0001pt;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="12%" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Percentage</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="15%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:15.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="16%" valign="bottom" style="padding:0in 0in 0in 0in;width:16.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Breakdown&nbsp;of&nbsp;the</font></b></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="33%" valign="bottom" style="padding:0in 0in 0in 0in;width:33.5%;">
<p style="margin:0in 0in .0001pt;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="12%" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Breakdown</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="15%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:15.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Total&nbsp;Cumulative</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="16%" valign="bottom" style="padding:0in 0in 0in 0in;width:16.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Total&nbsp;Cumulative</font></b></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="33%" valign="bottom" style="padding:0in 0in 0in 0in;width:33.5%;">
<p style="margin:0in 0in .0001pt;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Current</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="12%" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">of&nbsp;Current</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="15%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:15.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Distributions&nbsp;for&nbsp;the</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="16%" valign="bottom" style="padding:0in 0in 0in 0in;width:16.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Distributions&nbsp;for&nbsp;the</font></b></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="33%" valign="bottom" style="padding:0in 0in 0in 0in;width:33.5%;">
<p style="margin:0in 0in .0001pt;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:12.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Distribution</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="12%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:12.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Distribution</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="15%" colspan="2" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:15.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Fiscal&nbsp;Year&nbsp;to&nbsp;Date(1)</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="16%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:16.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Fiscal&nbsp;Year&nbsp;to&nbsp;Date(1)</font></b></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="33%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:33.5%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Net Investment   Income</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0.0000</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">%</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="13%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:13.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0.0000</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="16%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:16.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">%</font></p>    </td>   </tr>
<tr>
<td width="33%" valign="top" style="padding:0in 0in 0in 0in;width:33.5%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Net Realized ST   Cap Gains</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0.0000</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">%</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="13%" valign="bottom" style="padding:0in 0in 0in 0in;width:13.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0.0000</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="16%" valign="bottom" style="padding:0in 0in 0in 0in;width:16.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">%</font></p>    </td>   </tr>
<tr>
<td width="33%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:33.5%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Net Realized LT   Cap Gains</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0.4100</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">100</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">%</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="13%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:13.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1.1700</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="16%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:16.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">100</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">%</font></p>    </td>   </tr>
<tr>
<td width="33%" valign="top" style="padding:0in 0in 0in 0in;width:33.5%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Return of   Capital or Other Capital Source</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="10%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:10.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0.0000</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0.375pt 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">%</font></p>    </td>
<td width="1%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="13%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:13.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0.0000</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="16%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:16.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0.375pt 0in;width:1.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">%</font></p>    </td>   </tr>
<tr>
<td width="33%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:33.5%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">TOTAL (per   common share):</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:10.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0.4100</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">100</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 1pt 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">%</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="13%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:13.86%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1.1700</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="16%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:16.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">100</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 1pt 0in;width:1.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">%</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The table below includes information relating to the Fund&#146;s performance based on its NAV for certain periods.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="84%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:84.0%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Average annual total return at NAV for the period   from May&nbsp;31, 2012 through May&nbsp;31, 2017</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">16.06</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">%</font></p>    </td>   </tr>
<tr>
<td width="84%" valign="top" style="padding:0in 0in 0in 0in;width:84.0%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Annualized   current distribution rate expressed as a percentage of NAV as of May&nbsp;31,   2017</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">8.41</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">%</font></p>    </td>   </tr>
<tr>
<td width="84%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:84.0%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Cumulative total   return at NAV for the fiscal year, through May&nbsp;31, 2017(2)</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3.85</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">%</font></p>    </td>   </tr>
<tr>
<td width="84%" valign="top" style="padding:0in 0in 0in 0in;width:84.0%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Cumulative   fiscal year-to-date distribution rate expressed as a percentage of NAV as of   May&nbsp;31, 2017(1)</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">6.00</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">%</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">You should not draw any conclusions about the Fund&#146;s investment performance from the amount of this distribution or from the terms of the Fund&#146;s managed distribution plan.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The composition of this and subsequent distribution may vary from quarter to quarter because it may be materially impacted by future realized gains and losses on securities. The aggregate of the net unrealized appreciation of portfolio securities and net realized gains on sale of securities is $169,921,052 of which $134,750,869 represents net unrealized appreciation of portfolio securities.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The amounts and sources of distributions reported in this 19(a)&nbsp;Notice are only estimates and are not being provided for tax reporting purposes. The actual amounts and sources of the amounts for tax reporting purposes will depend upon the Fund&#146;s investment experience during the remainder of its fiscal year and may be subject to changes based on tax regulations. The Fund will send you a Form&nbsp;1099-DIV for the calendar year that will tell you how to report these distributions for federal income tax purposes.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="1" width="25%" noshade align="left" style="color:black;"></div>
<p style="margin:0in 0in .0001pt 12.95pt;text-indent:-12.95pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(1)The Fund&#146;s current fiscal year began on October&nbsp;1, 2016.</font></p>
<p style="margin:0in 0in .0001pt 12.95pt;text-indent:-12.95pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(2)Cumulative total return at NAV is the percentage change in the Fund&#146;s NAV and includes all distributions and assumes the reinvestment of those distributions for the period of September&nbsp;30, 2016 through May&nbsp;31, 2017.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .2pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Tekla Life Sciences Investors</font></p>
<p style="margin:0in 0in .0001pt .2pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">CUSIP: 87911K100</font></p>
<p style="margin:0in 0in .0001pt .2pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">www.teklacap.com</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .2pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Tekla Capital Management LLC <br> 100 Federal Street, 19</font><font size="1" style="font-size:6.5pt;position:relative;top:-3.0pt;">th</font>&#160;Floor <br> Boston, Massachusetts 02110</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .2pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">617-772-8500 <br> Fax: 617-772-8577</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\105435\17-24477-1\task8658795\24477-1-mq.htm',USER='105435',CD='Dec  5 01:56 2017' -->


<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">TEKLA LIFE SCIENCES INVESTORS</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Notification of Sources of Distribution</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Distribution Paid Date:&nbsp;&nbsp;September&nbsp;29, 2017</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Distribution Amount Per Common Share:&nbsp;&nbsp;$0.42</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The following table sets forth the estimated amounts of the current distribution, paid September&nbsp;29, 2017, and the cumulative distributions paid this fiscal year-to-date from the following sources: net investment income, net realized short-term capital gains, net realized long-term capital gains, and return of capital or other capital source. All amounts are expressed per common share.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="32%" valign="bottom" style="padding:0in 0in 0in 0in;width:32.5%;">
<p style="margin:0in 0in .0001pt;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="12%" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="16%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:16.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="16%" valign="bottom" style="padding:0in 0in 0in 0in;width:16.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Percentage</font></b></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="32%" valign="bottom" style="padding:0in 0in 0in 0in;width:32.5%;">
<p style="margin:0in 0in .0001pt;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="12%" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Percentage</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="16%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:16.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="16%" valign="bottom" style="padding:0in 0in 0in 0in;width:16.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Breakdown&nbsp;of&nbsp;the</font></b></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="32%" valign="bottom" style="padding:0in 0in 0in 0in;width:32.5%;">
<p style="margin:0in 0in .0001pt;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="12%" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Breakdown</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="16%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:16.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Total&nbsp;Cumulative</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="16%" valign="bottom" style="padding:0in 0in 0in 0in;width:16.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Total&nbsp;Cumulative</font></b></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="32%" valign="bottom" style="padding:0in 0in 0in 0in;width:32.5%;">
<p style="margin:0in 0in .0001pt;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Current</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="12%" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">of&nbsp;Current</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="16%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:16.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Distributions&nbsp;for&nbsp;the</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="16%" valign="bottom" style="padding:0in 0in 0in 0in;width:16.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Distributions&nbsp;for&nbsp;the</font></b></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="32%" valign="bottom" style="padding:0in 0in 0in 0in;width:32.5%;">
<p style="margin:0in 0in .0001pt;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:12.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Distribution</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="12%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:12.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Distribution</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="16%" colspan="2" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:16.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Fiscal&nbsp;Year&nbsp;to&nbsp;Date(1)</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="16%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:16.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Fiscal&nbsp;Year&nbsp;to&nbsp;Date(1)</font></b></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="32%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:32.5%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Net Investment   Income</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0.0000</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">%</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="14%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:14.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0.0000</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="16%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:16.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">%</font></p>    </td>   </tr>
<tr>
<td width="32%" valign="top" style="padding:0in 0in 0in 0in;width:32.5%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Net Realized ST   Cap Gains</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0.0120</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">%</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="14%" valign="bottom" style="padding:0in 0in 0in 0in;width:14.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0.0120</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="16%" valign="bottom" style="padding:0in 0in 0in 0in;width:16.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">%</font></p>    </td>   </tr>
<tr>
<td width="32%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:32.5%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Net Realized LT   Cap Gains</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0.4080</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">97</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">%</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="14%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:14.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1.5780</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="16%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:16.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">99</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">%</font></p>    </td>   </tr>
<tr>
<td width="32%" valign="top" style="padding:0in 0in 0in 0in;width:32.5%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Return of   Capital or Other Capital Source</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="10%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:10.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0.0000</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0.375pt 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">%</font></p>    </td>
<td width="1%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="14%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:14.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0.0000</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="16%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:16.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0.375pt 0in;width:1.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">%</font></p>    </td>   </tr>
<tr>
<td width="32%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:32.5%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">TOTAL (per   common share):</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:10.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0.4200</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">100</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 1pt 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">%</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="14%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:14.86%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1.5900</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="16%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:16.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">100</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 1pt 0in;width:1.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">%</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The table below includes information relating to the Fund&#146;s performance based on its NAV for certain periods.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="84%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:84.0%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Average annual total return at NAV for the period   from July&nbsp;31, 2012 through July&nbsp;31, 2017</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">17.09</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">%</font></p>    </td>   </tr>
<tr>
<td width="84%" valign="top" style="padding:0in 0in 0in 0in;width:84.0%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Annualized   current distribution rate expressed as a percentage of NAV as of   July&nbsp;31, 2017</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">7.84</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">%</font></p>    </td>   </tr>
<tr>
<td width="84%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:84.0%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Cumulative total   return at NAV for the fiscal year, through July&nbsp;31, 2017(2)</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">13.86</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">%</font></p>    </td>   </tr>
<tr>
<td width="84%" valign="top" style="padding:0in 0in 0in 0in;width:84.0%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Cumulative fiscal   year-to-date distribution rate expressed as a percentage of NAV as of   July&nbsp;31, 2017(1)</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">7.42</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">%</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">You should not draw any conclusions about the Fund&#146;s investment performance from the amount of this distribution or from the terms of the Fund&#146;s managed distribution plan.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The composition of this and subsequent distribution may vary from quarter to quarter because it may be materially impacted by future realized gains and losses on securities. The aggregate of the net unrealized appreciation of portfolio securities and net realized losses on sale of securities is $180,845,130, of which $135,884,800 represents net unrealized appreciation of portfolio securities.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The amounts and sources of distributions reported in this 19(a)&nbsp;Notice are only estimates and are not being provided for tax reporting purposes. The actual amounts and sources of the amounts for tax reporting purposes will depend upon the Fund&#146;s investment experience during the remainder of its fiscal year and may be subject to changes based on tax regulations. The Fund will send you a Form&nbsp;1099-DIV for the calendar year that will tell you how to report these distributions for federal income tax purposes.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="1" width="25%" noshade align="left" style="color:black;"></div>
<p style="margin:0in 0in .0001pt 12.95pt;text-indent:-12.95pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(1)The Fund&#146;s current fiscal year began on October&nbsp;1, 2016.</font></p>
<p style="margin:0in 0in .0001pt 12.95pt;text-indent:-12.95pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(2)Cumulative total return at NAV is the percentage change in the Fund&#146;s NAV and includes all distributions and assumes the reinvestment of those distributions for the period of September&nbsp;30, 2016 through July&nbsp;31, 2017.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .2pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Tekla Life Sciences Investors&#160; <br> CUSIP: 87911K100 <br> www.teklacap.com</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .2pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Tekla Capital Management LLC <br> 100 Federal Street, 19</font><font size="1" style="font-size:6.5pt;position:relative;top:-3.0pt;">th</font>&#160;Floor <br> Boston, Massachusetts 02110</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .2pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">617-772-8500 <br> Fax: 617-772-8577</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\105435\17-24477-1\task8658795\24477-1-ms.htm',USER='105435',CD='Dec  5 01:59 2017' -->

</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.906CERT
<SEQUENCE>5
<FILENAME>a17-24477_1ex99d906cert.htm
<DESCRIPTION>EX-99.906CERT
<TEXT>


<html>
<head>



  </head>
<body link=blue lang="EN-US">
<div>
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Exhibit&nbsp;99.906CERT</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">EXHIBIT&nbsp;5: CERTIFICATION PURSUANT TO SECTION&nbsp;906 OF THE SARBANES-OXLEY ACT</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:26.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Pursuant to Section&nbsp;906 of the Sarbanes-Oxley Act of 2002, each of the undersigned officers of TEKLA LIFE SCIENCES INVESTORS, do hereby certify, to such officer&#146;s knowledge, that the report on Form&nbsp;N-CSR of TEKLA LIFE SCIENCES INVESTORS for the period ended September&nbsp;30, 2017 fully complies with the requirements of Section&nbsp;13(a)&nbsp;or 15(d)&nbsp;of the Securities Exchange Act of 1934, as applicable, and information contained in the Form&nbsp;N-CSR fairly presents, in all material respects, the financial condition and results of operations of TEKLA LIFE SCIENCES INVESTORS for the stated period.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.26%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Dated:</font></p>    </td>
<td width="38%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:38.34%;">
<p style="margin:0in 0in .0001pt 30.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">12/5/17</font></p>    </td>
<td width="5%" valign="top" style="padding:0in 0in 0in 0in;width:5.42%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.26%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="38%" valign="top" style="padding:0in 0in 0in 0in;width:38.34%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="5%" valign="top" style="padding:0in 0in 0in 0in;width:5.42%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.26%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="38%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:38.34%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">/s/ Daniel R. Omstead</font></p>    </td>
<td width="5%" valign="top" style="padding:0in 0in 0in 0in;width:5.42%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">/s/ Laura Woodward</font></p>    </td>   </tr>
<tr>
<td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.26%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="38%" valign="top" style="padding:0in 0in 0in 0in;width:38.34%;">
<p style="margin:0in 0in .0001pt .3in;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Name:   Daniel R. Omstead</font></p>    </td>
<td width="5%" valign="top" style="padding:0in 0in 0in 0in;width:5.42%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt 11.5pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Name: Laura   Woodward</font></p>    </td>   </tr>
<tr>
<td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.26%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="38%" valign="top" style="padding:0in 0in 0in 0in;width:38.34%;">
<p style="margin:0in 0in .0001pt .3in;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Title:   President</font></p>    </td>
<td width="5%" valign="top" style="padding:0in 0in 0in 0in;width:5.42%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt 11.5pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Title: Treasurer</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">A signed original of this written statement required by Section&nbsp;906 has been provided to TEKLA LIFE SCIENCES INVESTORS and will be retained by TEKLA LIFE SCIENCES INVESTORS and furnished to the SEC or its staff upon request. This statement accompanies this report on Form&nbsp;N-CSR pursuant to Section&nbsp;906 of the Sarbanes-Oxley Act of 2002.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\109752\17-24477-1\task8657101\24477-1-mu.htm',USER='109752',CD='Dec  1 22:21 2017' -->

</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>j17244772_ba018.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 j17244772_ba018.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ C0%0 P$1  (1 0,1 ?_$ :(    & @,!
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MO_GEJS_SZ8?_ .J_?NO9Z]_%<W_SRU9_Y],/_P#5?OW7L]>_BN;_ .>6K/\
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M<NW-KU'9]:E'MG$154(R=1!DJJHQX2JBI)3[KW6Q(CI(BR1LKHZJZ.C!D=&
M965E)#*P-P1P1[]U[KE[]U[KWOW7NO>_=>Z][]U[HG_Q/_X^/YA_^+@;U_\
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M]ULO?WHQO_*MN+_T$-V?_63WZAZ]U[^]&-_Y5MQ?^@ANS_ZR>_4/7NDOO?\
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MTUR.%%R+L0/J??NO=,O][]I_\]1MW_S]XW_ZI][H?0]>Z]_>_:?_ #U&W?\
MS]XW_P"J??J'T/7NO?WOVG_SU&W?_/WC?_JGWZA]#U[KW][]I_\ /4;=_P#/
MWC?_ *I]^H?0]>Z]_>_:?_/4;=_\_>-_^J??J'T/7NO?WOVG_P ]1MW_ ,_>
M-_\ JGWZA]#U[KW][]I_\]1MW_S]XW_ZI]^H?0]>Z]_>_:?_ #U&W?\ S]XW
M_P"J??J'T/7NO?WOVG_SU&W?_/WC?_JGWZA]#U[KW][]I_\ /4;=_P#/WC?_
M *I]^H?0]>Z]_>_:?_/4;=_\_>-_^J??J'T/7NO?WOVG_P ]1MW_ ,_>-_\
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M )7:3_SIA_Z/]^Z]4=>_B%!_RNTG_G3#_P!'^_=>J.O?Q"@_Y7:3_P Z8?\
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M'OW7NL,]/!51/!500U,$FG7#/&DT3Z6#KKCD5D;2Z@BXX(O[]U[IN_N_@?\
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M<?2T.3VC6"EGA95A\L/LC/3L6_VJW"0"Y296.FH1@/MUY0D>8!K3-.K(,?\
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MP73U#G=V8_M6NI3446;7 ;+RM3N6+)4;0QUN0P.2FAA*PT,62]U[H)MU=/\
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MU\?_ (Q;3ZL[,^074FUOCYA^JMH]A;TPO?Q[$P/:V&WC7G/=>;[VO_H0BGV
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MKW1H.^/X)_LG\G]Y_P#9A/[K_P!R^OO[S?W>_N3_ *<_X%YMO?Q#^_?^D/\
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%]U[K_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>j17244772_ba019.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 j17244772_ba019.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ )P"Z P$1  (1 0,1 ?_$ :(    & @,!
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MIJ.(S31XO%93.9!T! (I<3A:/(96OEN?\W!#(Y'-N#[KT9NXC0NU:#T!)_(
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MG>/7G0VS-J?(O)9?;V1PW2^P^N1O^J[#Q]%LRHK5W5E>SLGN#?-3/A*58/X
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ML=MTN+IQ92@_CM8W)!/%SH>%YZOY?['2F8\UH^FW7;I(Z?$S31DG_2!90/\
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&WKI7U__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>j17244772_ba020.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 j17244772_ba020.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ H@!T P$1  (1 0,1 ?_$ :(    & @,!
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M[J;%0$FRH3;\VO\ \5]^Z]U,6@<'E2#_ +'_ (W8^]=>Z<(\6Y4G3_AS^?\
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M-]GEJ4-P6L!JX(]TD'=^75XSCJC<038]G0JVF)PR2@']R._%C:X8%N03]?\
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M>]@.6+ &Y!_UC^/?NO=)*7_<;E-14BASLL<+L>%ILV D-'.;*=,>4B1:=O\
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K_F]_3_:O?AU[JSO_ +IN_P#=N=_V6G_Y:G_S(S_W_P#_ /*[[W^+KW7_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>j17244772_ba021.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 j17244772_ba021.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ W@&I P$1  (1 0,1 ?_$ :(    & @,!
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MDL3'CJJHCBG:HBC$,CJKV) /NO=5_P#QW^*W<>ROC[F=K5B;'AKMS_+#KSY
M;.V+6]AY/=6V.K^N=H=J=:;N&T-I]C1;(RFXLS1S;2V T>'I*T9 4(KA2QY*
M+&I345![KW1QMW[7W]OG>'3>XTVSMG$T75W<V]\_G9:G=647,9?9;=4=L]:[
M=K-KQQ;.A,V6RM;V#3U5325D^.IZ/[:805=9&8*B7W7NBQ9CXE[VJ]M;CVQL
MO</8^UL1N;;_ &'U/L?$[][(B[%HNHNG>TMM=58'L2FS>1W//OG>NY:QLKUZ
MV6VOAJ+-R1T,LCTK9C&T52M)0^Z]U9'[]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_
M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[J#C<GC<S0T
M^3P^0H<KC:M6>ER&-JZ>NH:E$D>)VIZNEDE@F5949258@,"/J/?NO=>R63QN
M&H:C)YC(4.*QM(JO59#)5=/0T-,CR)$C5%752100JTKJH+, 6('U/OW7NB(;
M$Z'W_A/FY\I^],M@E?K'L#KW9>VL=MV?+8O=:]BY;#;1Z_@H\W@*/=$,,_6>
M2Q\^WLQALUB::NI=NYR)<)D94>NBJY8?=>Z4>U.MNR\?UI\;.O*[9N-GK.@-
M@]:R;@ILIFJ.3;N^\U4=&]Q='[FV<)4Q^0I1B<!DLEC,M43L96J<;5V6G\Z"
M";W7NN-3\;)\=A,#D/LY,QV#U=MOJG![+WAAZ#:,>Z.P]Q[+R>S]Y[PW%OJL
MS,%(E7@^Q=R[0QD.6I:_(/50QXIJS'3TV2DIIU]U[HI_R3F[9Z*V9TKM:+L+
M,8/<627M3=.[TZ]W#G,%MN/.;QWU)O:JP.'-"N ER.WMH5.YY<9C)YJ.DDEH
MJ=)#3TQ=H4]T%^8KBX@>(0NZ AJZ6(KP]#T4?_3GW9_S^'M/_P!&#NW_ .N_
MO70;^OOO]_2_[VW^?JQ#^7]OW?6\\QV=%O#>F[-UQT&-VO)01[EW'F,ZE$]1
M59M9WI$RE95+3/.L2!RFDL%%[V'O?0DY=N+B=Y1,[N %IJ8FG'U/5FGOW0HZ
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7N@=^1&&R>X_C_P!Y[>PN!S6Z<SGNG>S<-B=L;;S(V[N+<>3RFRLW
M0T&!P.X&JJ)<%FLO53I3TM89H12SR+)K33J'NO=5L==?$7MK%])]-=<35M5M
MS<3;)Z[P&]=X8[9F%VMN_JW9FQ.XNR.S)MYX3<FT:J*A3Y&]O;2W8<3O"'!8
MVJHZ[<$DV1<4=+(E/5^Z]T)\?1OR-7(97=VUQA=ETJ;=W+M[K;9&RMM;+VAM
M^B[-P^!P='UQ\E-[]=;FR&[-MX)<O)3Y;%5V)I*G)9:CP!PTXIX,E]Y38SW7
MNC%_,_=FY=E](UV;VGG<GMW,)N/;],F2Q%7+15BT]1/,L\*SPLKB.50 PO8^
M_=%&]S2P6)DA8J^H9&#U3_\ [,9WQ_S]S?W_ *$F1_Z_>]= W]Y;A_OZ3_>C
MT9[X?=R=K;P[WVS@=T]A;LW!A:G&[EDJ,7E<U6UE%-)38&OGIWDIYI6C=H9H
MU921PP!]^Z-=FO;N;<%CED=D(;!)(X'I8_S)O^+WU-_VJMW?^Y> ][Z>YG_M
M(?L;_".JR?>N@MU9M_+9_P"+WVS_ -JK:/\ [EY_WOH4\L?VDWV+_A/5L'OW
M0NZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z1>[.QMA[$K-JX_>>[MO[9K]\;@HMJ[0HL
MSDZ6AJMQ[BR-13TE#B,1!/(LM965595PP(J @SSQ1WURQJWNO=3H-Z;/JJ/,
MU])NK;M91;=61L]54>:QU7#AA$LK2#*/35$HH640/Q)I/H/'!]^Z]TB-M?(+
MH7>?8FX.H=G]W=1;K[9VDN3?=75^VNR=F9WL3;*82MIL;F6W!LK%YJJW+A5Q
M&1K8:>J-331BGFE1'TLR@^Z]T!>^_FGLWKSOCL?I7/[<R47^C'X^UOR"SV7:
MNHZ++UNU<96_;Y++;8VGD5I*W=NR<69$I<CG,?-/!BLH?MJJ*--<\7NO=9<5
M\M,CNV?KS)=;=15G:?76^=Z/U^_:6P^T>JLGM2FW)BM];EV?NU]N05>Y*#/;
M[P>V,;M6KSDM7CJ0EL5#*6CBGIJF&'W7NC$; W\^]Y]\T%3M[(;<RFP-X0;/
MR]+655#7T]35UFR-F;_IJC&U]!+)#51TV)WS34=98!8,K2U<,3SP1154_NO=
M5,==?(_Y.9&I[TH\;O#&;YRM/\L]XX?"[PR.YML;(Z;CZII]E]IU&W=B8+<^
M9ZTWE)TOVGM*MVI@\=F=MYK&YLRU45/.]5%4YO)9"D]U[H=-L=I_*O?F+IMK
M8^JRFW.S\UU7N3L#<+[II>O.O-K=>X/,[KVA4]5U4]?3[([XS/5_9&7Z_GR4
M=3A-TX?<,$>8I<I)"M;18R.2H]U[HU.Q]Z;KR?Q>@WGEJG.1;THNL=Q3U>:S
M=9M?,U^4W!MO&Y6B.[J/,[3VAL3:&Y,'N2MQ@RF*R5#@,-19/&U-/4QT%(DP
MIX_=,W+,EO(ZX8(Q'V@'JH?_ &;OY'?\_0RO_GJVW_\ 67WKH _OC<_]^G]B
M_P";I0;2^6'R%R&ZMLT%9V7E)Z2NW!AJ.J@;&;=59J:IR--#/$S)AU<"2)R"
M00>>#[]T[#N^XM,BM*=)8#@/7[.K%_GK_P!D^Y'_ ,.K;/\ [DS^]]"3F#_D
MG'_3K_AZHX]ZZ ?1NO@U_P!E';2_[56[/_>;R7OW1SL/_)33[&_XZ>A\_F3?
M\7OJ;_M5;N_]R\![WT8<S_VD/V-_A'59/O706ZLV_EL_\7OMG_M5;1_]R\_[
MWT*>6/[2;[%_PGJV#W[H7=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=<7=(T:21E1$5G=W8*B(H+,S,Q 55 N2
M> /?NO=<O?NO=>]^Z]T1[Y,]"]C=K_(7X:]A;(^QQ&(Z/WEO?=&[]XONF>BR
M>-QF6?8,-5M!-B5>(S.V=]87L7;.+RU!435*0Y# UZT-=CZBGF1I5]U[H(L9
M\-N^]K]4=G;4VKVOA?[R9WIG9FP]A4.Z\_NK<& V[O?9>-[,AQFYL/O.GP6)
M['V1M7$YO>>/R> PAGW'3[8K,;Y*(F1O)[]U[JP+';?R53OG(;NST-&K8S;]
M-M/::TTYJ##19)J#.;TRHO3TTE)_>',46/I#32M4:(\%%.CH:F2,>Z]T4ONC
MKWXSR=Z?Z0.X>R)Z/=$>R:2AV_M',9!#CMJUYKH6I-][:OCJBJHLE)%B1 ])
M))-BI[2/+2.TLI?W22:^M+=_#GD57I6A].E'@.R_BUMO)S9N@[BQSY>NR&YL
M_EZZHJZ1ES.[]T8[;F$GWM78Z';\&'BW1B]O[9BQU'-34U/%%15-5&T3_<RE
MO=-?O7;O]_)TNOBUM;8&T.O<MBNM^VMZ]QX"3>F8R53N/?.;Q6<R>/SF2H,-
M59C%4U1A]M[6HXX*NJ?^*U):F>HJLGDZNKGFEFJ)&]^Z507$-RFN!@R TJ/7
M_4>BR;N^>V/Z[WMOO9U!TK1R?P'>NY\56Y&CWI#BOXWD,7EJG%U.;JJ2'8\^
MBLR7V*R/KEF<<*9'M?W[H/W',7@3O#X-=#E:ZZ5H:5IIZ1DO\P[!3TE503?'
MS$S4-;7#)UM%+O6CDI*O)"KBKQD*JG?KTPU%<*Z!)O*X,GE17OJ /OW37]9_
M^$?\;_Z$Z/?D-W_W_P#CGF][?P[^$_WIZBS^<_AGW?W_ -A_$-JUU1]K][]M
M1?=>'7;7XH]5KZ1]/?NCQIOJ-M:>E-<)-.-*J?/'6NW[UU&_2IV-_P ?ML__
M ,.G;_\ [MJ3W[IZW_MT_P!./\(ZN>^>O_9/N1_\.K;/_N3/[WT-N8/^2<?]
M.O\ AZHX]ZZ ?1NO@U_V4=M+_M5;L_\ >;R7OW1SL/\ R4T^QO\ CIZ'S^9-
M_P 7OJ;_ +56[O\ W+P'O?1AS/\ VD/V-_A'59/O706ZLV_EL_\ %[[9_P"U
M5M'_ -R\_P"]]"GEC^TF^Q?\)ZM@]^Z%W7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW3?ELMC,#BLGG,WD*/$X;"X^MRV7RN1J(J3'XS
M&8ZFDK*_(5U7.R0TM'14L+R2R.0J(I)( ]^Z]T#^Q/D)UWV3M?9^Y]H-N2N;
M?E1F8-M;9R.V,QMS>%2FW*A(-PY&MV]N6GQ%7A\'A?/ T^0J_!0WK*2-)GFK
M:.*?W7NI0^07434"9*/=C3038VCSE)!3[>W349/(;;R&)RF<H-V8K#0823+Y
M;9M=BL'6RPYBF@EQ<HI)E6<M&ZCW7NB^_P P_#[BWM\1=\8G8F5W!!79W(;
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M !*>;_\ >2V1[WT-N6_]P7_YJG_CJ]59]Y_\SL[A_P#$I]@_^];E_>N@I?\
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M1O(  ?D.M #VHZQOZ5&Q_P#C]-H?^'1@/_=M2>_=/6_]NG^G'^$=;N?\[O\
M[=V=L_\ AT=5?^_'VY[3Q_&.I[Y^_P"59F_T\?\ Q]>M&3VHZQ^ZM!_DR?\
M;RGXW_\ E8?_ 'PG:7NLGP'H6\B_\K3:_P#-S_JS)U:#_P *1O\ N3/_ ,N)
M_P#F%^Z1>?0M]T?^(/\ S>_ZQ=:OOMWJ)>MEK_A.)_Q^GRM_\-?J;_W;;\]M
M2^74J^U_]O>?Z2/_  OT0[^=W_V\3[9_\-?JK_WW&W/=X_@'0=Y^_P"5FF_T
MD?\ QQ>JEO=N@9UNY?R)/^R MO?^)1[*_P#=E1>V)/BZGSV]_P"5;7_FL_\
MAZTW>[_^9T=O?^)0W_\ ^]7EO;XX=0?N'^Y\_P#S6?\ X\>@O]^Z1];X?<__
M &YZW)_XH=A__?-XOVG_ -$_/_+UD/?_ /*DO_TKA_U:'6AY[4=8\=&@^$'_
M &6E\0O_ !:'H'_WZ^T_>F^$_9T;[!_R7;+_ )ZX?^KB];MG\Q7_ )DGM?\
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M/)ZV_P##IRW_ +J4]^Z$',W]A%_IS_@ZJ+]^Z!W5AO\ +D_YFCOG_P ,%O\
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M_P".+U4M[MT#.MW+^1)_V0%M[_Q*/97_ +LJ+VQ)\74^>WO_ "K:_P#-9_\
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M^G'^$=7/?/7_ +)]R/\ X=6V?_<F?WOH;<P?\DX_Z=?\/5''O70#Z-U\&O\
MLH[:7_:JW9_[S>2]^Z.=A_Y*:?8W_'3T/G\R;_B]]3?]JK=W_N7@/>^C#F?^
MTA^QO\(ZK)]ZZ"W5FW\MG_B]]L_]JK:/_N7G_>^A3RQ_:3?8O^$]6P>_="[K
MWOW7NO>_=>Z][]U[KYX?\P[_ ++G^67_ (GCL?\ ]Z.M]JE^$?9UC1S-_P K
M!>?\]#_\>/1-_>^B+K?"^&/_ &Z8ZW_\5>WC_P"Z;=/M.W]I^?61&Q?\J;%_
MSR-_@;K0]]J.L=^E1L?_ (_3:'_AT8#_ -VU)[]T];_VZ?Z<?X1UNY_SN_\
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M,A_X\GK;_P .G+?^ZE/?NA!S-_81?Z<_X.JB_?N@=U8;_+D_YFCOG_PP6_\
M>APOOW0DY:_W*D_YI_Y1TE?Y@O\ S/BD_P##!V]_[L<][]TSS%_R4!_S3'^$
M]$<]^Z(>KGOY=7_,D]T?^)3S?_O);(][Z&W+?^X+_P#-4_\ '5ZJS[S_ .9V
M=P_^)3[!_P#>MR_O704O_P#<Z;_FJ_\ QX]!;[]TDZOPV3_V1OC/_$!UO_O&
M5?O?4@P?\D4?\\Y_X[U0?[UU'W2IV-_Q^VS_ /PZ=O\ _NVI/?NGK?\ MT_T
MX_PCJY[YZ_\ 9/N1_P##JVS_ .Y,_O?0VY@_Y)Q_TZ_X>J./>N@'T;KX-?\
M91VTO^U5NS_WF\E[]T<[#_R4T^QO^.GH?/YDW_%[ZF_[56[O_<O >]]&',_]
MI#]C?X1U63[UT%NK-OY;/_%[[9_[56T?_<O/^]]"GEC^TF^Q?\)ZM@]^Z%W7
MO?NO=>]^Z]U[W[KW7SP_YAW_ &7/\LO_ !/'8_\ [T=;[5+\(^SK&CF;_E8+
MS_GH?_CQZ)O[WT1=;X7PQ_[=,=;_ /BKV\?_ '3;I]IV_M/SZR(V+_E38O\
MGD;_  -UH>^U'6._2HV/_P ?IM#_ ,.C ?\ NVI/?NGK?^W3_3C_  CK=S_G
M=_\ ;NSMG_PZ.JO_ 'X^W/:>/XQU/?/W_*LS?Z>/_CZ]:,GM1UC]U:#_ "9/
M^WE/QO\ _*P_^^$[2]UD^ ]"WD7_ )6FU_YN?]69.K0?^%(W_<F?_EQ/_P P
MOW2+SZ%ONC_Q!_YO?]8NM7WV[U$O6RU_PG$_X_3Y6_\ AK]3?^[;?GMJ7RZE
M7VO_ +>\_P!)'_A?HAW\[O\ [>)]L_\ AK]5?^^XVY[O'\ Z#O/W_*S3?Z2/
M_CB]5+>[= SK=R_D2?\ 9 6WO_$H]E?^[*B]L2?%U/GM[_RK:_\ -9_\/6F[
MW?\ \SH[>_\ $H;_ /\ WJ\M[?'#J#]P_P!SY_\ FL__ !X]!?[]TCZWP^Y_
M^W/6Y/\ Q0[#_P#OF\7[3_Z)^?\ EZR'O_\ E27_ .E</^K0ZT//:CK'CHT'
MP@_[+2^(7_BT/0/_ +]?:?O3?"?LZ-]@_P"2[9?\]</_ %<7K=L_F*_\R3VO
M_P")3PG_ +R6]_:7J?.9/]P4_P":H_XZW5,/O70)Z/'_ "^O^9\5?_A@[A_]
MV.!]^Z/N7?\ DH'_ )IG_".E5_,;_P"9H[&_\,%?_>AS7OW3W,O^Y4?_ #3_
M ,IZKR]^Z#?5L'\MG_BR=L_]K7:/_N)G_>^A=RQ_9S?:O^ ]$O\ EW_V4=VA
M_P!K7%?^\WA?>NB3>/\ DIR_:/\ CHZ+?[]T6=7X?"O_ +)FZT_\G+_WO]U>
M]]2#L?\ R2XO]M_Q]NJ#_>NH^Z][]U[J_#Y/?]DK;X_\-7;7_NXV_P"]]2#N
MO_))D_TB_P"$=4'^]=1]T/GQ<_[*"ZI_\.JG_P#<:I]^Z,=I_P"2C#_I_P#)
MT?C^9#_QY/6W_ATY;_W4I[]T(.9O["+_ $Y_P=5%^_= [JPW^7)_S-'?/_A@
MM_[T.%]^Z$G+7^Y4G_-/_*.DK_,%_P"9\4G_ (8.WO\ W8Y[W[IGF+_DH#_F
MF/\ ">B.>_=$/5SW\NK_ )DGNC_Q*>;_ />2V1[WT-N6_P#<%_\ FJ?^.KU5
MGWG_ ,SL[A_\2GV#_P"];E_>N@I?_P"YTW_-5_\ CQZ"WW[I)U?ALG_LC?&?
M^(#K?_>,J_>^I!@_Y(H_YYS_ ,=ZH/\ >NH^Z5.QO^/VV?\ ^'3M_P#]VU)[
M]T];_P!NG^G'^$=7/?/7_LGW(_\ AU;9_P#<F?WOH;<P?\DX_P"G7_#U1Q[U
MT ^C=?!K_LH[:7_:JW9_[S>2]^Z.=A_Y*:?8W_'3T/G\R;_B]]3?]JK=W_N7
M@/>^C#F?^TA^QO\ ".JR?>N@MU9M_+9_XO?;/_:JVC_[EY_WOH4\L?VDWV+_
M (3U;![]T+NO>_=>Z][]U[KWOW7NOGA_S#O^RY_EE_XGCL?_ -Z.M]JE^$?9
MUC1S-_RL%Y_ST/\ \>/1-_>^B+K?"^&/_;ICK?\ \5>WC_[IMT^T[?VGY]9$
M;%_RIL7_ #R-_@;K0]]J.L=^E1L?_C]-H?\ AT8#_P!VU)[]T];_ -NG^G'^
M$=;N?\[O_MW9VS_X='57_OQ]N>T\?QCJ>^?O^59F_P!/'_Q]>M&3VHZQ^ZM!
M_DR?]O*?C?\ ^5A_]\)VE[K)\!Z%O(O_ "M-K_S<_P"K,G5H/_"D;_N3/_RX
MG_YA?ND7GT+?='_B#_S>_P"L76K[[=ZB7K9:_P"$XG_'Z?*W_P -?J;_ -VV
M_/;4OEU*OM?_ &]Y_I(_\+]$._G=_P#;Q/MG_P -?JK_ -]QMSW>/X!T'>?O
M^5FF_P!)'_QQ>JEO=N@9UNY?R)/^R MO?^)1[*_]V5%[8D^+J?/;W_E6U_YK
M/_AZTW>[_P#F=';W_B4-_P#_ +U>6]OCAU!^X?[GS_\ -9_^/'H+_?ND?6^'
MW/\ ]N>MR?\ BAV'_P#?-XOVG_T3\_\ +UD/?_\ *DO_ -*X?]6AUH>>U'6/
M'1H/A!_V6E\0O_%H>@?_ 'Z^T_>F^$_9T;[!_P EVR_YZX?^KB];MG\Q7_F2
M>U__ !*>$_\ >2WO[2]3YS)_N"G_ #5'_'6ZIA]ZZ!/1X_Y?7_,^*O\ \,'<
M/_NQP/OW1]R[_P E _\ -,_X1TJOYC?_ #-'8W_A@K_[T.:]^Z>YE_W*C_YI
M_P"4]5Y>_=!OJV#^6S_Q9.V?^UKM'_W$S_O?0NY8_LYOM7_ >B7_ "[_ .RC
MNT/^UKBO_>;POO71)O'_ "4Y?M'_ !T=%O\ ?NBSJ_#X5_\ 9,W6G_DY?^]_
MNKWOJ0=C_P"27%_MO^/MU0?[UU'W7O?NO=7X?)[_ +)6WQ_X:NVO_=QM_P![
MZD'=?^23)_I%_P (ZH/]ZZC[H?/BY_V4%U3_ .'53_\ N-4^_=&.T_\ )1A_
MT_\ DZ/Q_,A_X\GK;_PZ<M_[J4]^Z$',W]A%_IS_ (.JB_?N@=U8;_+D_P"9
MH[Y_\,%O_>APOOW0DY:_W*D_YI_Y1TE?Y@O_ #/BD_\ #!V]_P"['/>_=,\Q
M?\E ?\TQ_A/1'/?NB'JY[^75_P R3W1_XE/-_P#O);(][Z&W+?\ N"__ #5/
M_'5ZJS[S_P"9V=P_^)3[!_\ >MR_O704O_\ <Z;_ )JO_P >/06^_=).K\-D
M_P#9&^,_\0'6_P#O&5?O?4@P?\D4?\\Y_P".]4'^]=1]TJ=C?\?ML_\ \.G;
M_P#[MJ3W[IZW_MT_TX_PCJY[YZ_]D^Y'_P .K;/_ +DS^]]#;F#_ ))Q_P!.
MO^'JCCWKH!]&Z^#7_91VTO\ M5;L_P#>;R7OW1SL/_)33[&_XZ>A\_F3?\7O
MJ;_M5;N_]R\![WT8<S_VD/V-_A'59/O706ZLV_EL_P#%[[9_[56T?_<O/^]]
M"GEC^TF^Q?\ ">K8/?NA=U[W[KW7O?NO=)O=F\MH;"PE3N;?6ZMM[+VW1R4T
M-9N#=F<QFW,)2RUDZ4M)%4Y;,55'002553*L<:M("\C!5N2![]U[KYUGS][3
MZQS'S9^4^4Q/8VP\IC,AWCV%5T&1QV[]OUM!6TLVX*QX:FDJZ;(2T]33RH05
M=&96'(/M4I&D?9UCCS'97K[]>.D,I0W#T(1B#D\#3HH?^D'87_/;[0_]"7#?
M_5OO=1T2_N^__P!\3?[PW^;K>&^'WR5^.>-_E7]>;?R/?W2E!GH?C3NZAFPE
M;VIL6ER\5;+A]SK'1R8V?/1UB54C2*%C*!R6%AS[3M\?Y]3]LD<B<H11LI$G
MTC"A&:T;%./6CS_I!V%_SV^T/_0EPW_U;[45'4 _N^__ -\3?[PW^;I2[+[%
MZ^BWCM.67?6S8XX]S8)Y)'W/A$1$3*4K.[NU<%5%47)/ 'OU1T[!87PG0F":
MFL?@;U^SK<\_G/\ R2^.VY_Y?O:>'VUWYTMN'+U&Y>KY(,7@^T]C9;(S)!V%
MMZ:=XJ&@SM14R)#"A=R%(502>![3Q_&.ITYZCDEY;F2)69R\> "3\8\AUI/?
MZ0=A?\]OM#_T)<-_]6^U%1U W[OO_P#?$W^\-_FZLM_D^]N]3[;_ )BWQXS6
MXNS^O,!AZ+_2U]YELUO7;>+QE)]QT9V;24_W-?79."E@\]5.D2:G&J1U47)
M]T<C0>A5R39W<7,]M)+%(J#Q*DJP _2D'$CJRS_A1#WST;O/_90/[G]S]3[K
M_AO^S ?Q'^[78NT,[]A]Y_H2^T^]_A>8JOM?NOM9?'KTZ_&VF^DVI%Y]"KW,
MMYY_HO 1WIXU=()I7PJ5H.M:;_2#L+_GM]H?^A+AO_JWV]4=17^[[_\ WQ-_
MO#?YNMC3_A/1WMTALW>/RBEW?W)U5M6.OVUU7'0R;D[#VC@TK7I\IOEITI'R
M>7I5J'A652X2Y4,+VN/;,OEU)_MI;W$$]V9XW0%(Z:E(KE^%1T1W^<_W#U)N
M?^8%VGF-M]I=<[AQ%1MGJ](,I@][[9RV.G>#KW;T,Z0UU!DZBFD>&9"CA6)5
M@0>1[O&1H'0?YZM+N7F29XHI&0I'D*2/@'F!U5;_ *0=A?\ /;[0_P#0EPW_
M -6^[U'00_=]_P#[XF_WAO\ -UN=_P D+Y'?'G:OP2P&)W/WSTQMS*IV7V-.
MV,SW:.Q\/D%@FR-&89FH\AG*>I6*4 E6*V:W'MB3XNITY!BEAY>5)597\5\$
M$'CZ'K4/[H[(Z[J>XNV*FFW[LNHIZCLO?<]/40;IP<L,\,NZ<K)%-#+'7,DL
M4J,&5E)# W'MX$4ZA:_L+XWTQ$,I!E?\#?Q'Y=!I_I!V%_SV^T/_ $)<-_\
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M -._1_\ S^7JG_T8FT/_ *\>_=![Z>?^!_V'_-U:5_+K^2WQQPN%[37,=_\
M2>):HRFU&@7)]J[$H&G6.DSHD:$56>B,@0N+E;VN+^]]"OEN-T276I%2O$4]
M>B>?+#Y"=!Y#Y"]EUE!WAU!74<^4QC05='V7LRIIIE7;N'1FBGAS3Q2 .I!(
M)Y!'O71-N\,S;C*RHQ6HX ^@Z+Q_IWZ/_P"?R]4_^C$VA_\ 7CW[HM^GG_@?
M]A_S=7H_#CY1_&;&?'#KFBR7R*Z*Q];!_>_S4E;VYU_254/DWWNB:/RT\^X(
MY8_)%(K+<"ZL".#[WT/=E5DVR)6!#=V#_IVZHN_T[]'_ //Y>J?_ $8FT/\
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MXK-U'P3BI-P4NWLS4BGR,=#/4IBZ^58*H0SN$/NO=+;_ &6GN?\ [V$_+_\
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M<LV=PF:^!&$S"Y:HK*;R&IJ*<&N@:*HC>6"6*5_=>Z7W^RT]S_\ >PGY?_\
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MR^;K:+K3X.YVHI,=2+KJ:I,3@/@?E,Q6+!'=W6"GE=4!8BP)'NO=1Z#J/?\
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MPGY?_P#H%? 7_P"X>]^Z]TC]R]2]@;1R^SL'G_YBWS+I,EO[.3;;VK'!U?\
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M"372R_9L?=>Z)7D>M/Y>N5Q&QJW!?(7M3;>RZWJ#L.FZMQ&U,+#/M_$]:3?
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?#E/XCNZFW;7^1B9X9*IZ=KPPT\DGNO="I[]U[K__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>j17244772_ba022.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 j17244772_ba022.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ S@&7 P$1  (1 0,1 ?_$ :(    & @,!
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M\S1?^A W_P!9O?NO=>_B>Z?^>9HO_0@;_P"LWOW7NO?Q/=/_ #S-%_Z$#?\
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M:WL;XG_S".RJK%4D\X,D])A:O<S4<4K)&98H _CCU:%]U[H[W]S,3_QUK_\
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M2LQ&R\UD*9*A(TBD>!IJ=0X5E)6]B#S[\.D.Z2-%MEQ*M-2P2$?:$)ZT8_\
MAP#N?_G2;"_\].5_^O7N_A#U/6.?]:=Q_AB_8?\ /U[_ (< [G_YTFPO_/3E
M?_KU[]X0]3U[^M.X_P ,7[#_ )^C_P#\KGY:=D=Q?.OHSKC=&,VK2X+<?^DW
M[Z?#T-?2Y*/^$=/=@YVF^VGJ,E50IJK,7&KWC:\98"Q((T8PHKGH3\G;_>7O
M,=M;2B,1MXE: UQ$Y]?4=;?G]S,3_P =:_\ \Z$_Z\^Z]3GU[^YF)_XZU_\
MYT)_UY]^Z]U[^YF)_P".M?\ ^="?]>??NO=>_N9B?^.M?_YT)_UY]^Z]U[^Y
MF)_XZU__ )T)_P!>??NO=>_N9B?^.M?_ .="?]>??NO=>_N9B?\ CK7_ /G0
MG_7GW[KW7O[F8G_CK7_^="?]>??NO=>_N9B?^.M?_P"="?\ 7GW[KW7O[F8G
M_CK7_P#G0G_7GW[KW7O[F8G_ (ZU_P#YT)_UY]^Z]U[^YF)_XZU__G0G_7GW
M[KW7O[F8G_CK7_\ G0G_ %Y]^Z]U[^YF)_XZU_\ YT)_UY]^Z]U[^YF)_P".
MM?\ ^="?]>??NO=>_N9B?^.M?_YT)_UY]^Z]U[^YF)_XZU__ )T)_P!>??NO
M=>_N9B?^.M?_ .="?]>??NO=>_N9B?\ CK7_ /G0G_7GW[KW7O[F8G_CK7_^
M="?]>??NO=>_N9B?^.M?_P"="?\ 7GW[KW7O[F8G_CK7_P#G0G_7GW[KW7O[
MF8G_ (ZU_P#YT)_UY]^Z]UVNSL4IN):_Z,O_  (3Z,I4_P"Z?Z'W[KW2L]^Z
M]U[W[KW7O?NO=% ^2W_,Y_Y>W_BW^]?_ ( 7YP^_=>Z-_P"_=>Z][]U[KWOW
M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z ;Y4?\ 9,'R/_\ $#=O_P#OO=P^
M]CCT6[Q_R2+K_GFE_P".-U\VOV_UBGU[W[KW5H?\F'_MY7\;?_*P_P#O@^T_
M=6^'H7\A?\K9:?\ -W_JS)UOE>V>LC^O>_=>Z][]U[KWOW7NO>_=>Z][]U[K
MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NDKO;+5N"VQE<Q
M0UN.QTN.A2KDK,GA\ON&"*E@E22JB@V_M^HILWF\E60*T%)2TCFHEJI8PB3-
M:&3W7NB*U?R?[[V?N+9='V?UY0;4QV_]F=48/;4D&R9LIMJJ[PW_ $NQ(]R4
M,G8^'[CS-52;;V!5Y[-UM90U>UJ6.3#[?J9XLV[Z$D]U[K!VWV/D=Q[G^ V[
M<E@*ZJR>&^>G?VR*S%;;H9):G)5'77Q:_F%=8RY7%8^NK/)'294[:_B"QO4.
M8J>6VN33=O=>Z.1_I/F_Y]IVG_Z#5#_]>_?NO=>_TGS?\^T[3_\ 0:H?_KW[
M]U[KW^D^;_GVG:?_ *#5#_\ 7OW[KW7O])\W_/M.T_\ T&J'_P"O?OW7NO?Z
M3YO^?:=I_P#H-4/_ ->_?NO=>_TGS?\ /M.T_P#T&J'_ .O?OW7NO?Z3YO\
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M]O\ 6*?7O?NO=67?R>\H<-_,8^.^27&97,&F_P!+=L=A*:.LR=1YNB^S:?\
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M#_Y[LY_]E_MGK(_KW]V]R_\ /50_^>[.?_9?[]U[KW]V]R_\]5#_ .>[.?\
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M-_@/7S&O:CK$?KWOW7NCY?RP/^R__BO_ .)1Q_\ [K<G[JW ]"/E#_E9;/\
MYK#_  'K>B^5'_9,'R/_ /$#=O\ _OO=P^VAQZR)WC_DD77_ #S2_P#'&Z^;
M7[?ZQ3Z][]U[JT/^3#_V\K^-O_E8?_?!]I^ZM\/0OY"_Y6RT_P";O_5F3K?*
M]L]9']>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U2%_/\ O^R%L1_X
MGGK_ /\ ><WY[NG'J/O<O_E75_YZ4_XZ_6E?[=Z@+KWOW7NME[_A.!_Q^ORN
M_P##7ZE_]VV_?;;^74L^U?\ N1>_Z2/_  OUM7^V^IEZ][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NJP/DQB-NMV]FGK
MNI]V9*JJZ:BR61WI4=4U^\=KY*F7;VWL?BJ;';MJ.T-G[<P<>*.+K(ZBEGCA
MEDJ9%9"^J[>Z]T<K,[UJNGOC=4]A5>"J]P3=9].Q;LRN!$\>#R%?3;1VC%E,
MU3(]:*F.AKUHZ"8K')J_=41EN=7OW7N@VWE\ML/LGN?</4.5VY2Q2XS%[6CV
M]D*O<57C,KO7>>]\ULK;FUMK[>PU=M:+#UE'79W?E%335T.7FDI&29Y*410R
M.ONO=!3WQV[MG)[G^ O8F7,VW\1AOG)W)M'.K-'491L=GMC_ !(^??6.<IX_
MX92SSUU,-U8*:.&6.+UQ%9"J@FWNO=&@_P!F4Z5_Y[-O_0:W=_\ 6#W[KW7O
M]F4Z5_Y[-O\ T&MW?_6#W[KW7O\ 9E.E?^>S;_T&MW?_ %@]^Z]U[_9E.E?^
M>S;_ -!K=W_U@]^Z]U[_ &93I7_GLV_]!K=W_P!8/?NO=>_V93I7_GLV_P#0
M:W=_]8/?NO=>_P!F4Z5_Y[-O_0:W=_\ 6#W[KW7O]F4Z5_Y[-O\ T&MW?_6#
MW[KW7O\ 9E.E?^>S;_T&MW?_ %@]^Z]U[_9E.E?^>S;_ -!K=W_U@]^Z]U[_
M &93I7_GLV_]!K=W_P!8/?NO=>_V93I7_GLV_P#0:W=_]8/?NO=>_P!F4Z5_
MY[-O_0:W=_\ 6#W[KW7O]F4Z5_Y[-O\ T&MW?_6#W[KW7O\ 9E.E?^>S;_T&
MMW?_ %@]^Z]TG]V?(KINOVMN6AIMX%ZFMV_F:2G0[<W:H>>HQU3#$I9L"%4-
M(X%SP/?NF+D@6TA/#0W^ ]?.&]J.L2.O>_=>Z/!_+8R^.P'SJ^,^;R]3]IC,
M5V-35U?4^&HJ/!2T^*RDDLG@I(9ZF72J_1$9C_3W5N!Z$?*'_*RV?_-8?X#U
MNF_);Y"=09?XY=_XG'[M:>ORG2?:N.H8#M[=47FK*W8F>IJ:+RSX..&+R32J
M-3LJK>Y('/MH<>LB=Y_Y)%U_SS2_\<;KYZ7M_K%/KWOW7NK)OY0VY<)L_P#F
M(?'O<6XJTX_#8[_2Q]Y6"FK*SP_=]'=ET-/_ )-04]55R>2JJ47T1M;5<V )
M%6^'H7\A?\K9:?\ -W_JS)UNY_[,ITK_ ,]FW_H-;N_^L'MGK(_KW^S*=*_\
M]FW_ *#6[O\ ZP>_=>Z]_LRG2O\ SV;?^@UN[_ZP>_=>Z]_LRG2O_/9M_P"@
MUN[_ .L'OW7NO?[,ITK_ ,]FW_H-;N_^L'OW7NO?[,ITK_SV;?\ H-;N_P#K
M![]U[KW^S*=*_P#/9M_Z#6[O_K![]U[KW^S*=*_\]FW_ *#6[O\ ZP>_=>ZI
ML_GG=O\ 7>_?A5C<-M3<)RF2A[LV)D9*8X?/4&FC@P6]()9?-DL71TYTRU2#
M2'U'5<"P-KIQZC[W+_Y5U?\ GI3_ (Z_6GS[=Z@+KWOW7NMBW_A/EV!M'K_=
M/RBKMW9?^$TU?M_J>DHW&.RV0,TZ9'?TSKIQ5!7-$$C%[OI!OQ?FS;^74L>U
M9'U-Z//1'_A?K9L_V93I7_GLV_\ 0:W=_P#6#VWU,W7O]F4Z5_Y[-O\ T&MW
M?_6#W[KW7O\ 9E.E?^>S;_T&MW?_ %@]^Z]U[_9E.E?^>S;_ -!K=W_U@]^Z
M]U[_ &93I7_GLV_]!K=W_P!8/?NO=>_V93I7_GLV_P#0:W=_]8/?NO=>_P!F
M4Z5_Y[-O_0:W=_\ 6#W[KW7O]F4Z5_Y[-O\ T&MW?_6#W[KW7O\ 9E.E?^>S
M;_T&MW?_ %@]^Z]U[_9E.E?^>S;_ -!K=W_U@]^Z]U[_ &93I7_GLV_]!K=W
M_P!8/?NO=9(_DATQ*Q2/>+,PCEE(_NWNT>B&)YI6NV! ],<9-OJ;6'/OW7N@
MX[6^)&V^X>PQO[>V[L[N6GQDV K=G=?;MHL;N?K/8N:P'VLL6Y]O[0JTIZ.3
M=%960-)-5UC50*N$5%51[]U[H=]T]>8[??6&:ZMWGD<MEL3NG9M3LK=>2HZM
M\/E\SCLGB3B,Y,*NATO0U&8II)?(8K:1*P6W'OW7NF;<O3VV][5E#/O6IR&Y
MJ3 Q$[2H*^2,)MG+-BH<6=V4-1&@J9-Z4R?<-2Y1F%12?>2B+3JO[]U[HO'=
MVV,1L_L[^7C@L)#)#1)\S>S<I*TTK3U-9EMQ?!_YX;BS^5K:A_545^8SN5J:
MNHD/+S3,WY]^Z]T>#W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]TE][DC9>[R"01M?/D$&Q
M!&*JR""/H1[]TS<?[CR?Z1O\!Z^8U[4=8C]>]^Z]T?+^6!Q\_P#XKV_Y^C0?
M[SC<F#_MQ[JW ]"/E#_E9;/_ )K#_ >MZ+Y4?]DP_([_ ,0-V_\ ^^]W#[:'
M'K(G>/\ DD77_/-+_P <;KYM?M_K%/KWOW7NK0_Y,/\ V\K^-O\ Y6'_ -\'
MVG[JWP]"_D+_ )6RT_YN_P#5F3K?*]L]9']>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U2'_/]_P"R%L3_ .)YZ_\ _>=WY[NG'J/O<O\ Y5T?\]*?
M\=?K2N]N]0%U[W[KW6R__P )P"?[Z?*\7-CM?J0D7X)&5W\ 2/ZBY_V_MM_+
MJ6?:K_<B]_TD?^%^MJ[VWU,O7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]T4#Y+?\SG_E[?^+?[
MU_\ @!?G#[]U[HW_ +]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>ZU\,O_/2ZYQ66R>,D;;HDQN1K:"0&'-$AZ.IE
MIV!(H[$ZH_?J-U&C^X=HCE"8Z@D<&\OSZ;O^'X.MO]5MS_J1FO\ ZC]^HW5/
M]<6T]8_V-_GZ6?7/\[/KW?W86P]B4K;?^YWKO/:^TJ?QPY@2>?<>;H</#XR]
M($#^2L%KFU_K[]1NG[7G^UN;F.W!2LDBKP;\1 ]?GU>+OC_CRMW_ /AK[@_]
MU-7[]U(-S_N/)_I&_P !Z^8U[4=8C]>]^Z]T?+^6!_V7_P#%?_Q*./\ _=;D
M_=6X'H1\H?\ *RV?_-8?X#UO1?*C_LF#Y'_^(&[?_P#?>[A]M#CUD3O'_)(N
MO^>:7_CC=?-K]O\ 6*?7O?NO=6A_R8?^WE?QM_\ *P_^^#[3]U;X>A?R%_RM
MEI_S=_ZLR=;Y7MGK(_KWOW7NO>_=>Z][]U[JOG^:AV)F>J/@;WMO_;]+C:W+
MX#_1A]I39>F2LQTG\4[DZ\PM1]Q32(Z2:*7(NR7!LX4_CWL"IIT&^;[V;;^7
M;B\MS29/#IQ'&5%/#Y$]:=O_  X?W)_SR_6__H,T7_U+[OX8]3U"/]<]Z_B_
MXTW^?KW_  X?W)_SR_6__H,T7_U+[]X8]3U[^N>]?Q?\:;_/U=3_ "0/E!OO
MO3Y ]L[?W7B-JXZCP_3DN9II<!B8,?4/4_WUVK1>.>2&*,R0^*J8V-_4 ?>F
M4 =#OD'?K_=MRFANVJBP:ADG.I1YGY]&R_G_ '_9"V(_\3SU_P#^\YOSWY./
M1M[E_P#*NK_STI_QU^M*_P!N]0%U[W[KW6R]_P )P/\ C]?E=_X:_4O_ +MM
M^^VW\NI9]J_]R+W_ $D?^%^MJ_VWU,O7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW0&_)LY\?';N\[3K,[0[M'
M5V]CM&?;#RQY]]V# 5QVQ1XEH(Y9369#._;TZJHN_ETW6^H>Z]T77LR'O'*;
MTW#7[!7-U-!6=I;5J\K-%]V8*SXDS]5=;-OC&;23R110]BY'L09E\$$"UHD%
M:054K[]U[I*=@1;SBS?\ON.L4MEQ\\OD$=KQY:LFI57K]_B[_,.?K5)*J7'Y
M>IBACZP;&"$2022Z BOI:[#W7NCSZ>R/^5?;O_H3S_\ VNO?NO=>T]D?\J^W
M?_0GG_\ M=>_=>Z]I[(_Y5]N_P#H3S__ &NO?NO=>T]D?\J^W?\ T)Y__M=>
M_=>Z]I[(_P"5?;O_ *$\_P#]KKW[KW7M/9'_ "K[=_\ 0GG_ /M=>_=>Z]I[
M(_Y5]N_^A//_ /:Z]^Z]U[3V1_RK[=_]">?_ .UU[]U[KVGLC_E7V[_Z$\__
M -KKW[KW7M/9'_*OMW_T)Y__ +77OW7NO:>R/^5?;O\ Z$\__P!KKW[KW7M/
M9'_*OMW_ -">?_[77OW7NOFL[VO_ 'SW=JL6_O/G]16]B?XK5WM?FU_;_6(]
MQ_N1)_IV_P )Z3'O?3/0Z_%P2GY,_'44YC6<]Z]1B$S:O$)?[_[?\9ETJ[>,
M/;58$V_!]Z/#HQV;_DKVO_/3%_Q]>OH:;R7L7^Y^Z_+#MU(O[MYWR/\ WBJ)
M]$?\+JM;>$;!IC-I7G2)(]7TU+]0QUE/<?[CR?Z1O\!Z^:M[4=8C]>]^Z]T>
M?^6=]X?GG\8/X?X#7?Z3*/[45,K0P&;^&9/0LDR4U:T*L>-?AETGG0UK&K<#
MT(^4/^5EL_\ FL/\!ZW=/D^O8/\ LM/R'^Z@P"TO^@WMK[EH]Q3SR+3_ -P=
MP>9HX/[A4?F<1WLGFBU'C6OZ@T./61.\_P#)(NO^>:7_ (XW7SI/;_6*?7O?
MNO=69_R=?XD?YCGQU_A"TSY'_C+GVZU=4U%3G_C!/9WE\E2N.RS1V@U6_P G
MDNUAZ;ZA5OAZ%_(7_*V6G_-W_JS)UO-:>R/^5?;O_H3S_P#VNO;/61_7M/9'
M_*OMW_T)Y_\ [77OW7NO:>R/^5?;O_H3S_\ VNO?NO=>T]D?\J^W?_0GG_\
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M_E7V[_Z$\_\ ]KKW[KW7M/9'_*OMW_T)Y_\ [77OW7NO:>R/^5?;O_H3S_\
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M"?;?4L,$V8R=%C(YY1D]_.8X7K9X%E=44DA;D#Z^VW\NI9]J_P#<B]_TD?\
MA?K:0_TE]<?\]_LG_P!"K!?_ %?[;ZF7KW^DOKC_ )[_ &3_ .A5@O\ ZO\
M?NO=>_TE]<?\]_LG_P!"K!?_ %?[]U[KW^DOKC_GO]D_^A5@O_J_W[KW7O\
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M_$BMQ_VW15?^'I-B_P#/JMB_^B4VS_T=[]H?Y=$W^N2?5O\ >!U[_AZ38O\
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MU<M$GV[NR2:^#=?\<;K9,]TZE+KWOW7NO>_=>Z*!\EO^9S_R]O\ Q;_>O_P
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MXSVVOQ=37S?_ ,JS>?\ -$_X1U\^7V]UC+U[W[KW5R?\B+_LO_;O_B+^R_\
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MX:LH9:DO3\>*5P;BW/'NX>@IU&V]>WEYNFZS[@ES&B2OJ *L2/V=%Z?^1?\
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M2)^XN8/^,RT_[]D,A\/^_<_<M&-7IOQS]/?M?RZ]_K67W_*5%_O+=&'^)_\
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MC[>JEU_D2_S$&"E=D]%L'D>)"O<%(0TL9D$D:D;:]4D9B;4!R-)O]#[MXAZ
M'^M7>_\ *5#_ +RW7<G\B/\ F)0HTLNR.C(HT&IY).WZ1$0?U9VVT%4?Z_OW
MB'KW^M7>_P#*5#_O+=6H_P O_H7YJ_RN.JODGNCL/XZ[1[$PV5Q6/[#KGV'W
M1M"FGQN'ZPVYN[(Y>&6/<--AA45=92UQ, 34NI"&87'NK-JZ'/)_*\W+4<Z3
M2I)XS*1I!%-(;C7[>GG^8Y\</G)_,@V/T1/LCX];.ZZI=FG<.Z?+O'NW:54<
MI1;ZQ&V'H(J4;<I\OXYJ2/%$R^32I\BZ2;'WY6IU[F_EB?F6.!(94B\%F)U
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MEGI\OB8FJJ9U!6>G4R(60$^_=>Z@UW:G6.,R$V)R78NQL?E*?)TV%GQM;NS
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M7=.6R&\=QXE8:'$9S)U&.QTE'58NMJJ&66B6.::/W7NA [HZYZ%J,=GEW?\
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%NO=?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>j17244772_ba023.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 j17244772_ba023.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ Q0&J P$1  (1 0,1 ?_$ :(    & @,!
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M #IVG_\ 91[]0>O7NO?QO)?\\AN+_P Z=I__ &4>_4'KU[KW\;R7_/(;B_\
M.G:?_P!E'OU!Z]>Z]_&\E_SR&XO_ #IVG_\ 91[]0>O7NO?QO)?\\AN+_P Z
M=I__ &4>_4'KU[KW\;R7_/(;B_\ .G:?_P!E'OU!Z]>Z]_&\E_SR&XO_ #IV
MG_\ 91[]0>O7NO?QO)?\\AN+_P Z=I__ &4>_4'KU[KW\;R7_/(;B_\ .G:?
M_P!E'OU!Z]>Z]_&\E_SR&XO_ #IVG_\ 91[]0>O7NO?QO)?\\AN+_P Z=I__
M &4>_4'KU[KW\;R7_/(;B_\ .G:?_P!E'OU!Z]>Z]_&\E_SR&XO_ #IVG_\
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M49+_ .Q#W['SZ]U[[G=G_.DV[_Z%&2_^Q#W['SZ]U[[G=G_.DV[_ .A1DO\
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MT-1)#(T3*7B=D)*L0?=>ZER?YN3_ ((W_0I]^Z]T4'X&_P#9,6T/_#W[V_\
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M;O\ YW9/_P"M_OV.O9Z]KW;_ ,JVW?\ SNR?_P!;_?L=>SU[7NW_ )5MN_\
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M1;NV36S-%2T.6S,+TIAKDTN90Q-QI%O?E4K( >M;IO5GOO*-[>60<1*I0Z@
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M?)?_ &7^_8^?7NO?;;L_YW>W?_07R7_V7^_8^?7NO?;;L_YW>W?_ $%\E_\
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M.N_]/=9*8KT?>VWQWW_-%?\ G_K7FJ/\_/\ \MI/^AV]N]1D>)ZV1,O'E?\
MH'7VO(U9CSC/[T5%J08RI%<#_LV.X@"<B<LU.0)>?^ O*\?7U>VL>+\^I4?_
M *=>G^G/_:2W6ML/J/;O45'AU].?[?<__.WP7^;M_P >YD/\]_J_^/I_S?\
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M9O\ YZFL_P#/7A__ *D]^Z]GKW\*S?\ SU-9_P">O#__ %)[]U[/7OX5F_\
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MR?\ 9ZHI^+8)^3'QZ]3*B=W=5R3!=.J:FBWS@Y*JF5G5Q$U73(T0DTL8]>H
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M_P#D@[9_I1_U;3JK[^5=%--_,"^,\<%2U)*=WYS3.D<4K);8NZ[V297C-_\
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M?Z+_ *O3J5'_ .G7)_IS_P!I3=:TP^H_UQ[=ZBH\.OJ">T?66G1"_FIOG ;
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M]^KUZG7OX!-_ST>XO_.F@_\ K;[]7KU.O?P";_GH]Q?^=-!_];??J]>IU[^
M3?\ /1[B_P#.F@_^MOOU>O4Z]_ )O^>CW%_YTT'_ -;??J]>IU[^ 3?\]'N+
M_P Z:#_ZV^_5Z]3KW\ F_P">CW%_YTT'_P!;??J]>IU[^ 3?\]'N+_SIH/\
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MZP"U-33%<-NWUTS1JQ\F,$/J$L4R-H$FI>.' /U'NS_#T'N0_P#E9H/]*_\
MQP]%R_F$.9/G#\K7;2".^.RX"$1(U/V6Z<E0^8I&JIYZH4OFF8 >2>1WXU6]
M^3X1T7\U_P#*R7O_ #7/^ =6_?RBX7A_E\?S%<DM3.PH]G]EU)QTHIYL95^#
MHW)/X*VFE@=IJ:;1:1 ZZE)'NLG$=#?D+.P[B/D?^K9_U#K6_==#LFIGT,RZ
MG.IVTDC4[<78VN3_ %]N=1.. ZV+/F90/!_)-^%DYR&0G5\SUX!3SRP/!'?:
MNZFN@6G26XT6%V/#'_8-K_:'J3]\_P"5 V__ $Z?\=?_ #?X>J1_BV"?DQ\>
MF#,IA[NZKJ18*5D-+OG!U(AF1U=)::H,6B5"+/&S*?K[NWPG[.@'LN=ZLA_R
M^0?]74ZLT_GQT[4_S:AC:IJ:HKU9LU?+4M$TK"U:WJ,44*L1JM>U[ #\>ZQ_
M#T+/<;_DOC_F@G^%NE9_PG^I6J?EUOT)65=(?]"N;C+4KPJ;-N?;$VJTT,ZB
M0&GTA@+A'8?VC[U)PZ=]M/\ DN2_\\K?\?CZJ3^2((^07=@+%C_I2WS=FT@D
M_P!X\A^%"J/]@ /;@X#[.@9N_P#R5;G_ )KR?\>/5UOQ.IG'\D#YG5 K*K2-
M]5=Z4M U,WGR'5M.;JT#3#Q"/7'9P$D)8<GVV?[4#H?;'_T[W</^:K_\=BZU
MYR+@BY%P1<?4?XC_ !'MSJ,.MD7^<Y2/2_#[^7[JK:RK$NW\BP%6T#^'Q;%Z
M^33"T5/"X637=[EM3 '\>VT^(]2KSW_R0=L_TH_ZMIU5]_*N@-3_ # OC/$M
M144Q;=^<M-3,B3+;8NZSZ3)'*G/^*GW9_A/0/Y/_ .5EM/\ FH?^.MTO_P"<
MQ&T'\QWY T[32U)@INHH_N*CQFHGOTCUQ-KJ'BCB221?+H!"CT*H_%_?D^ =
M*^?/^5HN/]+'_P!6UZ.Y_(%HGK,I\Q]-?7T7CZPV83]E) GDO)O[B3S4\]P+
M?BWNLGET?>VWQWW_ #17_G_K7GJ/^!$__+:7_H=O;O49'B>MD3+4+K_PG6VM
M6?Q#(,G]Z*D?8M) :+U?+/<@OH^W$]U+7'[G! _''MK_ $7J5'_Z=>G^G/\
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M *]^_5/7NO?W7QO_ "L[B_\ 0OW9_P#7OWZIZ]U[^Z^-_P"5G<7_ *%^[/\
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M+TE1"?&WW+>1?TRV76&T)IK)Y='WMF/U-P_YI1?X9>J)MUJ$W1N5 6(7<&9
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M0:67-=>!EGRV5J:87VINLGQT=362T<)NHL4C4@7 X)NVI_4(ZD[?/^5 V_\
MTZ?\=?JD;XO1K+\D_C^C%P/],_637CEDA:\>\\-(HUQ.CZ2RC4+V9;@W!(]W
M;X3]AZ FRBN]60_Y?(/^KJ=6:?SXJ.*B^;44,+U3H.KMFF]775M?+RE6>9Z^
MHJ9R/\-5A[K'\/0K]QO^2^/^:"_X6Z5O\@"AAKOEQOQ)GK$4=-9D@T>0K\>_
M_'Q;>;F2@J::1A=?R?I<?0GWJ3AT][:?\ER7_GE;_C\?527R/01_(#NI%+$+
MVCOA07=Y'(&XL@!JDD9G<\<DDD^W!P'V= S=_P#DJW/_ #7D_P"/'JZSXHT$
M#_R0?F96&2M$T>^9PJ+DLBE(0^6ZP0ZZ!*I:&0@?0M&2IY%CS[;)_5 Z'VQ_
M].]W#_FJ_P#QV+K7I(N"/Z\<$@_[ BQ'MSJ,.MD/^<YCJ>B^(/\ +]>&2N=I
M]O95G%7E,E7HI79'7MO#'75=3'3+ZN1&%!XO]![;3XCU*O/?_)!VW_2_]8TZ
MK _E74T=7_,"^-%/*U0B2;NSFIJ:JJJ*86V+NL^BIHYH*B/D?V7%Q[L_PGH'
M\G_\K+:?\U#_ ,=;I>_SEJ>.D_F._(2FB:=XX8>HE1JFJJ:VH(;H[K60^6KK
M)IZJ=M3FQ=V(6RCT@ >3X1TKY\_Y6BX_TL?_ %;7H[W\@;&T^0R?S&\\E?'X
M>L=F,GV65R>-N3)OV_E_AU92^<<?1]0'NLAI3H^]MOCOO^:*_P#/_6O-4?Y^
M?_EM)_T.WMWJ,CQ/6R)E\93#_A.OM?(B3(?<'=%0/&<ME6H>?ECN*/C%M6G&
M Z?SX;AO5^KGVU7]6G4J/_TZ]/\ 3G_M);K6V'U'MWJ*CPZ^G/\ W<Q__*QG
M?\WXO^/IW/\ I_K_ ,7?_.?[7^O_ !]I*]9:=)3(].=29C=V1W_F>L.O\SOK
M+8?&;=R6\\OL_ 93=-9MW"SUE5A]NS9^OQ]1E3M_%5N2JJBGH1**6&IJYYDC
M$D\K/KKW7+=6\-F].[;VN,I3U6)VP^?V-USB/X7BZJLQV%J-TYW#['VG#7O3
MH\>)PPR^5HZ5JB4B*!9 S$(K,/=>Z<]G;YV]O_#U66V[/4204TM/354-92RT
M=92OD,'B=S8O[FFE&N$Y+;>X*&NC5K2+!5H)%CE#QI[KW5+FQ?YGWQN^%O57
M7'5O<%!V94[ESC]R;[HI=F[7Q.:Q8PF4^2_=^!IHYZJNW-AIHZ]:W;507C$3
M*(RA#DDA;JA85'08WKFW:]BNUL[X2F5HPXTJ"*$LOFPS53Y>G1N/BC_-'^-7
MS([(R'5G45!V=3[GQNU,GO&=]X;7Q.%Q;8G%5N,H*E(ZNAW-F)FJS/EHM*&(
M*5U'4+6/F0J*GK6S<W;5OEV;.R$HE"%NY0!0$#R8YR.J]NQ_^%!6T.N^P]^]
M?S_&'<F4FV+O3=6SI<G#VGC*6+)2;8SM?A'KXZ5]CS/3)6&A\@C+N4#:=36N
M;"*HK7H-77N3!;7,EL;1R8Y&6OB#.DD5^#SIT<#KO^9=D>\_@/\ (CYA===9
M46R<]TW4;ZPV'VIO7,3[QQ&3R^T=F;6W;!79.7!1[.K&QU7_ 'I2%X(I8I1X
M21*-0TU*48*>CRWYI:_Y;N=\MHA')#K 5CJ!*A34TTFAKP%/MZI$'_"AGYHD
M@?Z,?B_R0/\ CR^U_P G_P 37[<\)?GT /\ 7+WW_?5I_O,G_6WHZ/\ -6^7
M7R#P7Q+^#'</7O9.Y>I=V]S[-VQO7>R=89O-[7QE3D-T]9X+<]9CJ>)<G5U[
M8>BR63D^VBJ*BHDC0+JD=@7.D45(/1_SIO&Y0;3M]Y:RO#+,NIM!*@DHK4XU
MH"32I/59WP)^<'S W[\R/CGLW>GR3[DW1M3<?:NT\5GMO9O?6=R&)R^-J\G#
M'4T-?15%6\-333QDJR,""#;W9E72305Z"O+6_P"]7._6L%Q=3O"TH!4N2"*'
M!'3;_.Z_[+]WY_X:&R/_ '73^_1_#TWS_P#\K-+_ ,TX_P#C@Z-__P )_O\
MBY?+?_Q%F-_]R,C[U+P'0@]L/[:\_P!(G^%NM>S<_P#Q\NX?^UYEO_<^H]N]
M16>/6P=)_P!P_D__ (E>C_\ >YH?;'^B_P"KTZE(_P#3KW_YJ+_VDIUK[;1_
MX^O;'_APX7_W94WMX\.HPB_M%_TP_P /6PW_ ,*%_P#CZ?BI_P"(YW+_ .['
M$^VHO/\ U>O4H>Y_Q[?_ *2;_K#T1?\ DM_]O"^G?^U9OW_WC,Q[M)\!Z#7(
MO_*SV_V2?]6VZ!C^9O\ ]EZ_)S_Q(C?^Z/#>[+\(^SI!S5_RL5Y_S6/5EO\
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MFS_E9+W_ )K?\^KU</\ RD/^W<O\R+_PQNT__?%97W23B.AQR#_R0MQ^P_\
M5MNM;J;_ #TO_+1_^AC[=ZB8<!UL=?-/_MR-\*?^UWUW_P"\GNWVTO\ :'J3
M]]_Y4#;_ /3K_P =DZHY^+7_ &4M\?\ _P 3+UK_ .]AB/;C?"?L/0$V3_DM
MV7_/9!_U=3JSO^?;_P!EOQ_^(MV9_P!:ZOW6+X?SZ%?N-_R7Q_S07_"W2O\
M^$^G_97>_?\ Q#.:_P#>AP'O4OP].^VG_)<F_P">5O\ JY'U41\D_P#LH/NS
M_P 2EOG_ -Z/(>W!P'V= S=_^2K<_P#->3_CQZNW^)W_ &XW^9__ (?4G_NY
MZQ]M'^U'0_V/_IWNX?\ -5_^.Q=:[OMWJ+^ME#^=/_V1]_+W_P##=RW_ +Q'
M7?MJ/XCU*O/?_)!VW_2C_JVG57/\J7_MX1\9?_#OSO\ [PFZ_=W^$] _D_\
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M=+_^<Q!#2_S'?D#24T20TU+3=11011J%6.-ND>N*AE%N3>:=C<W//]+>_)\
MZ5\^?\K1<?Z6/_JVO1W/Y N,H,CE/F/]]2Q5/AZPV88O*"=!,F_KE;$6)M[K
M)Y='WMM\=]_S17_G_K7GJ/\ @1/_ ,MI?^AV]N]1D>)ZV1,MBL<O_"=;:V26
MDA%=_>BI'W5CY;/\L]R*P)OS=7(_P'MK_1>I4?\ Z=>G^G/_ &DMUK:VOP?H
M>/;O45'KZ<W]V,!_SJJ7_->']+?YK_4?J_3[25/66=.G[WKK?0<=E]G87JS#
MT^X-PXS/5>%-=C*?*Y/$4M#)1;=Q^1SN%V^^<S-3DLCC(?LJ"JSL,CTU*U5E
M*B!)6I:2H,3J/=>ZD[#[%V]V3A\AE-O_ 'D7\,J:*@RF/R,=/#D<94Y;:^W]
MZ8F*MAI:JLAAER.T]V8VO2/R&2.*L195CF62-/=>ZT5_YDG_ !^?1'_B(>Q?
M_@R/E7[?B^'\^H.]R_\ DOQ?\\:?]7)>C4?R O\ LM+=O_B ][?^]-L?WZ7X
M?SZI[;_\EY_^>9O^/)U5/\F?^RD/D%_XF_M?_P![S/>W!P'0/W7_ )*ES_ST
M2?\ 'SU?#\#O^W'WSK_\//NK_P!\SU)[:;^T'4C;!_T[Z_\ ]-+_ ,<3K6Q7
M]2_\&'^]^W>HI/#K8>_FO?\ ;O;^6#_XASK+_P!\CM'VW'Q/V]2ASO\ \J_M
M7_-(?]6TZJ\_EN?]EV?%C_Q,NR__ ';0>[O\!^SH(\I_\K'9_P#-8?X#T93^
M=U_V7[OS_P -#9'_ +KI_=8_AZ,^?_\ E9I?^:<?_'!T;_\ X3_?\7+Y;_\
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M,7^,_:>MB>@_[<"UG_A]U/\ [T:^VA_:]2FO_3L/]L?^T@]:]?7'_,P]A_\
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M2."+$>]28 IT(/;$ RWE?X$_PMUK[;E1(]QY^.-51$S>55$10J*HKZ@!550
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M6:&GC1F%BRHH/ %J/\2_ZO/H9<E?\JQNI\]+?RB-/V=:]P  "@  "P %@ .
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M&J#'Y3#/#,Z.I.EE<@@@GW1B?$'4B;$!_K=W_P#I9O\ CBG_  YZUMR P*L
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M)_P]UC^'H5^XW_)?'_-!?\+=*W^0!CZ#(?+C?D=?0T==&O369*I64T-2@/\
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MGVYU%T/]LG^F'^'J]G^?I7T-=OSXOO15E+6(O2D43-2U$-0JRQ9FN\L9:)W
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M5?VK_FD/^K:=5>?RW/\ LNSXL?\ B9=E_P#NV@]W?X#]G01Y3_Y6.S_YK#_
M>C*?SNO^R_=^?^&ALC_W73^ZQ_#T9\__ /*S2_\ -./_ (X.C?\ _"?[_BY?
M+?\ \19C?_<C(^]2\!T(/;#^VO/](G^%NM>S<_\ Q\NX?^UYEO\ W/J/;O45
MGCUL'2?]P_D__B5Z/_WN:'VQ_HO^KTZE(_\ 3KW_ .:B_P#:2G6OMM'_ (^O
M;'_APX7_ -V5-[>/#J,(O[1?],/\/6PW_P *%_\ CZ?BI_XCG<O_ +L<3[:B
M\_\ 5Z]2A[G_ ![?_I)O^L/1%_Y+?_;POIW_ +5F_?\ WC,Q[M)\!Z#7(O\
MRL]O]DG_ %;;H&/YF_\ V7K\G/\ Q(C?^Z/#>[+\(^SI!S5_RL5Y_P UCU9;
M_*"_[(T_F2_^&5LC_P!T7:ONC_&O^KSZ&7)7_*L;K_I7_P"K1ZUY?;G46];(
MOS'_ .W)OQ#_ .UCB?\ W>9_VTO]H>I6YA_Y4#;_ /FS_P!6WZH5Z#_YG;U1
M_P") VK_ .[BD]N-\)^SJ.MH_P"2M:_\],7_ !]>K7/Y]W_9;,'_ (C':/\
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MU'\/2SGW_E9IO]+'_P <'1E?Y#'_ !]7RV_\5^RG_NQI/=9?+H_]L_[3</\
MFE%_AEZH>W;_ ,?7N;_PX<U_[LJGV[U&+_&?M/6Q/0?]N!:S_P /NI_]Z-?;
M0_M>I37_ *=A_MC_ -I!ZUZ^N/\ F8>P_P#P\]K_ /N\H?;O470_VR?Z8?X>
MKX/Y_P!_Q_WQ>_\ $(T__NZR/MN+@?MZDWW._P!R+/\ YIR?X4Z*-_)<_P"R
M^^LO^U-NC_W"B]V?X3T'N0_^5F@_TLG_ !QNBS_S!?\ LM_Y7?\ B?\ M?\
M][C-^_)\(Z+^;/\ E9+W_FM_SZO5P_\ *0_[=R_S(O\ PQNT_P#WQ65]TDXC
MH<<@_P#)"W'[#_U;;K6ZF_STO_+1_P#H8^W>HF' =;'7S3_[<C?"G_M=]=_^
M\GNWVTO]H>I/WW_E0-O_ -.O_'9.J.?BU_V4M\?_ /Q,O6O_ +V&(]N-\)^P
M] 39/^2W9?\ /9!_U=3JSO\ GV_]EOQ_^(MV9_UKJ_=8OA_/H5^XW_)?'_-!
M?\+=*_\ X3Z?]E=[]_\ $,YK_P!Z' >]2_#T[[:?\ER;_GE;_JY'U41\D_\
MLH/NS_Q*6^?_ 'H\A[<' ?9T#-W_ .2K<_\ ->3_ (\>KM_B=_VXW^9__A]2
M?^[GK'VT?[4=#_8_^G>[A_S5?_CL76N[[=ZB_K90_G3_ /9'W\O?_P -W+?^
M\1UW[:C^(]2KSW_R0=M_TH_ZMIU5S_*E_P"WA'QE_P##OSO_ +PFZ_=W^$]
M_D__ )66T_YJ'_CK=+W^=!_V\E^1/_++J'_WQ?67OT?P#I7SY_RM%Q_I8_\
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MYN5<YV;MRMQLNX-A8K$YVNW7A(XLQG)9&RN$I\8]=0:(I%8^5%.EE/T(NTI
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M/Q*ZCVSN,YWL_:>9V0^YMA8O"[@K-U8%,=MK<]-7297"PXIJVBBIJBHC1F=
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MN2BAGKJZIPR04\4E751Q@L0-3@?GW=V4J0#T%N5MAWJUW^UN+FUG2!7)+,A
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MW:P &IW8DG\DW]^Z]UQ,,)61#%$5F),RF-2LI*JA,@(M(2B@<WX 'OW7NN9
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M*%"UO=>Z%BM_V6#^]J^'_3;_  O[+J+Q_P -^R_N'_&_X)7_ .A?7Y?]RO\
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M=*[NC_97?],N6_CO^G(;V_T;=<_=';(VP=O_ .CS^[F__P"Z'VXW<0QH]/\
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M^.?=<_9?=_Q;_<?]M[]U[H9<4G1T>S_BLD]3WO6;'4[A%)54M#UWC=L3[O\
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
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>j17244772_ba024.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 j17244772_ba024.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ Q@&D P$1  (1 0,1 ?_$ :(    & @,!
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M^>C,?_4'OU.O5'7O[UX3_CO6?^>C,?\ U![]3KU1U[^]>$_X[UG_ )Z,Q_\
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M?_';+_\ H09[_P"N7OU>O=>_@E'_ ,=LO_Z$&>_^N7OU>O=>_@E'_P =LO\
M^A!GO_KE[]7KW7OX)1_\=LO_ .A!GO\ ZY>_5Z]U[^"4?_';+_\ H09[_P"N
M7OU>O=>_@E'_ ,=LO_Z$&>_^N7OU>O=>_@E'_P =LO\ ^A!GO_KE[]7KW7OX
M)1_\=LO_ .A!GO\ ZY>_5Z]U[^"4?_';+_\ H09[_P"N7OU>O=>_@E'_ ,=L
MO_Z$&>_^N7OU>O=>_@E'_P =LO\ ^A!GO_KE[]7KW7OX)1_\=LO_ .A!GO\
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MHJ/_ ,\*_P#UR][QUKKWV&Y/^>BH_P#SPK_]<O?L=>Z]]AN3_GHJ/_SPK_\
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ML=>Z]]AN3_GHJ/\ \\*__7+W['7NO?8;D_YZ*C_\\*__ %R]^QU[KWV&Y/\
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M%.?AJ2!0^?0^_P HSX\;AHM]]L;C[-ZHK=O97 XC9TFRLSV5UC6>>@K*JNW
M,I/M6HW-147V61$5/ )IJ4^81D*2%8AO#Y]&7).W,EQ-+>0$.JKH+H10U:NG
M4./#(SUL$?8;D_YZ*C_\\*__ %R][QU)77OL-R?\]%1_^>%?_KE[]CKW7OL-
MR?\ /14?_GA7_P"N7OV.O=>^PW)_ST5'_P">%?\ ZY>_8Z]U[[#<G_/14?\
MYX5_^N7OV.O=>^PW)_ST5'_YX5_^N7OV.O=>^PW)_P ]%1_^>%?_ *Y>_8Z]
MU[[#<G_/14?_ )X5_P#KE[]CKW7OL-R?\]%1_P#GA7_ZY>_8Z]U[[#<G_/14
M?_GA7_ZY>_8Z]U[[#<G_ #T5'_YX5_\ KE[]CKW7OL-R?\]%1_\ GA7_ .N7
MOV.O=>^PW)_ST5'_ .>%?_KE[]CKW7OL-R?\]%1_^>%?_KE[]CKW7OL-R?\
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M-0JJSB$L57W7NCU_<[L_YTFW?_0HR7_V(>]X^?7NO?<[L_YTFW?_ $*,E_\
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M49+_ .Q#W['SZ]U[[G=G_.DV[_Z%&2_^Q#W['SZ]U[[G=G_.DV[_ .A1DO\
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M3P4BSU#HH:>9:6EBB#-=A'&JWLH ]U[K-[]U[HG_ &M_V65\0O\ Q'_RH_\
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M8;^SFC=X(5>)@$0%V:JD:6=Z*M>!*KCB#Y]47_\ #3?S=_Y]QM__ -&+L?\
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=R,FV*"M&/%4L]7%#4O5.)8XHO=>ZL$]^Z]U__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>j17244772_ba025.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 j17244772_ba025.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ S &A P$1  (1 0,1 ?_$ :(    & @,!
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MW\5S?_/+5G_GTP__ -5^_=>SU[^*YO\ YY:L_P#/IA__ *K]^Z]GKW\5S?\
MSRU9_P"?3#__ %7[]U[/7OXKF_\ GEJS_P ^F'_^J_?NO9Z]_%<W_P \M6?^
M?3#_ /U7[]U[/7OXKF_^>6K/_/IA_P#ZK]^Z]GKW\5S?_/+5G_GTP_\ ]5^_
M=>SU[^*YO_GEJS_SZ8?_ .J_?NO9Z]_%<W_SRU9_Y],/_P#5?OW7L]>_BN;_
M .>6K/\ SZ8?_P"J_?NO9Z]_%<W_ ,\M6?\ GTP__P!5^_=>SU[^*YO_ )Y:
ML_\ /IA__JOW[KV>O?Q7-_\ /+5G_GTP_P#]5^_=>SU[^*YO_GEJS_SZ8?\
M^J_?NO9Z]_%<W_SRU9_Y],/_ /5?OW7L]>_BN;_YY:L_\^F'_P#JOW[KV>O?
MQ7-_\\M6?^?3#_\ U7[]U[/7OXKF_P#GEJS_ ,^F'_\ JOW[KV>O?Q7-_P#/
M+5G_ )],/_\ 5?OW7L]>_BN;_P">6K/_ #Z8?_ZK]^Z]GKW\5S?_ #RU9_Y]
M,/\ _5?OW7L]>_BN;_YY:L_\^F'_ /JOW[KV>O?Q7-_\\M6?^?3#_P#U7[]U
M[/7OXKF_^>6K/_/IA_\ ZK]^Z]GKW\5S?_/+5G_GTP__ -5^_=>SU[^*YO\
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M.W?_ #AR?_UP]^QU[/7M&[?^5G;O_G#D_P#ZX>_8Z]GKVC=O_*SMW_SAR?\
M]</?L=>SU[1NW_E9V[_YPY/_ .N'OV.O9Z]HW;_RL[=_\X<G_P#7#W['7L]>
MT;M_Y6=N_P#G#D__ *X>_8Z]GKVC=O\ RL[=_P#.')__ %P]^QU[/7M&[?\
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MW?\ T%\E_P#9?[]CY]>Z]]MNS_G=[=_]!?)?_9?[]CY]>Z]]MNS_ )W>W?\
MT%\E_P#9?[]CY]>Z]]MNS_G=[=_]!?)?_9?[]CY]>Z]]MNS_ )W>W?\ T%\E
M_P#9?[]CY]>Z]]MNS_G=[=_]!?)?_9?[]CY]>Z]]MNS_ )W>W?\ T%\E_P#9
M?[]CY]>Z]]MNS_G=[=_]!?)?_9?[]CY]>Z]]MNS_ )W>W?\ T%\E_P#9?[]C
MY]>Z]]MNS_G=[=_]!?)?_9?[]CY]>Z]]MNS_ )W>W?\ T%\E_P#9?[]CY]>Z
M]]MNS_G=[=_]!?)?_9?[]CY]>Z]]MNS_ )W>W?\ T%\E_P#9?[]CY]>Z]]MN
MS_G=[=_]!?)?_9?[]CY]>Z]]MNS_ )W>W?\ T%\E_P#9?[]CY]>Z]]MNS_G=
M[=_]!?)?_9?[]CY]>Z]]MNS_ )W>W?\ T%\E_P#9?[]CY]>Z]]MNS_G=[=_]
M!?)?_9?[]CY]>Z]]MNS_ )W>W?\ T%\E_P#9?[]CY]>ZT\<[MS%;DA@ILNE;
M/20R3N]'3Y?+XVBKHZFCJ*"HH\Q1XRNHZ7.8V:EJG#4M:D],6LYCUJK"G4,*
M[(:K2OV _LKP^T=<J#;V'QV3RF:IJ*/^,YH4\62RT[/4Y*II**2JEQ^,-94-
M)/%B,9+7U#TU(C+3025$SH@>:5G]UXNQ4*3VC@/\OVGS/' ].MCC^7W!N!_B
M[LMJ#)X>FICE]Y:(:S!5M=.I&ZLJ'+5,.XL?&X9[D 1+8<<_7W84IU)/+?\
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M"?@]MN&:?+?*GI!/M[>6FH=^X3,9%;R+'9<7AZFOR4A#/R%B) !/T4D;"L>
M/2:3F78(A5[RWQZ."?V"I_ETC&_F.]"9AECZNVE\C^\YF<(5ZC^-'<^;I$8R
M&'4^:SVT=M;?%.CV#SBK,":O4XLVG>@^=!TG_K1MSXM$NK@_\+@E(_:54?G6
MG7!/EC\D]U^OK'^7MWG44C*&CKNZ.P^E^DXU+Q*R&IQS;OWWN&-&FU*1'0S2
M(H!9 257VD#B1U[]\[K-_N)MEP1ZRO%%_+4[?R/649[^9CNHFHQO7?PTZ>HY
M6.BDWEO_ +>[DSM*I9)%$]-M':G6&%JM$,AC+)D$O+&6"A"OOW9\^M^)S7-E
M(K&!?Z3R2G_C*QC^?6'_ $ _.C<P#[Q^>F/VE3U!'W>'Z6^,W7V$,4.J=)(*
M3<W9><[-R0,L3HPE6F@EB=18D EO57T_GUK]V\P2_P!ON(0'B(H$'[&<R'^0
MZR_[(+A<W;_25\I/FIVA%*":[%YCY"9K9&WJUI(U61),#T_B^N*+[99$5XT;
M6T97]1U2:_:O0#K?]7(Y/]RKN_F'F#,44_E$$'0+_(_^7O\ #78/0W;&\,'T
M1MC(;LQFTJB:@W/O;)[J[+W!2S??TDOFBS'8V?W5D!,)&8ZO(6O(_/K?5XNW
MKTAW/EK8[?;YIX[=#,$PSEI#Q]7+'K7;W?UI09'+[/BVQMVHVZ^VMR;6W/39
MG!RX3#[4\6*W'25&<Q&?P%/4K/GZFMVW%50T/GQM73T5751U4$E)5PQU4-*D
M\>@3;B&W5M"H 5(H%H<C!! QFE<BH%#48+SUCL3+;,IHDRV1@JI*79FP=DPQ
M44]3/35:;%H,G2MN>K^YIZ5HLWN!LMXYT"R"."BIU\TEO3KIR>59#VBG<S?[
MU3'V"G\SCK<@Z8_YD]U1_P"(UV+_ .\OB_=NI8L?]PH?^:2?\='0E>_=*NM.
MOW7J%NO>_=>ZV-_Y=_\ V2MLC_M<;T_]ZO+>]CJ2^6_^21'_ *9O^/'H[OO?
M1]U4]VQ_,HS?6O9>^M@0=2XK+0[/W/E]O1Y.7=U71R5Z8RKDI5JGI4P%0M.T
MPCN4#N!?ZGWJO00O.:)+6ZDMQ""$<BNJE:'[.@^_X=>W!_SY7#_^AO6__8U[
M]7I-_6^3_?"_[T?^@>CU_$GY,UWR9V[N[.5VT*3:+[8S5#B8Z:DS$V86L6LH
M6K#.\DV/QYA:,KITA6O];^_#H_V?=6W2)Y&0)H8#C6M17T'1M_>^CGK7Z_F;
M_P#91U#_ .(UVQ_[M=R^ZGCU'7-7_)3'_-)?\+=5X>_=!OJR?^5K_P!E [P_
M\0YN#_WM>O?>QT)^4_\ DHO_ ,T#_P >3J^WWOJ0NJ=?YLO_ #0+_P JI_\
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M9C&5]5F!M.J@5<+GZJJDJZC%AVI!,([ ^)#[]U[KC\4=O0O\6_C6YRFX%+]
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MT^.P]-#FJNHI<=CLE5T6+IX*2FCET( ==,27$@5XUD)B:@H"VGRJ:$#. "2
M3D];(7\K;%ID-A=IN]9DZ7Q[OPRA:#(5%$KWPSF\BP.H=A^"?H/>QT+N4?\
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MN@7T:7X4TXJOE#U)3M+/"),OF 9:69Z>=+;5SS7CFC(=";6-OQ[\./1OL/\
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M1001QPPPQ[XBAAB18XHHH^LMXI'''&@")&B      6'OPX]&O+V=YA)_I_\
M'&ZV4_=NI/Z#OL[M?8'3>W(]V]D9_P#NYMZ7)TN'3(?PO-9?5D:R*IGIJ?[3
M X[*5P\D5'(=9B\8TV+ D7]TFNKRWLHO&NFTQUI6A.3]@)\NB_?[/Y\2?^?L
M_P#KB=E__8;[U4=%W]8MG_W]_P 8?_H'J9COG;\5,MD*'%X_M/[BOR592X^B
M@_N/V/%YJNLG2GIHO+-M".&/R32*-3LJB]R0.??J];7F#:'8(LU6)H.U^)_V
MO1N?>^CGHM?S#_[)C[F_\,ZH_P#<RC]^/17O7_)*G_TG^;K5_P#=>HJZ][]U
M[K;*Z8_YD]U1_P"(UV+_ .\OB_=NI?L?]PH?^:2?\='0E>_=*NM.OW7J%NO>
M_=>ZV-_Y=_\ V2MLC_M<;T_]ZO+>]CJ2^6_^21'_ *9O^/'H[OO?1]UJS?*7
M_LH[NW_Q)6[/_=K4>ZGCU$V[?\E.?_FJW^'H!/?NB_J[O^5/_P R_P"U_P#P
M\<+_ .Z63WL=#OE'_<:;_3C_  =6L^]]"[K7Z_F;_P#91U#_ .(UVQ_[M=R^
MZGCU'7-7_)3'_-)?\+=5X>_=!OJR?^5K_P!E [P_\0YN#_WM>O?>QT)^4_\
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M$51)71JG7#R*:')Y+%R%O[S8%;/-C*NDED2S?I9BM^;7 ]['0JY2_P!S9/\
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M,*["*GI\O%!!&"?2B*J*.   ![N#CJ7-M_Y)UO\ \T$_XZ.AG_@-#_QWS/\
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M)2UM-!5TTV7S EIJJ&.H@E"[5SSJ)(95>-P'4$7!Y%_?AQZ-]A_Y*\/^F/\
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MK:.A[>[!DK:NFHXWZW=$>JGBIT9_[SX!M*M*Z!FL";#FP]['0JY2_P!S9/\
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M/IBEJHP1KU'5P#S[\>B/F"UN+RP$5LI>3Q :8X4/K3JFN_8/_>-?S7_](/\
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M)0]A[7H&V5+]AO?;L]=M'<_DE_A=1(*.H/OW7NC3^_=>Z"GM;?&X-C4>V*O
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MS^<W7L#8^Z=S[9J-E;EW+L_;.?W#LVKFFJ:O:6<S&%HLCEMLU51446-GJ*C
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MOSGR6_\ I*+M39'2>Y-[YW&]48W?.Z=F;=KLN!2[JK^B,3W[2;6V[GZK9_\
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M'V9\P<UO7<73>*CZLI]LXWMS']3;TAKMQ[[I6K,)UIVWTMW_ -HXW)9&EP^
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M?Z,?)_?[[6F_YEUXO5_?#[+P_P#%L_RWQ:/[.GW[KW0D9;_1#_=G;_\ '?\
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M6/#_ .R[_9]<_P  _P!"_P!A_#Z/_1'_  ?^X_V?\*^^I?X?_HY^R_9_A_\
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MV^&_@7WO^A[^[7]U?] &._A_^C[_ )C_ /T'_P"A[[GS?P[_ 'X?W'\4\O\
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..=-K<>_=>ZD>_=>Z__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>j17244772_ba026.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 j17244772_ba026.jpg
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M*YTG:. C D E ]P&.U\-\OGZ>Q!ZO?6W&YS<Z !PL<\9K-"YKH!=6.]IW%L
M*QGD+!S$V#8&"28/\"@4UO.R:R'0G:3&]S(W@  #+N:C3.>&"FRWCQ^B5<<C
MB8]SNOH013)%(X$\5B1"13(.:36N>6%K([&LD7(   !A-;"W+Y]\ V QNUB'
M3_)!J70*@CBZ(9*X !B1E08F:8:/1:+Y18@    PER^>,EX!J!%MN+';\B-V
M3E/$0Q8' +H !B=E0H@:0:+19[]18P    P>R^=M!XAJ+%MMACV>4@R?1PCZ
M&F(!+XMGX.H]S)F:;56>.%D8ZFO\78   "*&GB-E00#8[&\6"=+X5P.@215/
M<D \#C/T2F4NG@Y@34P^FO.-ULLZH  >2,C9I=9IY0.)Z;OX_1*\.9RH1G6E
M 1A2'N/D  !&>>&^7S]H/$%AGIE%KN#';]4@RWAF9-3JM/( +^18]%(LZ2P\
MR(&?P6Q))4.,8!)HO@!55Q\FLJ;\ !XO>6HW$:<(7:'*@ E1M[2XWQ79MEY>
M2&R]NP5Q/'@-X[#K%@  H]-?S5FJ^0    $EMK8'&[2(V@C>=7S&!&U^1YCF
M$(8Q84]0   KZYF:V56AIH@ !VLKF1W-%XL[@>H!'<ZO@,&-IPCI$80SS/<>
MXTR9@  /A";0@*>:QVNHLI3;EDXZKK>P  -5X_@AU[.\3Q<$X?9X"\)(Z0
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MV@*_)661IU%BJ>QN2,.8Q?>)\!M[\-650,KN!0RXR854)Q\4^L3+QGTX].&
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M5A9/X@ANUF2_6UXU,<19C]5U)@QX>'\/:1/$#EL#Y?O.QUKG'OTK61Y_]6.
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M"MI#LZ8:1RCC(.QG:]O78;<A\L'NW,MHJH7,,"I#K-S(362H('SN/01C7E'
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M*2CDW(CD"V2)N@):0<3(F](F0@(!A!N(\7KY+7I3%]J*BJ(2(Z"T%3 P\LA
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ME%>2JY?J3+2A,3PGNCFDHZ7'*,S7KM[FT'JA7OB;-4!(4-'\QV3=Q@U"(.%
M8K;QW9-8+Z7[:A\?BIO5]K$4_5BG?9)-_P#5J<*']D1O\J,^)1-4!+1I$K1Y
MTN'2HD)BL0B_[]>0X.HM5Z_VU"_V'5=4\?_:  @! @,!/R'65%1]-%-%-'U+
M131],:&MJ*GZZ=#SCEGT)Q>8_0/,?H'F/-.+]2?_  8Y+]+'_P!R?IYJ:FI_
MXO\ _]H " $# P$_(=*N(/0I )%+R$0;4/,_3_:_R']/]JPQ=+9^_&IM8$Z4
MN<B6#KSI3RNQ_:$QESV:B#O9_53] S[_ /E#XOSHNSQOZ:DO?<W-'4*Z!S,7
M:=*]SU_S\^.'_G^[?RNUJ3R5]Z.M;7[7T@'@U.BQR?>W%)H(YF4W^T?W1Z8G
M]/K^:AYN3V:. !%&2O6_I2T)]NN- + ^>U#LCG;+!\[4YOIGC'>_X\UN(\NB
M!(JH[YW\?S1(=K\_Z<ZT6]WX/WQ!6XUUC9=_\UEOY?L_[Q,X#-%B0'WIP($Z
M4H4AT=^7'N@/B?WQ.?AGUV_O(-+<^=OG1<V4E(.: ,<MSY?$=Q)R0 8/R<79
M^UBD&: XY9@\0=3(_GDQ3A;\\3#=?T.&G<OM<']?KC%#]ZWSR.U2#R_<Z.XV
M_O\ YS89R_A_V- S_4[]_P"ZE EQ7I==WK_..5I11%B$5%Q";TZ@@.6BPD5E
MQ'[>(=(-$>O[/\H1),<8\#\^U?Z^OG^:+[AQ^S^O?A@8^2KB0^.9_P"I1T_F
MG\ZGZH#K]#^5:E!V@_%(23H>M ]#[Q0>R3@_Y(0I_P &(\V[\LZ]SO\ GS2(
MPYY.T+=V*]XSU>,O("R;/5YJ&@!9-WH\<[YX?WK6ZW68_P ]=4"5I[%._P#E
M1-@Z$J )=.7L=*"HTUD8>YU^@NXG46IN!Y)_E.Q[%+]K]U=U\!\7^:)@/#5'
M##JGXJ.6$97\^/\ @__:  P# 0 "$0,1   0  J3TP  A$     AXM27P ;
M    !RF;22& R @   $2Q3824@ $    B2K  220 @  @ J20  #2-7D@$@
M:2   %R2$     *4    J0-     J4    *56  @  R3   &26 DD   *6P
M +2,?@    M2-( Z2HD $   "R2G#21@W      K2222O D@     #"22G(
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MW7L@78EP2(('8T5E+(\BI1C8:WO$,$JN1*S (1(D@;R'%E7Y9@5\00D"(Q<
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M5L'K1X Q/4Z#M@>^5UD0B,#&7VN>R/4.+.P(>1DK!Q3P)H!*:R&XQN-'!E"
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%@_X/_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>j17244772_ba027.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 j17244772_ba027.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ J #D P$1  (1 0,1 ?_$ :(    & @,!
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A-DZ.:J%'F9Z6G]U[JP#W[KW7O?NO=>]^Z]U[W[KW7__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>j17244772_ba028.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 j17244772_ba028.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ C0'* P$1  (1 0,1 ?_$ :(    & @,!
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M=CP4^%J\;V9M*MQV5I-T[3J]];7R&/RD&5?'5>+W-M+'5==CJI)6IZZ*BJ1
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M8G<.6-5MG"U!R>?P-:F2P><R)FHG^]S&%R$:STE3)JFIIE#QLK"_OW7NF?\
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MP-=UY@=J8+ [9W=LK8<.'Q7:N>J.X<QN#;-13IB,?0[T^.%3@*K;N/KI,C_
MMQSU>.CG7(T=4_OW7NCO5?C^UJ?-]QX?MYO+]I]U]UX_&VO[;['_ "[[C3?1
MX?W=5M'JM[]U[JMO:6U>V&VIUTV:S^Y,-N7<?PCP/6VZ-[9G =AOO_HWLN/
MX#!_WSS>XLAO.#;V9K)=S[EK<CD8I\;29Q%Q;5\N5>CA1$]U[HVWQU@W+'UY
M4U.XJ:JQL&5WUV+F-IX6MJ\K7SX79&3WIFJK:]'%59W'XG,#$U&/<5>-IJBE
MI9,?BZFFH_! M.(D]U[JD?>?\[#M':^\-U[:@Z2V#50;=W+G<%#4S;@W$DM1
M%B<I54$<\J(FA9)DIPS < GCW;3U&,_/EW#.\0MXR%<CXF\C3I-_\/F=K_\
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M]DN]*?\ :BVC_P"\Y7^_'AT.T_Y),'^E7_CIZ0GNO2;H8NDO^/JR'_AOU?\
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M0A>_=*>O>_=>ZUXLS\A^](<OE88NV=^1Q19*NCCC3<>1")''52JB*!-8*J@
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M55?'!*Z>M8Y7@"L1R >/?NFIG,4+RC)52?V"O55O_#D.]_\ GVVU?_/KE_\
MHWWKH)_UFG_WTG[3TH]G_P P;>.Y=W;6VY/U[MFF@W!N/"82:IAR>4>6GBRN
M3I:"2>)770TD23EE!X)'/OW3L/,4TLR1&-0&8#B?,TZ-AW;_ ,?5C_\ PWZ3
M_P!V66]Z/1KN']L/]*/\)Z!WWKI#T[]D?]D9_+'_ ,0GW3_[ZK->[KU>Z_Y(
M=[_SSR_]6SUIF>W>H-Z,)\2/^RK/C)_XL)TO_P"_'VW[T>'1ELO_ "6+3_GI
MB_X^O6Y]W%@<;O7;E#M63>F!VAD:'?/56_8:G+PP9$.>LNS]I=DTU%)BVSN
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M@/\ PX=O?^\-M;V\.'43\U?\K!<_Z9?^.+T1CWOH/]7W]M_]N3>FO_#AP?\
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M/Y8_^(3[I_\ ?59KW=>KW7_)#O?^>>7_ *MGK3,]N]0;T83XD?\ 95GQD_\
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MU7;_ ,.5_.+_ +R W#_Z#VQO_L6]VH.@Q_6KF#_E);_>4_Z!Z,#\4?GY\O\
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MEQ=;?^&]V-_[PV<]U;AT*N3/^5@B_P!*_P#QP]%[^;W_ &5_\DO_ !,>^O\
MW>57O8X=%F__ /);NO\ FN_^'HK7O?11UNM?R^O^R+_CM_XCVC_]S\A[;/'J
M>.6_^2%:_P#-(?X3T<;WKH\Z][]U[K6[[S_YG9W#_P")3[!_]ZW+^]=1G?\
M^YTW_-5_^/'H+??NDG5YN _[)=Z4_P"U%M'_ -YRO]^/#H=I_P DF#_2K_QT
M](3W7I-T,727_'U9#_PWZO\ ]V6)]['2[;_[8_Z4_P"$=:<?R)_[*![T_P#$
MQ]G?^]KF_;PX=0AN?_)2N/\ FO)_QX] [[WTAZO._F*_]N_?Y=__ (CWKK_W
MRFUO=1Q/4@\S_P#*M;9_S23_ *M+U1C[MU'W5UO\CS_LH'MK_P 0Y)_[VNU?
M=6X=#SD#_DI3?\T/^?EZJ3[;_P"9K=F_^)"WI_[TF2]['0,O?]S)O^:K?\>/
M0?>]])NM][J/_F5'6/\ XCW9?_O-XWVUUD79?[AQ?\TE_P".CH0O?NE/7O?N
MO=:OV=_XO>9_[6N1_P#<N;WKJ*Y/[1OM/^'IJ]^ZIU?_ -L?\63KW_M55?\
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M=_[T..]^Z46G^Y47_-1?\(ZNW[M_X^K'_P#AOTG_ +LLM[T>AQN']L/]*/\
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M;*;/W9F,/5X2OJNEMSXN>I@I-K8'%SM)09!*>LIBM90R* Z*2!<<$>W 13H
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M0>AERSLFX[;97<-V@6251IHP->UAY'&2./53?^RM_+__ +PZ^3__ **7-?\
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MGE3>[3<X+F>-1#'*K$ZU. <X!ZVL/]F7PO\ SZ+Y(?\ 'G_WR_YD/O\ _P"
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MM?<5$F\-M==]P]X[>VQNJG?<$D4M)_&DJ)*5(*F2BH_N!"/=>Z-5[]U[JMO
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!V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>j17244772_aa015.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 j17244772_aa015.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ 90!E P$1  (1 0,1 ?_$ :(    & @,!
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MI[EV%MW;.0SO9-4.ICA^M^J^OMIR[^ZIHMX;;I=V=C9K#JU1D,5522C(Y?\
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M$##BA_D>/^KY]'7N%RS;7?-%[L-XP3;.;]L$*,?ACW3;^^U9C@ 21$4 [G,
M3@1IT0]T[8S^R=S[CV9NO%U6#W3M'/9?;&Y<)7*JUN'S^ R%1BLQBZQ49T6J
MQ^1I)(9 &(#H;$^S0$$5'#KG->6ESM]W+87J&.\@D:.1#Q5T8JRGYJP(/S'5
MWW_">#M_!]:?/Q]I;ARD&-I^Z^H-X]<X/[MXH::IW?1Y;;&_,-3-4RM&L556
M8_9U=2TR%O\ **FH2%5:62,>TUVI:*H\CUD']U_?+?:?<KZ*Z<(NX6,L"5P#
M*&CF45\B5B=5'FS!0"2.MIC^8"V<Z?WQ\5OG#CL-F=R[3^+&\.P<%W=@\#3U
M5;DZ+H/OK;F)VKOS?]-C**.>KRW^C'.;;PF9J*>.,G["FJ)&:..)W"&*C!HO
M-N'VC_/UF)[F&XV/<-F]PHHY);+9YYDNT0$L+.\18YI@HJ6^G>.*4J!\"L20
M 3UIJ_S(/Y?O9'QQ[.W/VYL+$U'9GQ+[8RE?V1U#W;L6"3<FR$VCO"K?.XO
M;BS6)^\HL+E,3!D%IX9JAXH,I!&M13,;RQ0&,,H==)Q(.(ZP0]U?;/=>5=WF
MWO;4-WR5>N9[:[A&N+PY3K5'=:A&4-0%B!(!J3S"U:^W^H?ZL9^'>5^+>PH,
M?O'OW</QPGEIJV;)18'='2WR,[][1D@AJ(XEP\FR:/>_6'QJ^PKXD=X9<CD:
MVK@(O+"5(C=F36<)7]H _P _4I<BS<G[:JWW,LNU$ABVB2UOKRXH#33X0EM[
M"C<07=V'XE\CLT]"?S#:+LWINGZ[^)_3^\.I-BR8O/U$?=6^-O\ 0_1%/!@=
MKQ0G?FZ=I[)V+CLUUOU[L'9T=3%%6[RRZ5F-PS.*:"FS>;-+BJA$\.EM4A!/
MID_[)^S_  #K+7EOW/CW?8AM?)=C/9;<4<_52I9V8"1@>-)'%"KP00Q5 :ZD
M#)%70J7%QHA;7L^<7S\AW:-U=&_'/-UR]=UKY+ ]D]QPPU&%W!W;CY<G)DZ[
M;&WJ6HEJMP;3Z.J-P2SU[T60K\CN#>>0E;-;HKJ_(SE85<45.]^/IZ?[/\AP
M'6,GN%[E+>B;EWE:1OW6VI)[H H]VNK48T!J\=H7)<J[O-=.3<7DDDK46I#V
MHZA/KWOW7NKC_P"4)M"AV#N?OSYY[KPPS&W?AGU?6Y+8&'J8)WIMY?(GM6*L
MV#T]M"$>$PUDE7D,E.MHV:II:VHH940DJ0GN#4"(<6/\AQZG7V0L8]MN]R]Q
M[V/Q+78;,M"I!I+>W ,-M$/(U9CP[E=HR!PZVN_]D8WA_P -<?[*[_%4_P!/
M?]S_ /2U_>C_ "3S?[--_?O_ &8/^(?Q'S^+[?\ TP_Y#]UY-/\ #?3I\7[/
MM!XH\?7^"M/RX?X.LS?];N^_UG_ZH:_^1)X'U/B8K^\/&^MU:JTI]3V:JT\/
MRT]O1Q/EO\>:?Y,]);@Z\I,N-I[\QF0PV_NG.PHXPU=UIW+L6M7.]=;ZQ\@@
MJ)H3B<Y3K'5B-"]1CJBII[%9F!;C?0U?+S^8Z'7.W+"\V\OR[6C^#N2,LUK-
MYP74)UP3+@D:7%&H,H77@QZTTOYI'1$_=^VJ_P"=6RMCTNS.S]E[CCZ5_F)=
M-XQ M;U7\A\"T>)3M"DQ]-+6QS];]H-&/MLJDIIJE_M9O)45%36O"8P-I/A$
MU4Y4^H_V.L$/>#EQN8;1O<6PMQ;[O;R_2[W:KQM[U.WZ@**U@N/PR Z6[&JS
M/(5I&V3O/<W7.\=J]@;+RU1@=W[)W%AMU[7S=)XS4XK/[?R%/E,3D(5E22&1
MZ6NI4?2ZLCVLP*D@J2 10\#UC[M]_=[7?0[G8.8[ZWE62-QQ5T8,K"N,$ YQ
MZ]?1._EQ_P R+I_^8-U-12P5N!V[WE@\)%#VYTW45):KH*C5)05.X=MTV11)
M-P[%SC*)4DA-2<?]RE)5N)=+2E$T+1-_1\CUU$]J_=78_<W95*M'%S#''2YM
M2<@\"\8;XX7X@C5HU!'.JA(D;0^"FU^G=Z4FX_C=W%W-\>]F2Y\9S<O1&S\Q
MMG=/0V>:HK_XAFH,5U[V7M;><?6SYV0LL[[5J<*JJY,:(X1TT92PHX!/KY_[
M/Y]&MC[=6>Q7ZW7*E]?[98&77)9Q-')9O4ZG"PSQR^!K\S;M%QP :$2NP>AO
MF1NC<#5NROGI6]9;;DQ^#I'P.+^,G3^YLC%5T5!24^<RE)G]V3Y...JSM;%-
M4(DM%/3TGF"+&ZH+^#Q@92I^T]7W/ESGN\N?$L.9&M+32@T+86TC5  =@\A;
M+D%@"I"UH 0.F#&?&?YG4$TDE5_,H[(S:/'H6GR?QH^+D4,3:E;S1MANO<1.
M9+#39W9+$^F]B/:X_P" ?M/^?I-#RESY&Q+\UW<@IP:PV\ ?/M@4_P Z="%\
M@_B#L;Y%_'?M[I/>TU)+N;N;K[ ;7WAVM#@,91;CRVZ=F4E%4;)W?7TM M-"
MU/MW=6.CR4.+B>*BC:2>.(1B>1FTDA1PPX \.C/F?D?;N:>5[[E_<"IN[^V2
M.6X"*':2( Q2D"@HDBB01@A!5@*:B3H1[O\ Y8'R>V=ELE@ZO+_&>ORV'R^1
MPN5QU/\ ,/XN8BOQU=BZF6CJXJ^@W?VSMFOHIHJF%D>":)*F)P5EB1@0#03(
M17N_8?\ -US=OO:'F^QF>W=]I::-V1E&Y[>I4J2#59;F,@U%*$!@<$ ](/+?
MR_ODGA<7DLQ6P]"/1XG'UF3JTQOS$^'N:R+TU!3R54ZT&'P_>]?E\M6M%$1%
M34L$U3.]DBC=V53;Q4^?[#_FZ+9O;3FNWA>>0;;X:*6.G<]L9J 5-%6\+,:<
M%4%B< $XZ+AU+U3OWO+LK97476&WZO=._NP,_1;<VSA*, /55]:YU3U,[V@H
M,7CJ9)*FLJYBE/1TD,D\K)%&["[,%!9N Z"NR[-N7,.[6^R;1$TVY7,H2-!Y
MD^9/ *HJS,:!5!9B ">MS'X0?$/:&1[$ZK^..PZB/<GQG_EZ[TG[ [O[#I$\
M.#^2_P#,.KL=0'Q4U.Y<UVUOCK0/&8&)5Z>M2DI91.(S,Q=+(:%S\;C'R7_9
MZSP]ON2+&7=+/E;;2)>4N6+@S7<XPE_O148 \X[$4IYJP1#JIJ.QA[1]92]>
M]^Z]U6A\POC#N^#?%3\LOCOM# [V[$DV74]=?(_X^9M::FVK\Q.B)*:2FK=B
MY>2I63&4?:&V<9--_=K*U,,JR!ACZHO1LL2O1N*>&^%K@^A_S>O43<\\HWR[
M@>=.5X([C=#;F"^LGH(]SLZ4,+5[1<1J3X$C U_LGK&0.M/CYH_R^\#B-GYC
MY=_"N3/]@?%*HR]=2[\V1E:'(0]P?$K>-,U,V>ZR[EVS7:\W14.WJVK\,&2D
M\OBA"BJED1J>OKS".4U\.3$G\C\QU@WS[[9VT%C)SOR"9;GDPN1-$P87.VRB
MFN"ZC/> A- YK04UD@K))59MK<^Y=EY[%;JV=N'.;3W1@JN/(83<FVLM7X+/
M8:OBN(JW%9C%U%+D,?5QACIDAD1Q?@^WR 10\.H<M+R[L+E+RQEDAO(VU))&
MQ1U/JK*0RGY@@]6L[5_GH_S--J8*@P$??U)N"#'0I3TV1W5UIUIG<Z]/&B)&
ME?FJG:BY#+3+IN9ZMYZF1F)>1N+,&UA)K3^9ZF6S^\3[M65NML-S654% TD$
M#O3YN8]3'YL2Q\R>E%_P_E_,U_Y_)M+_ -$_UA_]C'OWTL/I_,]*O^"2]V_^
M4^#_ +)K?_K7T]8S_A01_,GH(9(ZK?\ UOFW>36M1D^IMIQ31+I5?#&N&@Q$
M!CN-5W1GN3ZK6 T;2'T/[>E$/WF?=:)2'N;20UXM;1@CY=H4?RKTY_\ 00M_
M,=_YZ7J7_P!%7B__ *N]Z^DA^?[>G?\ @G?=3_?ME_V3K_GZ]_T$+?S'?^>E
MZE_]%7B__J[W[Z2'Y_MZ]_P3ONI_OVR_[)U_S]+_ *O_ )VG\V;OW>^$ZEZD
MH-A;_P!^;RG;%X7;6W>G</75M29D*U%54&JK#C,?BL? 6FJZRM:.@I*='EJ7
M2%'8::V@0:FJ /GT9[1]X#WIYEW"/9=D6VN=RG.E(TM5)->)-3I55&69Z(J@
MLY"@GHZGPB^$NXNC:_<GQR^,F<P.Z?EUN:EBV]\P?F?BZ&;)]<_"[9%9%2-N
M+HGI/<7VM52[F^1.7IYI!.\1@-',L;5(IOMPU,W+(&[W_L_(>;?,_+H?>WWM
M_=<NR2\K<I21S<[S#1N>Z*"T&UQ&FNSM'H1)>L":D4TFA?1IJNSMTATCUI\=
M>L=K]0]2;;I]K[(VG2-3T%%&\E36UU942M4Y3.YW)SEZW-;BSE?+)4UU;4,\
M]342,['FP1,S.VIN/67/+W+^T\K[1#L>R1"';X5H!Q))RSNQR[NU6=VJ68DG
MH6/=>CKKWOW7NO>_=>Z(+\@/A(-V]A5'R.^->_)_CQ\HQ14])F-U8^B;*]9=
MUXF@@:"FV;\A.N5E@QV^<)/3::=,G'XLWCD2)X)V^W@C5U):#0XJG\Q]AZC;
MF;V_^MW,\U<J7)VOG#2 TBC5;W:@4$5[!A9D([1(*2H "K'2H&O)\KO@'\<>
MPL_4M\BM@U7\K?Y#96?[*F["V_0C??\ +V[HW'422R1Y#!;QH(,=!U)E<R0)
M)*'*38+[&)^:>OJ [,KCE<#L.M/^-#_/UC!SG[:\J[G<D\TVS<G\SN:"9!XV
MRW3G\22@*+9FXE)##H!^&1JDU4=T_P H#YW]/4B[BQ?4;][]>U<+5>%[*^..
M2C[@VQG<<K26R=!CMNQ'>T..,*"3SU.)IX=!X8Z7TOK<1-BM#\\=0WO_ +'>
MXVQ)]5#9?O';&%5GL6^IC=?X@J?JA:9JT8%//!I7!G]N;AVIDY\+NC YG;>9
MIK?<XG/XNNP^3I[EE'GH,C!3545V0CU(.0?;P(.1PZBJYM;JRF-O>1R13CBK
MJ58?:& (_9TR^]],=#7U1\;?D%WK5T]'TUTGVEV<]3,84J-E;&W'G\;"RR^&
M22MR^/Q\V*QU/!*+22U$T441'K8>ZLZ+\1 Z/]EY4YFYB<1[#M]Y=DFE8H7=
M1Y995*J!YEB /,]6?[(_D[9KKF+ ;J_F ]^=<?$?;>8>FFQ?6%%DJ3M;Y);X
MCF9_!C-F=8['FS35%=DV588VA?)55-,]I:%G4QE@W .(@6/KP'[>I>V_V,N-
MK6.\]R]RM=DM'H5MPPN+Z6O!8K>(M4MP%"[*3F.HIU?)\5/A!OBNVL_7OQRZ
MHWI_+W^+>X:5*?L/N+>]1CYOYB'R3Q2V0T'W34]5'\<MLY!D+O&\<61IV59*
M2@I142@)9)16KD._I^$?Y^LCN3?;[<9+/]V<K65QRQR?**3W4I4[W?+Z5H?H
M8VXD$!UXI&FINKR^H.F^L>A-@8+J_J'9V(V-L?;L+ICL+B8Y3Y:B=O)79;+9
M"KEJ<IGL_EJ@F:MR-;-45U;4,TL\LDC%BF9F<ZF-3UD/L>Q;1RWMD>S[' EO
MMT0[47U/%F8U9W8Y=W+.YJ6))KT)GNO1MU[W[KW7O?NO=>]^Z]U[W[KW2=W=
M_=/^Z^X/[^?W=_N7_"*[^]/][OX;_=?^!?;O_$_[P?QG_<3_  C[75Y_N?V?
M'?7Q?WL5KCCTEO?HOHY?WEX7T&@^)XFGP]%.[7J[=-..K%./5!V[/^&T_P"\
MVX/]DC_V;K_2=_$6_CW_  UE_I7_ +K?<:ZC3_$?'_SA]]I]UJU?<_M:M'E]
M&CVJ'C4_5TZ?Z5/^+ZQMO?\ 6G^KE_UOOWW^]]??_5[ZGPZY^+_EF4K_ !8X
M:L4Z>I-N?/JLP=-)E.Y/D5MW80AK6IJ3YH_&K^6CO-'H?M<L:^/+9#;?RPV%
MNJ.$PF,5#UE,\PC4$(8&*KZL7D!J_HEO\W2@VON3);@S7^Z1;;0T&ZV&Q2XH
MU=31[C#)PI4LM:>6DX0.!VM\K):QEP/>OQ-HLM]ODCCI^N_B?\'<INP5@IZC
M[A<12Y#YGXC'FH:/R^1IIA&JZO("NKWZJ>C?M;_-T6VUGSF7I;;CLJS4;28-
MNVEI*T-=(;=%6O&M33C7%>E/N_'_ "7H)Z-/D_N_^<'NS9Y<"6H^,77/Q#Z^
MV*N%UN4;(4?Q+[2[-[D? "BLI6EG&0*>HG1=??AH_!X=?G7_ "@#I7?1<V1L
MHYOGYYFL?6P@VV&'1_2&VW%Q=:*?PG73Y8Z.7\&_^&P?X]E/]E/_ -''^F;0
M?[V_WZ_O+_LT>O[:'[S^]/\ IN_XS=]OHT^75_D-[:/3I]MR^-3]2NG^7\L=
M#SV\_P!:+ZE_ZE_2_O[_ $3QO$_>' 5\3ZO_ !NGK^#TQ3JT7VQU+_7O?NO=
+>]^Z]U[W[KW7_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>j17244772_aa016.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 j17244772_aa016.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ 8P!E P$1  (1 0,1 ?_$ :(    & @,!
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M6NJ*RISE1U%\7-B5/:.5QFWX<K.*6NDKM[]C;[6M>IK8[-%2O048:GQQGEO
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M>AFCEECEQ6_^SZB7%OO61Z99:NDH>O=N1UN8>J$4D4$]+");(]_;L*AGJWP
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MFLI8F,RX"FT^4GRE^'G\J**+;OQKZVZ.WU_,;;KO"]==B=@[,V1B\-USUE+
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
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>j17244772_aa017.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 j17244772_aa017.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ 90!E P$1  (1 0,1 ?_$ :(    & @,!
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M8BVD1SH-0'ZG8VHK').WC24??+CH;96S]F;QH?B9\*_DQENJ=N4S93?WS?\
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MJ@,M([-K)[NI5V;DKE?8.7GY4VNT1.7Y!('A9I)0PEKX@9I7=VU5(-6-!@4
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3:;K(?KWOW7NO>_=>Z][]U[K_V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
